MikeLigalig.com

Verinovum's focus on member experience reflected in HEDIS measures and CAHPS results drives interest in new Medicare Advantage data gap assessment

TULSA, OKLA. (PRWEB) DECEMBER 03, 2020
Following the release of the 2021 Medicare Advantage (MA) Star Ratings, health plans are seeking better ways to improve clinical data quality to meet digital quality measures. Star Ratings thresholds and requirements become more stringent year after year, creating challenges for health plans to keep up.
The MA Star Ratings system helps Medicare beneficiaries, their families, and their caregivers compare the quality of Medicare health and drug plans. Medicare health and drug plans are rated on a one-to-five scale, with one star representing poor performance and five stars representing excellent performance.
Verinovum, a health data curation and enrichment technology company, has taken notice and is offering solutions. "A health plan with a Star Rating of 4 in 2020 may have slipped to a 3.5 in 2021, even if their member satisfaction and quality scores remained the same," said Verinovum Chief Strategy Officer, Mike Noshay. "It's going to come down to having the best quality clinical data so each organization can achieve their best quality and financial outcomes."
In response to the increased demand for better quality clinical data, Verinovum has launched a risk-free data assessment to help payers analyze the quality and completeness of patient clinical data. The assessments will help MA plans learn where their clinical data can be improved to positively impact Star Ratings and improve member experience.
Utilizing Verinovum's Data Curation as a Service (DCaaS) solution, the Tailored Medicare Advantage Data Gap Assessment will analyze six-to-nine months of a plan's clinical data for the plan's most prioritized measures. The in-depth analysis can take 60-90 days. Once complete, Verinovum will present a report that outlines the data quality and where improvements can be made that have a tangible impact on the plan's most pressing use cases.
The assessment will show payers ways to materially impact data quality and improve processes for:

Transferring data from commercial products to retain members

Enabling ease of clinical data exchange with providers

Building more robust data across fragmented encounters

"We want to help payers really get the most from their clinical data," said Verinovum CEO Mark McCurry. "Something as simple as using different date and time formats from one system to another can cause data integrity problems that negatively impact reporting, downstream application use, and ultimately member satisfaction and Star Ratings. We know how to identify those problems and curate and enrich clinical data. When payers see their Data Gap Assessment reports, they'll be able to see exactly where they can make changes that will impact their bottom line."
Click here to learn more about the Tailored Medicare Advantage Data Gap Assessment.
About Verinovum
Verinovum is a market leader in clinical data curation and enrichment, enabling payers, providers, and partner organizations to improve operating performance and quality with actionable data. By delivering clean, complete, and accurate data, Verinovum supports healthcare organizations in their efforts to access the right information, in the right format, at the right time, so it may be tailored and curated to fulfill specific use cases and achieve mission-critical clinical and business goals. Discover more at Verinovum.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Fitness, training and physical therapy trainer used by professional athletes and elite training facilities is now available for home fitness

SAN DIEGO (PRWEB) DECEMBER 03, 2020
Reactive Training, a company known for manufacturing fitness and therapy used by gyms and professional leagues worldwide, answers the call to home gym fitness monotony with the consumer launch of the Core-Tex Reactive Trainer. Core-Tex is known for their products that are used by elite athletes and pro sports teams globally, alongside gyms, hospitals and training facilities. In response to customer feedback, particularly from the home fitness architects, Core-Tex is now offering the Core-Tex Reactive Trainer to consumers, enabling them to train in 3D, just like the pros. The new sleek all-black version of the Core Tex Reactive Trainer is portable, versatile and will complement any home gym set up.
Functionality, price point, footprint and total engagement make Core-Tex the all-in-one dynamic training, strength and metabolic conditioning tool to meet today's environment. "It's like Christmas for your hips," said Core-Tex inventor and internationally recognized biomechanics expert Anthony Carey. "The mobility aspect of Core-Tex is its secret weapon that so many of us are in need of to gain strength, flexibility and function pain-free. Our hips are a foundation to our bodies and the Reactive Trainer trains hip, spine and lower back mobility to help prevent injury, improve sports performance and most important, help people move better, feel better and perform better."
Brian Ngyuen ATC, CSCS, NASM Master Instructor and trainer to Mark Wahlberg and multiple NFL players attests to the immediate and profound improvements in flexibility created with specific applications on the Core-Tex Reactive Trainer. "Core-Tex hits the muscles and joints with angles and movements like nothing else can," Ngyuen comments. "You'll find those 'mini' muscles and motions that not only set the foundation for big gains in strength, power and definition, but also help you move better."
The unique patented design of the 30" Core-Tex platform allows the dish to move along 3 ball transfers, creating a simultaneous tilt, slide and unrestricted rotation environment of reactive variability that continually challenges the muscles in new ways while naturally avoiding injury-producing repetitive movements. Offering over 100 exercise options and video education the Core-Tex delivers an extremely smooth and responsive experience that spans strength, stability, balance and therapy. By gifting you core, balance, strength, metabolic conditioning and mobility, the Core-Tex has your home workout covered and is truly Christmas for your hips.
To learn more and watch a demo video visit: https://coretexfitness.com/collections/core-tex-rt/products/core-tex-reactive-trainer-black
About Reactive Training
Reactive Training, LLC, is the privately held manufacturer of Core-Tex. The San Diego-based company's innovative Core-Tex is used in physical therapy clinics, athletic training facilities, hospitals, universities, professional sports teams, private studios, and health clubs worldwide.
https://coretexfitness.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The America's Pharmacy "Rx Discount" App has been recognized as a top 5 Trending medical app on the Google Play Store. The free America's Pharmacy App displays the lowest prices on tens-of-thousands of prescriptions at your local pharmacy. People using it can save up to 80% off their prescriptions on drugs like Symbicort, Adderall, Eliquis, Tretinoin, Tadalafil, Phentermine, Augmentin, and thousands more.

NORWALK, CONN. (PRWEB) DECEMBER 03, 2020
The America's Pharmacy "Rx Discount" App has been recognized as a top 5 Trending medical app on the Google Play Store.
The free America's Pharmacy App displays the lowest prices on tens-of-thousands off prescriptions at your local pharmacy. People using it can save up to 80% of their prescriptions on drugs like Symbicort, Adderall, Eliquis, Tretinoin, Tadalafil, Phentermine, Augmentin, and thousands more.
"We're really excited that people are recognizing the value of the America's Pharmacy app," said Jon Jensen, General Manager. "It's great to see so people saving so much money. With more apps requiring people to pay, or register, but it's good that people see the value you in a free app like America's Pharmacy that delivers savings month over month."
America's Pharmacy "Rx Discount" app works at CVS, Walgreens, Walmart, Kroger, Albertsons, Rite Aid, Target, Costco, Stop and Shop, and thousands more pharmacies all over the United States. Small independent pharmacies too. People can just show the coupons on their phones and get instant savings.
To download the free app go to Google Play Store or the Apple Store or visit https://www.americaspharmacy.com/download
Our Lowest Prices on Prescription Medications
Our program is honored at more than 62,000 pharmacies nationwide, including CVS, Walgreens, Walmart, Rite Aid, Target, and Kroger stores (just to name a few). The free America's Pharmacy app is available for iOS and Android.
ABOUT AMERICA'S PHARMACY
America's Pharmacy https://www.AmericasPharmacy.com is a free prescription discount program created to help United States residents save money at more than 62,000 pharmacies nationwide. Consumers can save up to 80% instantly, with no limitations, registrations, and no member fees.
PRESS INQUIRIES
Contact: info@americaspharmacy.com
Media Contact: Lauren Eisenhauer
Email: AmericasPharmacyPR@gmail.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The new emergency center provides residents and businesses in Atascocita, Humble, TX the same top-quality emergency medical care which SignatureCare is known for

HOUSTON (PRWEB) DECEMBER 03, 2020
SignatureCare Emergency Center has opened a new 24-hour emergency room (ER) in Atascocita, Humble, TX.
The company's newest 24-hour emergency center is located in the old First Choice Emergency Center building at 5324 Atascocita Road, Suite T, Humble, TX 77346 (Google Map), and can be reached by telephone at 281-213-5063. It provides Atascocita residents and businesses with the same top-quality emergency medical care which SignatureCare is known for.
The emergency room serves residents and businesses in Atascocita and nearby cities including Humble, Porter, Huffman, Hamaston, Eastgate, Westfield, Aldine, Mount Houston, Dyersdale, Crosby, Sheldon, Barret, Timberline Acres, Porter Heights, Rayford, Spring, Lake Houston, New Caney, Nassau Bay, Clover Leaf, Channelview, Jacinto City, Moonshine Hill, Bordersville, Riverside Crest, Kingwood, North Shore, Pittsville, Victor, Parkwood Estates, Dogwood Acres, TX, and more.
"We are very excited to open a new emergency room location in Atascocita. It's long overdue. We know residents and businesses around Atascocita and Humble want an emergency center that responds to their emergency medical needs 24/7," said Dr. Aaron Braun, a board-certified emergency room physician and managing partner at SignatureCare Emergency Center.
"At SignatureCare Emergency Center, we believe in serving and partnering with the local community to provide top quality care, which is what led us to the Atascocita area," he added.
Dr. Braun said residents can be assured that a friendly face and welcoming smile will be waiting for them when they visit the new Atascocita emergency center.
"I want to assure Atascocita residents that from the moment they walk into our emergency center, they will feel welcomed. Also, they can be confident that they will only be seen by board-certified emergency medicine physicians and licensed ER nurses 24 hours a day. All our physicians have the required experience to diagnose and treat most minor and major medical emergencies," he said.
SignatureCare ERs offer patients faster and more personal service than typical large hospital emergency rooms, and wait times are usually 10 minutes or less.
More information about the new ER is available here.
About SignatureCare Emergency Center
Houston, TX based SignatureCare Emergency Center owns 24-hour emergency centers throughout Texas including nine locations in the Houston area (Montrose, Houston Heights, Cypress/FM 1960, Copperfield, Memorial City, Westchase, Bellaire, Mission Bend/Sugar Land and Stafford), Atascocita/Humble, Killeen, Austin, College Station/Bryan, Paris, Midland, Odessa, Texarkana and Lewisville, TX.
Additional information is on our website at https://ercare24.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The National Asthma Education and Prevention Program Coordinating Committee, coordinated by the National Heart, Lung, and Blood Institute of the National Institutes of Health, has updated its asthma guidelines.

MILWAUKEE (PRWEB) DECEMBER 03, 2020
For the first time since 2007, the National Asthma Education and Prevention Program (NAEPP) Coordinating Committee, coordinated by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), has updated its asthma guidelines.
The full document, 2020 Focused Updates to the Asthma Management Guidelines: A Report from the NAEPP Coordinating Committee Expert Panel Working Group, was published in the December issue of The Journal of Allergy and Clinical Immunology (JACI), an official journal of the American Academy of Allergy, Asthma & Immunology (AAAAI).
"The publication of the 2020 Focused Updates to the Asthma Management Guidelines represents a significant advance in asthma care. Inclusion of implementation guidance and shared decision making will enable providers to assure optimal care for their patients with asthma. I would like to thank Dr. Giselle Mosnaim for her work as the AAAAI representative to the NAEPP Coordinating Committee. In addition, a special thanks to AAAAI members Drs. Robert Lemanske, Michael Schatz, Alan Baptist, Kathryn Blake, and Edward Brooks who served on the NAEPP Coordinating Committee Expert Panel Working Group," said AAAAI President Mary Beth Fasano, MD, MSPH, FAAAAI.
The newly published asthma guidelines contain updated recommendations that cover the following six different topics:
Fractional Exhaled Nitric Oxide (FeNO) Test
The document lists four recommendations when it comes to FeNO testing. A FeNO test is a way to determine how much lung inflammation is present and how well inhaled steroids are suppressing this inflammation.
FeNO testing is not recommended for children aged 0-4 who experience recurrent wheezing to predict the future development of asthma.
For anyone 5 years and older, FeNO testing recommendations are somewhat different. It is not recommended to use FeNO as the only measurement for asthma control. It is recommended for individuals with asthma symptoms if a diagnosis is uncertain using other testing methods such as spirometry and clinical history. Additionally, for those with persistent allergic asthma, if there is uncertainty in choosing, monitoring, or adjusting asthma treatment therapies based on other methods, the Expert Panel conditionally recommends adding FeNO measurement to help monitor and manage asthma.
Allergen Mitigation
Another four recommendations were made regarding allergen mitigation as it relates to asthma. Allergen mitigation interventions are not recommended for individuals with asthma who lack sensitization to specific indoor allergens or who don't have any indoor allergen symptoms. For those who do have confirmed allergies to indoor allergens, multicomponent allergen-specific interventions are recommended.
The Expert Panel recommends the use of pest management alone or as part of a multicomponent allergen-specific mitigation intervention for individuals with asthma who are exposed and have symptoms related to exposure to pests such as cockroaches and rodents. For those with allergies to dust mites, the new recommendations do not support impermeable pillow/mattress covers alone but only as part of a multicomponent allergen-specific intervention.
Inhaled Corticosteroids (ICS)
ICS are medications used to treat asthma and were the subject of five recommendations. Low-dose ICS is recommended for individuals 12 and older with mild persistent asthma, either daily or as needed along with short-acting beta-agonists (SABA). For those 4 years and older with mild to moderate persistent asthma who adhere to daily ICS treatment, it is recommended that healthcare workers do not increase ICS doses in the short-term due to increased symptoms.
For moderate to severe persistent asthma, it is recommended to use ICS-formoterol in a single inhaler for daily asthma control and as reliever therapy. That recommendation varies slightly depending on the age group. In patients 4 to 11 years, the single inhaler is recommended compared to using a higher-dose ICS for daily controller therapy and SABA for quick-relief. It is also recommended over same-dose ICS-long-acting beta agonists (LABA) as a daily therapy with SABA for quick relief. For those 12 and older, the single inhaler is recommended compared to a higher-dose ICS-LABA for daily therapy and SABA for quick relief.
For children aged 0-4 who have recurrent wheezing due to respiratory tract infections but no wheezing between infections, a short course of daily ICS and as-needed SABA for quick-relief is recommended compared to SABA as-needed only.
Long-acting Muscarinic Antagonist (LAMA)
The document lists three recommendations when it comes to LAMA, which is a class of medications used for COPD that sometimes may be used for asthma.
It is not recommended to add LAMA to ICS therapy, compared to adding LABA to ICS therapy in children 12 and over with persistent, uncontrolled asthma. In the same population, LAMA is recommended to be added to ICS controller therapy if LABA is not used, compared to continuing the same dose of ICS alone. Adding LAMA to ICS-LABA is recommended in this population compared to continuing the same dose of ICS-LABA for uncontrolled asthma.
Immunotherapy
Two recommendations were released regarding immunotherapy and allergic asthma. The first recommends the use of subcutaneous immunotherapy (SCIT) for individuals 5 years and up as an additional treatment to standard medications in individuals whose asthma is controlled at the initiation, build-up and maintenance phases of immunotherapy.
For those with persistent allergic asthma, the use of sublingual immunotherapy (SLIT) in asthma treatment is not recommended.
Bronchial Thermoplasty (BT)
One recommendation was released regarding BT, a non-drug outpatient procedure developed to treat severe, persistent asthma. This treatment is not recommended for individuals 18 and older with persistent asthma. For those over 18 who are less concerned about potential harms and more concerned with potential benefits, they may consider BT.
Dr. Robert Lemanske, who as previously mentioned is a member of the Expert Panel Working Group that authored the guidelines, provided some context on how they were updated. "The updates were developed using some new approaches compared to those used previously. First, it was not a complete revision but rather a focus on six topic areas that were decided upon initially by a needs assessment committee. Second, it used a new technique of evaluating clinical data called GRADE (Grading of Recommendations Assessment, Development, and Evaluation). Third, was the inclusion of an Implementation Guidance (IG) section for each recommendation. The IG section provides further clarification of the population to which the recommendation applies, exceptions, and practical aspects of how to use the recommendation in patient care. At the end of each IG section is a list of issues suggested by the Expert Panel to communicate to patients as part of shared decision making about whether to use the therapy or intervention presented in the recommendation."
"From the beginning, the 2020 Focused Updates to the Asthma Management Guidelines was designed to help primary care providers, specialists, and patients work together to make decisions about asthma care," said James P. Kiley, PhD, director of the Division of Lung Diseases at the NHLBI, a part of the NIH. "Our goal was to provide clear summaries about each of the new recommendations, information to share with patients, and updated treatment diagrams."
You can learn more about asthma on the AAAAI website, aaaai.org.
The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI's Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Genesis Research announced today that it has merged with SIRIUS Market Access

HOBOKEN, N.J. AND NEWCASTLE, UNITED KINGDOM (PRWEB) DECEMBER 03, 2020
Genesis Research LLC (GR), a Value Demonstration Company providing Real World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services to the health and life sciences industries, announced today that it has merged with SIRIUS Market Access Ltd ("SIRIUS").
Headquartered in Hoboken, NJ USA, GR provides end-to-end strategy, evidence generation, and communication services powered by its deep expertise in Real World Evidence (RWE). GR client solutions incorporate data strategy, comprehensive RWE partnerships, data science and analytics, economic modeling, biostatistics, digital platforms, and scientific communications. Headquartered in Newcastle, United Kingdom, SIRIUS provides innovative expertise in Market Access Strategy, Health Technology Assessments, and Value Communications to life science companies in Europe and worldwide.
"As one of the fastest-growing Market Access companies in our industry – with an amazing corporate culture, a sterling reputation for quality and a client-first mentality – we could not imagine a better European partner," said Frank A. Corvino, Chief Executive Officer and Co-Founder of Genesis Research. "As one Company, with our expanded capabilities and geographic reach, GR will be uniquely positioned to provide comprehensive value demonstration to our clients across the product life cycle."
"We are extremely proud to be forming one company with Genesis Research. Over the past few years, we have built a strong partnership, and in the process learned how we share the same values in bringing the highest quality, integrity and an industry leading level of expertise to our clients," said Stephen Ralston, Founding Partner at SIRIUS. "Genesis is an industry leader in providing RWE solutions; they are a perfect partner for SIRIUS, and as one company, we are excited to better serve our global clients," added Mr. Ralston, the newly appointed Chief Commercial Officer of Genesis Research.
Genesis Research is a well-respected, trusted functional service provider that has been serving life sciences companies across multiple therapeutic areas including Oncology, Central Nervous System (CNS), Immunology, and Inflammation. GR's quality research and novel client engagement model allow life sciences companies to better understand and articulate their products' value. GR's work facilitates increased access to treatment, optimal clinical management strategies, and improvements in quality-of-life for patients, and decreased burden on healthcare systems.
Steve Arikian, Chairman and Co-Founder of Genesis Research, added, "Years ago, we were fortunate to begin a partnership with SIRIUS that arose from our shared values and their impressive reputation. Now, formally as one team, we will lead the market by meeting our clients' growing requirements for unified value demonstration services."
About Genesis Research:
Genesis Research is a Value Demonstration Company that serves as a Functional Service Provider to the Life Sciences industry, delivering Real World Evidence services to satisfy regulatory, payer, and commercial requirements throughout the product lifecycle. As a leader in evidence development and communication, Genesis Research also supports clients with unique services such as rapid response analytics, outcomes simulation, and payer data collaboration. For more information about Genesis Research, please visit http://www.genesisrg.com.
About SIRIUS Market Access:
SIRIUS, headquartered in Newcastle, UK, provides leading market access services to the pharmaceutical, biotechnology and device industry, both in the UK and worldwide. The SIRIUS team brings a new level of expertise in market access, HTA, and value communications. SIRIUS recognizes that success in market access requires a thorough understanding of the payer environment, developing innovative strategies and compelling evidence that can be packaged together and clearly communicated to all stakeholders. For more information about SIRIUS, please visit https://siriusmarketaccess.com.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Orchid Medical promotes Danielle Hague to Vice President of Business Development with expanded leadership responsibility in the Southeast.

ORLANDO, FLA. (PRWEB) DECEMBER 03, 2020
Orchid Medical, one of the fastest-growing providers of ancillary medical management services in the workers' compensation industry, today announced the promotion of Danielle Hague to vice president of business development.
"Danielle has extensive knowledge of our industry, services and clients with an ability to transform that knowledge into actionable results." said Tim Howlin, chief sales officer of Orchid Medical. "She is extremely deserving of this recognition and we're excited to see her role expanded to include driving new business growth throughout the southeast."
Hague joined Orchid Medical in 2014 as a member of the ancillary services operations team where she gained valuable knowledge of the company's service delivery model. Consistently recognized for her dedication and customer service excellence, Hague was promoted to manager of client services in 2015.
"Over the past six years, Danielle has shown great care and dedication to her clients cultivating strong relationships with them," said Jason Bliss, executive vice president of business development for Orchid Medical. "I have been continually impressed by her enthusiasm, drive and deep understanding of our clients' needs. This promotion reflects the value Danielle brings to Orchid and her continued commitment to providing outstanding service to Orchid's current and future clients."
As vice president of business development, Hague will lead efforts to grow the company's footprint in the southeast as well as build and maintain existing client relationships. Hague holds a Bachelor of Science in Marketing from the University of Central Florida.
For more information or for a headshot of Hague, please email marketing@orchidmedical.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Vaccine freezer bulk storage solution ideal for the multiple storage temperature requirements of different vaccine manufacturers. Reliably store vaccines at consistent low temperatures, saving floor space, operating and maintenance costs with full redundancy to protect valuable product.

CINCINNATI (PRWEB) DECEMBER 03, 2020
As the need for vaccines and pharmaceuticals rise worldwide, CSZ BioStore ultra-cold freezer rooms offer an ideal solution for customers with bulk cold storage needs. These freezer rooms address cold storage concerns of reliably storing vaccines at consistent low temperatures, saving floor space, operating and maintenance costs with full redundancy to protect valuable product.
The BioStore freezer rooms contain individual freezer compartments with temperatures from -75°C up to -40°C (-103°F to -40°F). These freezer rooms are comprised of an entry room of 2-8°C and -20°C storage room with multiple freezer compartments (10, 20 or more). This is ideal for large capacity storage to replace multiple upright freezers and cold chambers with a single room.
The many benefits of the freezer rooms include:

Fully redundant (single or dual) backup cooling systems that guarantee continuous operation to protect valuable samples and materials.

Reduces the amount of floor space required for equivalent individual freezers.

Utilizes less power per cubic foot.

Saves operating costs by dissipating less condenser heat into the room, saving on operating costs of the building's cooling system.

Minimizes frost accumulation.

Reduces maintenance and repair costs by only maintaining one system instead of multiple, individual freezers.

See of our Vaccine Storage Solutions



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Collaborative effort to drive awareness of rare kidney disease that leads to end-stage renal disease

WASHINGTON (PRWEB) DECEMBER 03, 2020
Today, Responsum Health (Responsum), an innovative developer of personalized patient apps and chronic disease knowledge communities, announces a new partnership with the IgA Nephropathy Foundation, a patient-focused non-profit organization for Immunoglobulin A nephropathy (IgAN) dedicated to both the funding of research for IgAN and patient advocacy.
Through this joint effort between Responsum Health and the IgAN Foundation, the goal is to continually improve available education and support for those who are impacted by IgAN. Through the Responsum for CKD app, professionally vetted information on IgAN will be distributed to the chronic kidney disease community, as well as syndicated to those with an IgAN Foundation membership.
IgAN is a form of chronic kidney disease in which an antibody blood protein, Immunoglobulin A, accumulates in the kidneys and causes damage. It is considered a rare disease by the National Organization of Rare Disorders, which means it affects less than 200,000 people in the U.S.—though it often goes undiagnosed.
In raising awareness and education on IgAN and empowering patients through community, knowledge, and resources, Responsum Health supports the IgAN Foundation's mission to encourage additional research on IgAN. As many as half of those with IgAN will develop end-stage kidney disease, which limits treatment options to dialysis and/or transplant. For this reason, increased support for IgAN research is necessary to better understand the disease, lead to improved diagnosis, and an eventual cure.
"Partnering on this initiative with the IgAN Foundation represents an important step towards the fulfillment of our vision to leverage Responsum's uniquely impactful digital platforms—in collaboration with the leading subject matter experts in chronic disease—to expand and improve patients' access to trustworthy information," stated Founder and CEO of Responsum Health Andrew Rosenberg. "We are excited and honored to be working with such a highly respected organization."
"We are excited to partner with Responsum Health. This opportunity will bring valuable information to the patients we serve much faster than we possibly could," said Founder and Executive Director of the IgAN Foundation Bonnie Schneider. "There is so much happening in our IgAN space that time is of the essence to educate our patients. This will allow them to make empowered decisions about their disease journey."
About Responsum Health
Responsum Health's mission is to build and support online knowledge communities for chronic disease patients. The company offers a free, revolutionary patient engagement platform that monitors, searches, and curates the internet to generate a personalized Newsfeed of article summaries, which are vetted by Responsum's patient group partners. Each comprehensive platform enables patients to comment on and rate articles, as well as share them with their professional care team and loved ones. Responsum also helps patients to better organize their health information, find local patient support groups and services, and support one another through a moderated, disease-specific social wall.
About IgA Nephropathy Foundation
The IgA Nephropathy Foundation's mission is to be a patient-centric organization focused on finding a cure for Immunoglobulin A nephropathy (IgAN). Using the power of the patient community, the IgAN Foundation is focused on funding research, using patient advocacy to empower IgAN patients, and building a network of support.

"We are excited to partner with Responsum Health. This opportunity will bring valuable information to the patients we serve much faster than we possibly could," said Founder and Executive Director of the IgAN Foundation Bonnie Schneider.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The National Foundation for Cancer Research is accepting applications through February 28, 2021, from academic laboratories and very early stage start-up companies for its third Salisbury Award Competition for Entrepreneurial Translational Cancer Research. Finalists for the event will make pitch presentations in the spring to a world-class judging committee consisting of prominent cancer research scientists, clinicians, early-stage investors and business leaders.

ROCKVILLE, MD. (PRWEB) DECEMBER 03, 2020
The National Foundation for Cancer Research (NFCR) is accepting applications through February 28, 2021, from academic laboratories and very early stage start-up companies for its third Salisbury Award Competition for Entrepreneurial Translational Cancer Research. The Salisbury Award Competition encourages, promotes and supports innovative scientists translating their discoveries into technologies that can improve the lives of cancer patients.
The program was established in 2019 and is named after the founding Salisbury family, whose shared vision and legacy has defined NFCR's mission and continues to guide the organization's commitment to funding "high-risk, high-impact and high-reward" cancer research. The Salisbury Award Competition is designed to identify and promote the development of highly promising therapeutic, diagnostic and preventive technologies made in the lab to be commercialized, with the ultimate goal of benefiting cancer patients.
Applications will be reviewed by a selection committee comprised of world-class cancer research, oncology and biomedical industry professionals. Finalists for the event will make pitch presentations in spring 2021 to a judging committee consisting of prominent cancer research scientists, clinicians, early-stage investors and business leaders. Top projects will be selected and announced based on their assessed feasibility, novelty and cancer patient impact.
Competitors will benefit from increased visibility and insightful feedback from the key opinion leaders comprising the judging committee. First, second and third place finishers will receive prize checks of $5,000, $3,000 and $2,000, respectively. They will also have access to NFCR's extensive translational cancer research network in the U.S. and around the world.
Additionally, the top-ranked technologies will be introduced to the AIM-HI Accelerator Fund, which was spun out of NFCR in 2019 and is focused on catalyzing company formation with seed investment for early stage oncology companies.
"The Salisbury Award Competition is a unique platform, energizing and elevating translational-stage research projects that are still well under development—and, therefore, risky—yet that hold promise as potentially groundbreaking technologies for cancer patients and their families," said National Foundation for Cancer Research President and CEO Sujuan Ba, Ph.D. "Supporting such initiatives has long differentiated NFCR within the cancer research field."
Learn more about the spring 2021 Salisbury Award Competition and apply before February 28 at https://www.nfcr.org/salisbury-award.
About the National Foundation for Cancer Research:
The National Foundation for Cancer Research (NFCR) is a 501(c)(3) non-profit organization that provides scientists in the lab the funding they need to make and apply game-changing discoveries in cancer treatments, detection, prevention and, ultimately, a cure. NFCR has distinguished itself by emphasizing long-term, transformative research often overlooked by other major funding sources and/or deemed too risky. Since its establishment in 1973, NFCR has provided more than $385 million for cancer research and public education. For more information, visit https://www.nfcr.org.
###




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Announcement Follows a Year of Rapid Industry Growth that Brought Patients Greater Access to Remote, Specialist Care

ATLANTA (PRWEB) DECEMBER 03, 2020
Eagle Telemedicine announced today that Jason Povio is the company's new president and chief operating officer.
Since joining Eagle in early 2019, Jason Povio has served as senior vice president of operations with effective oversight of the business, including operations, program implementation, post-implementation support, and credentialing as well as marketing and business development.
"Eagle started as a physician-led organization and my role has been to solidify a professional, structured platform," said Povio. "Eagle has developed a solid foundation over the past 10 years, and in the past year we have moved the company forward, refining and maturing our operations. We projected expansion in 2020 and have achieved tremendous growth. It's been very satisfying and gratifying."
During Povio's tenure at Eagle Telemedicine, the company implemented a targeted business development strategy, expanded its clinical leadership, doubled the roster of telemedicine physicians, and created a clinical satisfaction survey to support continuous improvement initiatives.
"Over the past year, Jason has accomplished great things," said Dr. Talbot "Mac" McCormick, chief executive officer of Eagle Telemedicine. "In his role as senior vice president of operations, he worked closely with the entire Eagle team to position Eagle Telemedicine for efficiency and rapidly respond to the growth we are seeing across all our specialties. The COVID-19 pandemic has only amplified the growth we are seeing. Jason's background is well-suited for this expanded role."
The company expected and prepared for increased interest in telemedicine services this year. The COVID-19 cases expedited demand for remote physicians to provide infectious disease, intensive care, and virtual hospitalist telemedicine.
In addition to positioning Eagle Telemedicine to manage unexpected demand for virtual medicine, Povio also spearheaded the company's application for The Joint Commission's Gold Seal of Approval for accreditation, which is currently under review. In addition, the company is also making enhancements to its cloud-based technology platform—creating a more efficient operating environment for the company's telemedicine physicians.
Povio has a background in systems engineering along with broad experience in healthcare, working in large integrated healthcare systems in several operational and executive positions. Before joining Eagle Telemedicine, he served as executive director of acute medicine at Mission Health in Asheville, NC. His experience also included senior performance excellence consultant at CHE Trinity Health in Livonia, MI.
Povio received his Bachelor of Science in Industrial Engineering and Master of Science in Engineering Management from the University of South Florida along with several graduate certificates in quality and change management.
Povio also holds a Lean Healthcare Certification and is a Lean Six Sigma Black Belt from the University of Michigan.
About Eagle Telemedicine
A leader in industry since 2008, Eagle Telemedicine now provides care at more than 185 hospitals in 24 states. Our providers perform approximately 20,000 annual inpatient encounters and 25,000 remote patient admissions each year. We offer access to 14 specialties, including cardiology, hospitalist medicine, infectious disease, neurology, psychiatry and pulmonology/critical care. We believe that telemedicine is the "great equalizer." Eagle can help reduce transfers and solve nightshift challenges by covering everything from floor call to admissions. Eagle partners with hospitals of all sizes but focuses on facilities in rural areas with limited staffing resources and specialists are often not available. For more information, visit http://www.eagletelemedicine.com. Connect with us on LinkedIn.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Kyocera DuraForce PRO 2 ultra-rugged smartphone provides one-button access to Mutualink Edge@Team multimedia, broadband push-to-talk to help first responders save precious time in emergencies.

SAN DIEGO (PRWEB) DECEMBER 03, 2020
Time is never more precious than in an emergency. The right communication tool can literally save lives. With the advanced Mutualink @Team multimedia push-to-talk (PTT) application and Kyocera's ultra-rugged DuraForce PRO 2 Android smartphone, first responders can reduce crucial communication time with quick access to individuals and information. The secure multimedia PTT with broadband connectivity provides Incident Command System (ICS) based True Interoperability between agencies in emergencies, enabling instant real-time sharing of crucial video, text messages and location to pre-determined or ad hoc talkgroups. The @Team app is an easy download from the Google Play store on DuraForce PRO 2*.
First responders can find themselves in extreme temperatures and weather - fires, snowstorms, flashfloods, etc. – and they require a mobile device that can withstand the elements. Kyocera's DuraForce PRO 2 is built rugged from the inside out, without bulk, with cutting-edge technology and features designed to function seamlessly in life's emergencies. Its built-in certified IP68 dust proof and waterproof and Military Standard 810G protection against drops, shock, dirt, rain, snow, and other harsh conditions ensure the device can withstand even the harshest environments. Robust all-day batteries easily power through shifts and front-facing dual loudspeakers with an advanced echo and noise cancellation system enable clear audio even in the noisiest situations. A dedicated button can be programmed for instant one-touch communication using the @Team PTT app. A wide-angle lens captures images and video in both vertical and horizontal formats, enabling first responders to share more accurate images of their environments, providing a cost-effective body worn camera option. The touchscreen is designed to work when wet or with gloves, ensuring ease-of-use in emergency situations. Android Enterprise Recommended with ongoing security updates, the device utilizes FIPS 140-2 validation module and includes a fingerprint security sensor for biometric authentication, plus it's covered by a 2-year manufacturer's warranty that includes water damage.
"Fast, accurate communication is important for every industry, but never as much as when getting crucial information during an emergency since lives can depend on it," said Vipul Dalal, general manager at Kyocera's Communications Equipment Group. "Hardware, software and network capabilities must be optimized at all times for first responders to communicate instantly with each other and other agencies. This solution turns the ultra-rugged DuraForce PRO 2 into a mobile Command Center with real-time communication along with highly secure video, location and data sharing to streamline operations when it counts the most."
"Pairing Mutualink's multimedia interoperability apps with Kyocera's ultra-rugged smartphones creates more competitive choice for the nation's first responders, who require dependable, flexible communications solutions to more quickly resolve emergency incidents," said Joe Mazzarella, president and chief operating officer of Mutualink. "This partnership with Kyocera is our next step in providing extended communications solutions during the coronavirus pandemic, enabling clear, complete and timely sharing of information between and among first responders, hospitals and private security teams."
Kyocera's rugged devices are used by first responders nationwide and Mutualink has been providing secure, interoperable communications to public safety for years, making the combined offering an especially trusted, reliable solution. The @Team application on DuraForce PRO 2 enables:
Push-to-Talk Plus Video – secure push-to-talk. Beyond traditional voice PTT, emergency teams can share photos, locations, streaming video, even data files with each other.
One-to-Many Sharing – secure one-to-many voice, text, video and data sharing to a group in real time. Each user can also participate in collaboration sessions with outside agencies through their agency's Interoperable Workstation (IWS) appliance or Edge IWS application.
EoIP & Location Services – secure Everything-over-IP protocol turns push- to-talk to push-to-see + talk. All forms of connectivity are supported. Geolocation maps show where your team is in real time (optional by device/user).
Multiple Talkgroups – multiple talkgroups are possible per device, including managed and ad hoc groups. Broadcast voice, video and text to all group members at once.
Access to the Mutualink Network – users can participate in network incidents to collaborate daily with other agencies for large planned events and during emergency situations. Mutual aid incidents resolve faster with LMR – LTE communications bridged across agencies.
Secure & Scalable
The secure and scalable @Team is HIPAA- and FERPA-compliant, with AES-256 encryption to protect communications from leakage or hacking plus a Virtual Private Network (VPN) for added security.
DuraForce PRO 2 and Mutualink are certified to operate on FirstNet -- built with AT&T -- the first nationwide network dedicated to public safety, and the Verizon network.

Mutualink app is a separate download and purchase.

**IP68 dust proof and waterproof for water immersion up to 6.5 feet for up to 30 minutes.
ABOUT KYOCERA
Kyocera International Inc.'s Communications Equipment Group (CEG) is the headquarters for Kyocera wireless devices in the Americas. With a history of quality and innovation delivering many "firsts" to the U.S. market, Kyocera is the leader in rugged mobile solutions. Launching more than 100 waterproof and rugged mobile devices globally over the last 10+ years, Kyocera strives to offer rugged, reliable technology as an integral part of a total mobile offering: combining Military Standard 810G-certified ruggedization and enterprise-grade security with a partner ecosystem, industry-specific applications and innovative accessories. Working with leading service providers, Kyocera has created a "Total Solution" offering that helps deliver a significantly lower total cost of ownership to a wide range of industries such as public safety, transportation, and construction. White glove services including overnight advanced replacement, custom provisioning, repair, and more help productivity for business customers. When it comes to blending performance, durability and support, Kyocera's rugged mobile solutions are in a class of their own. For more information, visit Kyoceramobile.com or follow the company on Facebook, Twitter, Youtube, Instagram and LinkedIn.
Kyocera Corporation (TOKYO: 6971), the parent and global headquarters of the Kyocera Group, was founded in 1959 as a producer of fine ceramics (also known as "advanced ceramics"). By combining these engineered materials with metals and integrating them with other technologies, Kyocera has become a leading supplier of industrial and automotive components, semiconductor packages, electronic devices, smart energy systems, printers, copiers, and mobile phones. During the year ended March 31, 2020, the company's consolidated sales revenue totaled 1.6 trillion yen (approx. US$14.7 billion). Kyocera is ranked #549 on Forbes magazine's 2020 "Global 2000" list of the world's largest publicly traded companies.
About Mutualink
Mutualink, Inc. provides an interoperable communications platform that enables community-wide multimedia sharing of radio, voice, text, video, data files, and telephone communications in a secure environment. Mutualink's system is deployed by thousands of public safety and private security entities and facilities, including homeland security, police and fire departments, emergency operations centers, hospitals, schools and universities, transit authorities, stadiums, shopping malls, casinos, and more. Mutualink is a privately held company headquartered in Wallingford, CT, with R&D facilities in Westford, MA; Allen, TX; and Mayagüez, PR. For more information, please visit http://www.mutualink.net.
True Interoperability is a registered trademark of Mutualink, Inc.
2020 KYOCERA International, Inc. (KII), San Diego, California, USA. All rights reserved. No reproduction in whole or in part is allowed without prior written approval. Kyocera is a registered trademark of Kyocera Corporation. DuraForce PRO 2 is a trademark of Kyocera International, Inc. Google and Android are trademarks of Google LLC. All other marks are held by their respective owners.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Fujifilm enters multi-year global distribution agreement to deliver MaxQ's ACCIPIO suite of clinical artificial intelligence applications through the Fujifilm Synapse PACS platform

TEL AVIV, ISRAEL (PRWEB) DECEMBER 03, 2020
MaxQ AI, the industry-leading healthcare technology company that delivers comprehensive clinical workflow with improved patient triage and diagnosis, announced today a multi-year partnership with FUJIFILM Medical Systems U.S.A., Inc., a leading provider of enterprise imaging solutions, to commercialize the ACCIPIO Clinical Platform.
The Accipio Clinical Platform generates multiple insights into a patient's medical imaging study that may provide a faster and clinically accurate diagnosis. The platform is comprised of Accipio Ix (Intracranial Hemorrhage (ICH) triage and notification, Accipio Ax (Slice-Level Annotation), and Accipio Dxg (Triage for ICH Presence or Absence)**. MaxQ is the only AI platform company offering advanced AI applications and AI platform solutions, such as MaxQ Xpress, as a seamless, integrated offering, secured through ISO 27001 and ISO 27799 cybersecurity standards. When launched through Fujifilm's Synapse PACS platform, which ranks among the fastest and most secure enterprise imaging solutions in the industry—the Accipio and Synapse seamless solution deliver deep clinical and actionable insights, enabling clinicians to make faster assessments of patients.
"At MaxQ, our goal is to equip physicians with AI-based solutions that enable them to deliver faster, more confident patient care, while reducing costs, and physician workload," says Michael Rosenberg, Chief Executive Officer of MaxQ. "We've worked extensively with Fujifilm over the last year on our deployment at Capital Health Hospitals in New Jersey. In collaboration with Fujifilm and the wonderful staff at Capital Health Hospital, our teams have successfully integrated Accipio into Fujifilm's Synapse PACS, achieving a seamless clinical workflow enhanced with deep clinical AI."
About Fujifilm
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of innovative diagnostic imaging products and medical informatics solutions that meet and exceed the evolving needs of healthcare facilities today and into the future. It's ever expanding medical imaging solutions span digital radiography (DR), detectors, portables and suites, mammography systems with digital breast tomosynthesis, computed tomography solutions for oncology and radiology applications, technologically advanced flexible and surgical endoscopy and fluoroscopy solutions. Fujifilm enables interoperability through its Systems Integration offering as well as its comprehensive, AI-supported Synapse Enterprise Imaging portfolio, which includes the TeraMedica Division of Fujifilm. Fujifilm's in vitro diagnostics (IVD) portfolio includes clinical lab reagents, and biomarkers to assess the risk for the development of hepatocellular carcinoma in patients with chronic liver disease. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Lexington, Massachusetts. For more information please visit http://www.fujifilmhealthcare.com.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2020, the company had global revenues of $22.1 billion, at an exchange rate of 109 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: http://www.fujifilmholdings.com.
About MaxQ AI, Ltd.
MaxQ AI is transforming healthcare by empowering physicians to provide 'smarter care' with enhanced clinical workflow, improved patient triage and artificial intelligence (AI) clinical insights. Based in Tel Aviv, Israel and Andover, MA our team of deep learning and machine vision experts develop innovative software that uses AI to interpret medical images and surrounding patient data. Working with world-class clinical and industry partners, our software enables physicians to make faster, more accurate decisions when diagnosing intracranial hemorrhage, stroke, brain trauma, and other serious conditions. To learn more, visit http://www.maxq.ai or follow us on LinkedIn.
Press Contacts:
For MaxQ AI:
marketing@maxq.ai
For Fujifilm:
Danielle Brown, Danielle.brown@fujifilm.com
**MaxQ Device Regulatory Status Available at http://www.maxq.ai



START your own Wordpress site, business or personal website, or online store at www.siteground.com

CISA, FBI and HHS warn of Ransomware attacks on Healthcare Facilities. MailRoute stops those attacks.

LOS ANGELES (PRWEB) DECEMBER 03, 2020
On October 29, 2020, the Cybersecurity and Infrastructure Security Agency (CISA), the Federal Bureau of Investigation (FBI) and the U.S. Department of Health and Human Services (HHS) warned of an increased, imminent threat to U.S. hospitals and healthcare providers.
The agencies have credible information that malicious cyber actors are targeting the healthcare and public health sectors with malware that can result in ransomware attacks, disruption of healthcare services and data theft.
Protective measures to prevent ransomware attacks often include alerting employees to be vigilant with respect to phishing attempts. This "people-centric approach" touted by most data security services is simply a way of saying the onus is on the end-user. This appears to be an abdication of responsibility by paid services who are employed to protect their clients. When reassessing an entity's essential cyber incident response plan, it is imperative to include a HIPAA-compliant gateway security service.
To protect clinicians and patients from targeted threats and ensure data is HIPAA compliant requires a gateway security service, which sits outside the network and functions as the first, and most stringent, line of defense against malicious attacks.
"These targeted ransomware attacks are being waged on hospitals and healthcare facilities because those entities retain data valuable to bad actors as well as the monetary gain from paid ransom," explains MailRoute founder and CEO Thomas Johnson.
"Finding a HIPAA-compliant security service is difficult, because they must meet the stringent standards of the Federal government as relates to email handling, including legitimate encryption and storage timeframes on a vendor's network.
"Companies that focus on myriad data services often cannot meet these standards, since they use third-party encryption services that are less robust than required. MailRoute focuses on a core competency of email security, so we are compliant on all levels," Johnson concludes.
A gateway service eliminates heightened security risks, should have API-level integration and should work with all email platforms and servers. MailRoute's cloud-based email filtering solution, for example, stops unwanted inbound emails and potential attacks before they ever reach mail servers. Outbound monitoring also blocks confidential files from leaving a client's network.
Cyber Threat Protection
Virtual healthcare is becoming the new normal with the continual increase in the use of web-based mobile apps between doctors and patients and the resulting electronic health records stored in a virtual black hole. Because medical records contain the most lucrative data for hackers to sell on the black market, cyber-attacks on healthcare systems continue to grow.
Email Compliance
While it is critical that hospitals and healthcare facilities meet HIPAA compliance regulations, it's also important to streamline compliance and regulatory processes for IT teams by using a reliable, efficient and secure gateway service to stop malware, ransomware, phishing attacks, and other spam and viruses.
The joint CISA, FBI and HHS alert (AA20-302A) can be found here.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Conventus Inter-Insurance Exchange and Navvis, a leading population health company, are excited to announce a unique, innovative partnership to help physicians in New Jersey lower the cost of care, improve quality, ensure access, and provide a better experience for their patients. The new partnership offers Conventus insured physician members access to Navvis' integrated population health management capabilities with one of the largest New Jersey commercial health plans. These services are provided by Navvis' Value-Based Services Organization, which is committed to achieving a new national standard in value-based care performance. Recently, the organization announced top-tier results in Florida, scoring among the top 6% nationwide of 541 participating ACOs.

WOODBRIDGE, N.J. (PRWEB) DECEMBER 03, 2020
Conventus Inter-Insurance Exchange and Navvis, a leading population health company, are excited to announce a unique, innovative partnership to help physicians in New Jersey lower the cost of care, improve quality, ensure access, and provide a better experience for their patients. The new partnership offers Conventus insured physician members access to Navvis' integrated population health management capabilities with one of the largest New Jersey commercial health plans. These services are provided by Navvis' Value-Based Services Organization, which is committed to achieving a new national standard in value-based care performance. Recently, the organization announced top-tier results in Florida, scoring among the top 6% nationwide of 541 participating ACOs.
Physicians will gain access to analytics, technology, and multi-disciplinary care coordination services, as well as support to optimize their practices. This exclusive complimentary offer to Conventus primary care physician practices helps them have access to the infrastructure and support needed to successfully participate in commercial and Medicare Advantage value-based care programs through Per Member Per Month (PMPM) payments and potential shared savings. Conventus will provide hands-on assistance in coordinating and streamlining workflow processes across other value-based care programs, such as MIPS and other commercial carrier value based programs, to avoid duplication of work.
The partnership is among the first in the nation to align patient safety and risk management strategies directly with value based care. Susan Lieberman, Vice President of Practice Resources at Conventus stated, "Conventus understands that physician practices want to deliver high value care to their patients and the communities they serve. Through our partnership with Navvis, we can help our physician members capture opportunities in value-based care and achieve high levels of performance. Patient care coordination is essential to reducing financial and clinical risk, closing care gaps, and enhancing quality of care. This partnership allows us to develop more specialized risk management programs to support our physician members."
Dr. Anthony Wehbe, Senior Physician Executive at Navvis, added, "Navvis is committed to helping physicians and their practices optimize their performance and succeed in value-based care. Our solutions engage and empower physicians and create a connected care eco-system to advance the health of populations. We are thrilled to be collaborating with Conventus and their network of physicians."
Brian Kern, Partner with Acadia Professional, who helped facilitate this collaboration, noted, "We see huge opportunities in New Jersey for value-based risk arrangements. As providers in New Jersey transition from fee-for-service to value-based care, the healthcare risk system will change. Working with Conventus and Navvis, two exceptional companies that share our vision, is a perfect way for physicians to accelerate their transition to value-based care and ensure its success."
About:
Conventus Inter-Insurance Exchange supports the best interests of New Jersey's physician practices. As one of New Jersey's largest professional liability insurers, formed and governed through an alliance of physicians, it uniquely understands the complexity of running a successful practice. Its sole purpose is to help independent physicians and practice administrators succeed in today's rapidly changing healthcare environment.
http://www.conventusnj.com
Navvis is a population health market maker. We drive transformation. We work with health plans, health systems, and physician organizations to develop new business models that accelerate and fundamentally change the way healthcare is delivered. We create markets and unique partnerships that allow healthcare organizations to unlock value-based care opportunities in their markets. This model redesigns and constructs new markets to solve the underlying systemic issues, to maximize the performance in value-based risk arrangements.
Our capabilities create a solution that is physician-led and patient centric. We support all payers, payment models, and lines of business, connect the full continuum of care, and activate all providers, caregivers, and family members. Delivered and operated by HealthSync, our innovative value-based care platform provides an end-to-end solution for our partners. The result is a healthcare ecosystem that never stops caring—one that is sustainable and eliminates complexity for consumers, empowers providers, and reduces the high cost of healthcare.
http://www.navvishealthcare.com
Acadia Professional is a renowned medical professional liability insurance brokerage that works with thousands of physicians throughout the US. With a long-standing mission to protect independent physicians, Acadia has been building a national stop loss market for physicians taking risk in value-based care programs.
http://www.acadia.pro



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Health and wellness solution designed to educate and connect people to care

PLEASANTON, CALIF. (PRWEB) DECEMBER 03, 2020
Amidst a pandemic in which many Americans are delaying medical care due to COVID-19 concerns, ConnectWell, a leading-edge provider of digital health and wellness content, and Outgrow, a leader in creating interactive online experiences, today introduced a suite of turnkey interactive digital health tools designed to re-engage, educate, and connect people to care. The companies co-developed the new virtual tools for healthcare providers, health plans, employers, and benefits providers seeking to re-engage those they serve using evidence-based health and wellness information as the driver and the means to access care.
The U.S. Centers for Disease Control and Prevention (CDC) reported that by the end of Q2 this year, 41 percent of U.S. adults acknowledged that they had delayed or avoided healthcare due to concerns related to COVID-19.* Separately, a study of primary care revealed that during the same quarter, even with exponential growth in telehealth appointments, there was still a 21.4 percent decline in primary care visits overall in the U.S. compared to Q2 in 2018 and 2019. Vital health measurements connected with those Q2 visits also declined, with decreases of 50.1 and 36.9 percent in blood pressure and cholesterol checks, respectively.**
While the kind of user-friendly interactive tools provided by the ConnectWell-Outgrow suite are useful for reconnecting anyone to care, they are especially vital for re-engaging people with COVID-related health risks to help them bolster their health and better protect themselves during a surging pandemic.
"The value of these tools stems from Outgrow's track record of creating engaging interactive experiences that prompt user action combined with ConnectWell's expertise in developing consumer-friendly digital health content, which is expertly sourced from the UC Berkeley School of Public Health, a pioneer in creating evidence-based health and wellness information," said Andrea Bloom, Founder and CEO of ConnectWell.
The interactive digital health tools have three components—risk assessments, knowledge tests, and reading recommendations that inform and educate people on 11 key conditions. These conditions represent COVID-19 health risks that impact a significant portion of the U.S. population, including diabetes, hypertension, obesity, high cholesterol, coronary heart disease, heart attack, stroke, lung infection, asthma, COPD, and depression. Healthcare organizations, benefits providers, and employers can use these interactive digital health tools with their populations virtually. This enables patients, employees, and health plan members to safely assess their risk online for these manageable conditions. The tools will also provide them with the opportunity to learn more about conditions that warrant attention, and reduce their risk of delaying diagnosis or serious complications by seeking follow-up care.
"Working jointly with ConnectWell, our aim has been to enable Health and Wellness companies and HR departments to educate their patients and employees to learn about health risks and best practices for a healthy lifestyle," said Randy Rayess, Co-founder of Outgrow. "We do this by providing access to vetted health content from the UC Berkeley School of Public Health, including knowledge surveys, risk assessments, and article recommendations, while helping people take the next steps in connecting with the care they need."
Healthcare organizations understand the need for these kinds of virtual care tools, yet to create them from the ground up would require extensive resources during a time when healthcare organizations are already stretched thin. It requires contracting with both an interactive software platform and a digital health content provider, then securing or allocating significant internal resources with expertise in content and software development as well as health condition management.
The ConnectWell-Outgrow suite of digital health tools, on the other hand, is a turnkey solution that comes fully developed from collaborators with top-tier expertise in creating interactive digital engagement experiences and expertly sourced and vetted consumer health content. And the tools are customizable, enabling companies to steer those they serve to connect with the care they need, based on their risk assessments. This can include prompts for scheduling lab tests and appointments with appropriate providers, connecting users with a call center, arranging for health coaching, and more. The ConnectWell-Outgrow suite also provides reporting and analytics, enabling customers to gain insights on the usage of the tools as well as the population health data of users on an aggregate level.
The ConnectWell-Outgrow digital health tools can be integrated with the virtual care experience of a range of organizations. Healthcare providers are looking to reconnect, re-engage, and restore interactions with patients who have dropped off. Health plans are seeking to keep member populations healthy through a digital delivery option. Employers are working to keep office-based and remote employees healthy, productive, and safe. Whereas benefit providers are looking to bundle interactive digital health tools with their wellness program and benefits packages.
ConnectWell and Outgrow are building out these turnkey digital health tools across dozens of health conditions to expand this initial launch and further engage people in care through early detection and intervention. To learn more about the ConnectWell-Outgrow interactive digital health tools, please visit the page about the tools on the ConnectWell website.
About ConnectWell
ConnectWell is a leading-edge provider of digital health and wellness content that is academically sourced and designed for a consumer audience to engage people in their total health and well-being. ConnectWell's public-private partnership with the UC Berkeley School of Public Health guarantees access to a vast library of health and wellness content that is continually reviewed and updated to include the latest standard of care guidelines and scientific findings on health, wellness, and disease management. ConnectWell licenses its content to healthcare providers, health plans, telemedicine providers, wellness engagement platforms, health device companies, employers, and benefits providers to engage their target audiences in their health and well-being.
About UC Berkeley School of Public Health and Health & Wellness Publications
For more than 70 years, the UC Berkeley School of Public Health has been a leading institution in public health education and research, contributing to the improved health and welfare of communities, the state, and the world. The Health & Wellness Publications of the School of Public Health date back to 1984, when the Berkeley Wellness Letter was founded. UC Berkeley experts carefully examine the latest health and wellness information so readers can make quality lifestyle choices and self-care decisions.
About Outgrow
Outgrow has been the G2 Crowd Market Leader in the interactive industry for 3 years in a row and has been ranked the #1 B2B Tech Company in New York. Outgrow's interactive experiences have a proven record of increasing engagement, providing personalized value to every single person, increasing the time they spend on your educational efforts, the value they receive and their chances of making positive changes in their lives.
Media Contact:
Jeff Christensen
SignalWest Public Relations
Email: Jeff@SignalWestPR.com
Mobile: 831.566.0275
*"Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020," Morbidity and Mortality Weekly Report, U.S. Centers for Disease Control and Prevention, 11 Sept. 2020
**"Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US," JAMA Network Open, 2 Oct. 2020



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A new tool to help with pharmacists' corresponding responsibility and to help fight the opioid epidemic.

SAN DIEGO, CALIF. (PRWEB) DECEMBER 03, 2020
RPhAlly, the new network for pharmacists, today announced the launch of the Prescriber Review, a new tool for community pharmacists. The Prescriber Review is a new feature within the RPhAlly app where pharmacists can provide their professional opinion of a prescriber in the form of a four-star review. When other pharmacists receive prescriptions issued by providers unknown to them, they can utilize the Prescriber Review to see how their colleagues feel about the particular provider.
Pharmacists act as gatekeepers for dispensing controlled substances. They have a corresponding responsibility to make sure the prescription is legitimately prescribed for a valid medical purpose in the usual course of the provider's professional practice. While pharmacists play a crucial role in combatting the opioid epidemic, many dispense controlled substance prescriptions without knowing the prescriber or their prescribing habits. This innovative tool allows pharmacists to work together to better understand their colleagues' professional opinions of providers unknown to them and protect their licenses.
"We created this tool so that pharmacists could have an additional data point to serve their patients better and make more informed decisions when dispensing a controlled substance." - Shawn Bjorndal, RPhAlly Founder.
RPhAlly is committed to becoming a hub for all things pharmacy. The app is free and includes a live feed, a pharmacy specific news feed, pharmacist groups, a directory, and forums. Members can also listen to the Pharmacy Podcast Network from within the platform, the first of many partnerships to come. The Prescriber Review is located within the RPhAlly app, available on Apple and Google Play stores.
About RPhAlly:
RPhAlly is an exclusive platform for pharmacy professionals in the United States to share vital industry information, network with colleagues, grow their careers, and adapt to a rapidly changing industry resulting in more productive, successful, connected, and compliant professionals.
Launched in 2020, RPhAlly allows pharmacists to connect, share, learn, and advocate for the practice of pharmacy all within one app. The platform is available on both iOS and Android or visit https://rphally.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Cypress Place Senior Living, one of Ventura's distinctive independent, assisted living, and memory care communities, announces its recognition of a first-place position in the Retirement Home category in the 35th Annual "Best of Ventura County 2020" awards. More than 450 businesses in Ventura County, CA representing 150 categories were recognized as award winners.

VENTURA, CALIF. (PRWEB) DECEMBER 03, 2020
Cypress Place Senior Living, one of Ventura's distinctive independent, assisted living, and memory care communities, announces its recognition of a first-place position in the Retirement Home category in the 35th Annual "Best of Ventura County 2020" awards. More than 450 businesses in Ventura County, CA representing 150 categories were recognized as award winners. To earn a coveted spot on the "Best of Ventura County 2020" list, VC Reporter readers responded to online polls for service providers they consider the best in their specific category. A complete list of winners can be found here.
"We're incredibly pleased that Cypress Place has earned this coveted best-in-class award on VC Reporter's "Best of Ventura County 2020" for Retirement Homes," says Glen Cummins, Regional Director Operations at Meridian Senior Living. "We are so proud of the amazing staff and how tirelessly they work to create a safe and active environment while delivering exceptional care that surpasses the expectations of their residents and families."
Cypress Place Senior Living, operated by national senior housing company Meridian Senior Living, LLC, offers independent living, assisted living, and memory care services. The community features a wealth of amenities such as activity and game rooms, libraries, movie theaters, fitness centers, beauty salons, private dining rooms, landscaped gardens, and enclosed courtyards. Located at 1200 Cypress Point Lane in Ventura, CA, Cypress Place is open and admitting new residents for move-ins. In these times of isolation, it has been particularly difficult for older adults who may not have options to go out to obtain necessary items or connect with others as society reopens. The community offers active living: daily engaging and social activities, restaurant style meals, and the highest quality of care. For more information about Cypress Place Senior Living, visit cypress-place.com or call (805) 650-8000.
About Meridian Senior Living:
Meridian Senior Living, a privately held company based in Bethesda, Maryland, owns and operates seniors housing communities across the country and provides operational consulting to 24 communities in China. With more than 70 communities in 21 states and more in development, Meridian is one of the largest seniors housing operators in the U.S. The company prides itself on providing the highest quality care, exceptional lifestyle programming and a distinctive dining experience for its residents. For more information on Meridian Senior Living, visit meridiansenior.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Opening in mid-January 2021, Regency Palms Oxnard is excited to introduce distinctive programming options to its future residents. An array of robust programming offerings to meet each resident's unique needs will be available for its future residents to encourage complete whole-body wellness.

OXNARD, CALIF. (PRWEB) DECEMBER 03, 2020
Opening in mid-January 2021, Regency Palms Oxnard (RPOX) is excited to introduce distinctive programming options to its future residents. An array of robust programming offerings to meet each resident's unique needs will be available for its future residents to encourage complete whole-body wellness.
"I am excited to welcome our new residents and provide them with meaningful programs that improve their physical, psychosocial, and emotional well-being," said Ken Mahler, Executive Director of Regency Palms Oxnard. "Our team has been diligently preparing and developing these programs to encourage complete whole-body wellness, while implementing measures to keep residents as safe as possible."
RPOX will emphasize an active senior lifestyle for its residents through its programming that includes daily engagement and social activities. An active senior lifestyle is an important key to support overall wellness among the resident population. The National Institute on Aging has conducted several research studies that show a correlation between social interaction among seniors and their health and well-being. These emotional bonds can lead to healthier lifestyles including being active, eating healthy foods, and ceasing poor health habits such as smoking.
For all residents, RPOX will offer active programs that focus on social engagement such as ongoing adult education, card clubs, history club, onsite salon, art studio with classes, reduced rates for season ticket holders for the Arts, local sporting events, art classes, and open studio for independent art. Additional engagement experiences for residents are available through transportation services provided by RPOX to local events, shopping, scenic drives, and appointments.
For residents in all care levels, RPOX has partnered with Revolution in Motion to offer their innovative wellness and strength-building program. Dr. Edythe Heus developed the Revolution in Motion program which integrates novel, integrative, and complex movements that through neurologically based activities stimulate cognitive function and improve mobility. RPOX provides certified instructors who have attended hands-on training from Dr. Heus. These certified instructors use somatosensory tools to create functional movement exercises that stimulate the brain and improve the body. Older adults participating in Revolution in Motion have gained benefits including improvements in balance, agility, posture, gait, reaction time, flexibility, fall prevention, energy, focus and concentration.
For seniors with Alzheimer's or other forms of dementia, RPOX will offer its distinctive dementia care program based on a Montessori methodology: Montessori Moments in Time (MMIT). The goals of MMIT are to enhance living for those with memory impairment by the guidance of the program's five directional paths and by using Validation techniques for communication. Other foundational elements of the program include: The Resident Life Story and the Snacks that Pack Program.
Five Directional Paths: Each directional path has the resident and family in mind to encourage independence and help deal with the progression of Alzheimer's disease and other related dementias. These paths include Family Connections, Health and Wellness, Dining Experience, Life Engagement, and Team Promise. Family Connections focus on the well-being of our families through virtual workshops, social connections, volunteer opportunities, support, and education. Health and Wellness is based on providing satisfying experiences, promoting independence, and encouraging positive behavior while maintaining respect and dignity. The Dining Experience leverages meals as a time to reminisce, create new memories, maximize independence, and promote socializing, all in an inviting, safe environment. Life Engagement includes scheduled programs that support the whole person allowing residents to function at their highest potential, giving them a sense of purpose and overall well-being. Team Promise focuses on developing care partnerships through ongoing education and training.
Validation: Validation is a method of communicating with and helping cognitively impaired seniors. It is a practical way of communicating that helps reduce stress, enhance dignity and promote happiness. Validation is an empathetic and holistic approach in which caregivers are asked to "step into their shoes" and "see through their eyes" to understand the meaning of behaviors. This method allows seniors the opportunity to express, both verbal and non-verbal, their feelings and needs, often having been suppressed for years.
Resident Life Stories: Every resident has a life story and a vast group of experiences. The MMIT program leverages resident life stories, past routines, and preferences to create a day tailored to the resident, guiding them through their activities of daily living, such as programming and meals. Using the residents' past routines not only directs them to what comes next, but also increases their feelings of self-esteem. Used in conjunction with Validation, it increases feelings of belonging and safety.
Snacks that Pack Program: Nutrition is important for seniors particularly with Alzheimer's or other dementias. The Snacks that Pack program offers residents nutrient-dense, antioxidant-rich snacks three times a day with a specialized hydration program.
RPOX has partnered with MUSIC & MEMORY to deliver a music program that provides emotional and behavioral benefits to its future residents with Alzheimer's or other forms of dementia. MUSIC & MEMORY is a nonprofit organization that has more than a decade of experience working to incorporate music into memory care programming. Through personalized therapeutic music and custom playlists developed for each resident, MUSIC AND MEMORY may activate what some research has shown are areas of the brain spared by Alzheimer's disease, ultimately helping participants with recall, mood and temperament, and a reconnection with the long-term memories associated with favorite music or certain songs.
About Regency Palms Oxnard
Regency Palms Oxnard, offering assisted living and memory care services, is operated by national seniors housing operator Meridian Senior Living, LLC. Opening in mid-January 2021, Regency Palms Oxnard is now taking reservations at their community at 1020 Bismark Way in Oxnard, C.A. Regency Palms Oxnard offers 65 assisted living, and 36 memory care suites ranging from cozy studios to luxury 1- bedroom suites in a single-story, 34,000 square foot building. Nestled in a quiet residential area, Regency Palms Oxnard was thoughtfully redesigned to include customized room designs with extra storage and vistas of beautifully landscaped outdoor areas. Each of the nine outdoor courtyards have a unique design to enrich outdoor recreation. All spaces of the building have been carefully appointed to accommodate the superior services and luxurious lifestyle residents at Regency Palms Oxnard deserve. Learn more about Regency Palms Oxnard and its Charter Resident Program by visiting regencypalmsoxnard.com or calling (805) 342-2001.
About Meridian Senior Living:
Meridian Senior Living, a privately held company based in Bethesda, Maryland, owns and operates seniors housing communities across the country and provides operational consulting to 24 communities in China. With more than 75 communities in 21 states and more in development, Meridian is one of the largest seniors housing operators in the U.S. The company prides itself on providing the highest quality care, exceptional lifestyle programming and a distinctive dining experience for its residents. For more information on Meridian Senior Living, visit meridiansenior.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Learn how to turbocharge your clinical laboratory with complete workflow solutions from BD Biosciences

FRANKLIN LAKES, N.J. (PRWEB) DECEMBER 03, 2020
BD Biosciences today announced its "Sample to Answer Clinical Series" to be held virtually on December 9, 2020 via the LabRoots platform. It is a timely opportunity to learn how to streamline your flow cytometry workflow.
Hear from clinical labs that have improved flexibility, efficiency, and standardization through the BD FACSDuet Sample Preparation System integrated with the BD FACSLyric Flow Cytometer, which together offer the ultimate sample-to-answer solution.
Highlights of the conference include:

    Keynote address from BD Bioscience Clinical Scientific Liaison, Abigail Kelliher.

    Further presentations on:

Automating and standardizing the clinical lab workflow (Chris Scott, Lead Biomedical Scientist, Barts Health NHS Foundation Trust, Royal London).
Validation of the BD FACSDuet flow cytometry sample preparation system (Joanna Sin, Medical Technical Specialist, Unity Health Toronto–St. Michael's Hospital).

    Opportunities to "e-meet" BD Bioscience's clinical sales team and network with other attendees.

    Posters, tools, resources, and on-demand videos.

To register for this event, and view the agenda, click here.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. Specifically, BD Life Sciences - Biosciences provides flow cytometers, reagents, tools, and a wide range of services to support the work of researchers and clinicians who understand disease and improve care.
About LabRoots
LabRoots is the leading scientific social networking website, as well as a primary source for scientific trending news, premier educational virtual events/webinars and more. Contributing to the advancement of science through content-sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining Continuing Education Credits from a wide range of topics through their participation in the webinars and virtual events.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Accipio V2 shipping now with enhanced functionality to accelerate physician adoption.AI deployments are accelerating throughout the COVID19 Pandemic

TEL AVIV, ISRAEL (PRWEB) DECEMBER 03, 2020
MaxQ AI, the industry-leading healthcare technology company that delivers comprehensive clinical workflow solutions assisting with improved patient triage and diagnosis, announced today it is now shipping the Accipio V2 Clinical Platform, including enhanced functionality to support seamless and secure integrations throughout its CT, PACS, radiology reporting, and curated AI partner base of global acute hospitals.
The Accipio Clinical Platform, utilized in reading adult non-contrast head CT exams, is comprised of the following modules:

Accipio Ix – identifies and prioritizes suspected intracranial hemorrhage (ICH) in patient imaging studies.

Accipio Ax – now includes the exclusive SliceMap, an integrated view that rapidly guides clinicians to CT slices with suspected ICH while prioritizing the identified ICH-positive case.

MaxQ Xpress – adds native real-time intelligent orchestration between hospital worklist platforms and the Accipio ecosystem. Xpress is the direct-result of physician feedback demanding real-time intelligent prioritization without high onsite IT costs. MaxQ Xpress is harnessed through the seamless workflow integration of the trusted MaxQ partner experience.

MaxQ IQ – adds automatic triggers to Accipio, alerting a physician to consider patient reimaging due to unwanted image artifacts.

"Simply put, our commercialization strategy is working," said Michael Rosenberg, co-founder & Chief Executive Officer of MaxQ AI. "Clinically deep applications that are seamlessly integrated into our channel partners' platforms produce measurable ROI for our customers and their patients. Our partners trust our pedigree of compliance, security certifications, and standards leadership and is evidence by the fact that by the end of 2020, MaxQ will have deployed to several hundred institutions throughout U.S., E.U., and Australia."
Adoption of AI-based healthcare solutions is accelerating, with radiology departments leading the way. "We serve multiple hospitals where we may have several CT head cases with other stat exams to read-with no way of knowing what is the most acute without adding more radiologists," said Dr. Delano of Michigan State University. "This risk exposure is amplified when a priority stroke case hits the ED. Having an intelligent solution prioritize these cases would increase safety, improve patient care, and inform staffing decisions."
Similarly, "Each month Accipio Ix processes nearly one-thousand head CT scans, including upwards of 30 stroke cases per week, at Capital Health," said Dr. Ajay Choudhri, Chairman of the Department of Radiology at Capital Health Hospitals in New Jersey. "With Accipio Ax, we will be able to benefit from a comprehensive solution for triage through the intelligent workflow prioritization of MaxQ Xpress and slice-level preview of ICH, including the exclusive Accipio Ax SliceMap, which will guide users rapidly to CT images with suspected ICH." ICH accounts for up to 20% of strokes, and there is projected to be 3.4 million stoke victims by 2030, generating $240 billion in total direct and indirect costs*.
Accipio devices are globally available with multiple regulatory approvals and seamlessly deployed through MaxQ's trusted channel partner base, including GE, Philips, Nuance, FujiFilm, Blackford, IBM Watson Health, and TeraRecon. Radiology Departments, Emergency Room, and Neuroradiology teams utilize Accipio to make treatment path decisions while lessening burden and burn-out. The platform is comprised of Accipio Ix (Intracranial Hemorrhage (ICH) triage and notification, Accipio Ax (Slice-Level Annotation), and Accipio Dxg (Triage for ICH Presence or Absence)**.
MaxQ is the only AI platform company offering advanced AI applications and AI Platform solutions such as MaxQ Xpress as a seamless, integrated offering, secured through ISO 27001 and ISO 27999 cybersecurity standards. MaxQ's Accipio platform can be viewed at the 106th RSNA virtual exhibit through its unique AI experience within each of the MaxQ partners' AI platforms.
About MaxQ AI, Ltd.
MaxQ AI is transforming healthcare by empowering physicians to provide 'smarter care' with enhanced clinical workflow solutions assisting with improved patient triage and artificial intelligence (AI) clinical insights. Based in Tel Aviv, Israel and Andover, MA our team of deep learning and machine vision experts develop innovative software that uses AI to interpret medical images and surrounding patient data. Working with world-class clinical and industry partners, our software enables physicians to make faster, more accurate decisions when diagnosing intracranial hemorrhage, stroke, brain trauma, and other serious conditions. To learn more, visit http://www.maxq.ai or follow us on LinkedIn.
*References Available Upon Request
**MaxQ Device Regulatory Status Available at http://www.maxq.ai



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Program that provides individuals with cystic fibrosis & caregivers tools needed for work-from-home employment gains new supporters

LOS ANGELES (PRWEB) DECEMBER 03, 2020
Claire's Place Foundation, a non-profit organization providing support to children and families affected by cystic fibrosis (CF), is proud to announce that Vertex Pharmaceuticals Incorporated has awarded the foundation with a grant of $50,000 to support their Work Proudly Program. The grant is provided by the Vertex Circle of Care program, a competitive grant opportunity that funds innovative patient-centric programs for the CF community.
The Claire's Place Foundation Work Proudly Program provides job training and equipment needed for work-from-home employment to adults with CF and caregivers. The program helps people like Amanada whose son Jonathan has CF. The strain on her professional life and her family's finances has been far greater than she anticipated. Jonathan is now 13 years old, and Amanda has lost count of the number of times she has lost a job because she missed work while Jonathan was hospitalized. "I can no longer keep this depressing cycle of loss going," Amanda says. "I want a way to sustain myself and my family during trying times."
In 2018, only 39% of adults with CF had a college degree, and just 52% were employed. To help the CF community, the Work Proudly Program identifies potential careers, covers the cost of certificate job training and provides the technology needed for remote work. Through the program, CF patients and caregivers will see reduced unemployment and increased earning potential and self-esteem.
Since the program's launch in August 2020, the Work Proudly Program has attracted numerous partners. The generous partners are donating needed computers, tech support, career coaching and funds to help the participants kick-off their career from the safety of their home. Partners include:
human-I-T: Donated laptops and one year of tech support and internet service
Former Claire's Place Board Member Dave Gersholowitz: Donated computers for the first 15 Work Proudly Program participants
Certified Professional Career Coach Ashlee Anderson - Donating her career coaching services to help program participants identify a career interest and a path to employment
Founder of Transcribeanywhere.com Janet Shaughnessy: Providing a discounted price for all of her transcription courses to program participants
Ashworth College: Providing a registration liaison for program participants making registration and third party payments seamless
Mary and Joseph Family Fund: Donated $5000 in honor of the late Donna Frantom
"We are extremely grateful for the influx of support for our new Work Proudly Program," said Claire's Place Foundation Executive Director Melissa Yeager. "The program is so needed and timely and we are honored that Vertex, a global biotechnology company, as well as independent organizations and individuals all recognize this urgent need in our community. My daughter Claire personally experienced how difficult it was as a young adult with CF to find flexible employment that would provide her with a sustainable income. We created the Work Proudly Program to help CF patients and caregivers live proudly and that includes having a fulfilling career. We are thankful not only for our partners' show of confidence and support of our program, but also for their commitment to helping people living with this disease."
Claire's Place Foundation will pilot the Work Proudly Program through June 2021, participants will be recruited through a social worker referral found on our website. To help support the Claire's Place Foundation Work Proudly Program please visit here to donate.
About Claire's Place Foundation, Inc.
Claire's Place Foundation, Inc. is a 501(c)(3) non-profit organization providing support to children and families affected by cystic fibrosis (CF). Claire's Place Foundation is named in honor of Claire Wineland who lived with CF her entire life and passed away at the age of 21. Claire was an activist, author, TEDx Speaker, social media star and received numerous awards. Claire's foundation was a way for her to assure that others living with CF enjoyed the same hope, strength and joy that she enjoyed. Recipient of Los Angeles Business Journal's "Small Nonprofit of the Year," the foundation provides grants to families affected by CF, offering both emotional and financial support. Today, Claire's Place Foundation continues to carry on Claire's legacy. For more information and make a donation, please visit http://www.clairesplacefoundation.org.

"The program is so needed and timely and we are honored that Vertex, a global biotechnology company, as well as independent organizations and individuals all recognize this urgent need in our community," said Claire's Place Foundation Executive Director Melissa Yeager.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

FDA awards a contract to the American College of Medical Toxicology (ACMT) to establish a COVID-19 Sub-Registry to collect data on the safety of drug products used for the prevention or treatment of COVID-19 infection.

PHOENIX (PRWEB) DECEMBER 03, 2020
ACMT's Toxicology Investigators Consortium (ToxIC) is a unique multicenter toxicosurveillance and research network comprised of physicians specifically qualified in the field of medical toxicology. Since the network's establishment in 2010, there have been over 73,000 cases recorded into ToxIC's Patient Registry from 40 participating sites across the United States comprised of more than 60 hospitals and clinics. ToxIC was designed to provide accurate, reliable and timely data on adverse effects arising from exposures to medications, drugs of abuse, natural substances, metals, pesticides, or other chemical substances.
The COVID-19 Sub-Registry will be developed as an enhanced data collection tool within the ToxIC network that will specifically focus on identifying potential adverse reactions related to COVID-19 drug treatments. Physicians specialized in medical toxicology will oversee the program at 15 designated medical centers across various geographic regions in the United States.
"ACMT is very honored to receive this contract from FDA for this important project related to medication safety surveillance," said Dr. Paul M. Wax, ACMT's Executive Director and co-founder of ToxIC. "For over a decade, ACMT has worked diligently to develop the ToxIC Program as a useful tool for adverse drug reactions and overdose surveillance." Jeffrey Brent, MD, PhD, Co-Principal Investigator on this project states that "particularly now, in the midst of the COVID-19 pandemic, we anticipate this collaboration will deliver critical data that could improve public health decision making."
The FDA has had a contract with ACMT to access the ToxIC Registry for three years. The new ToxIC Sub-Registry is designed to provide FDA's Center for Drug Evaluation and Research (CDER) safety data related to drug therapies used in patients with or suspected to have COVID-19. ACMT will work in close collaboration with scientists in CDER's Office of Surveillance and Epidemiology (OSE) and Office of Translational Sciences (OTS).
The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians with recognized expertise and board certification in medical toxicology. Our members specialize in the prevention, evaluation, treatment, and monitoring of injury and illness from exposures to drugs and chemicals, as well as biological and radiological agents. ACMT members work in clinical, academic, governmental, and public health settings, and provide poison control center leadership.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Leading Pet Specialty Brand Takes Top Honors in Dog & Cat Healthcare Category by Pet Business Magazine

OCEANSIDE, CALIF. (PRWEB) DECEMBER 03, 2020
Skout's Honor, the environmentally and socially conscious pet specialty brand known for its stain and odor solutions and innovative probiotic grooming and wellness products, today announced that it has won a 2020 Pet Industry Recognition Award by Pet Business Magazine for its life-changing Probiotic Wellness line for pets.
The 19th annual Pet Business Industry Recognition Awards celebrate the best products within the pet care category and Skout's Honor's Probiotic Wellness Line has been singled out as a winner within the Dog & Cat Healthcare Category. The full list of winners are also recognized in the December issue of Pet Business Magazine.
Skout's line of scientifically-proven and Veterinarian-approved Probiotic Wellness products launched earlier this year, and includes:
Probiotic Ear Cleaner (4oz), MSRP $9.99

Gently cleans, soothes and protects dirty, itchy and irritated ears

Restores harmony and helps stabilize the ear's natural microbiome

Probiotics keep working for up to 2 weeks after application, to naturally defend the body against bad bacteria (that causes itch, odor, infection)

Alcohol and fragrance-free, non-medicated

Probiotic Itch Relief Spray w/Oatmeal (8oz), MSRP $14.99

Naturally calms, soothes and hydrates itchy, irritated skin

Offers comfort and long-lasting relief for pets who suffer from chronic skin irritations

May be used as needed or as a daily preventative spray

Probiotic Hot Spot Hydrogel (4oz), MSRP $19.99

100% natural and non-medicated

Soothe, heal and protect wounds, including hot spots, abrasions, lacerations, burns and irritated skin.

Adheres to the affected area to moisturize, prevent potential infection and promote optimal healing conditions with the natural benefits of aloe vera, hickory bark extract, alginate and topical probiotics

Prebiotic Pet Balm w/Manuka Honey (2oz tin), MSRP $16.99

Daily-use paw & nose protector

Provides instant relief and ongoing protection for paws, noses and more

100% Natural & Anti-microbial

For more information about Skout's Honor's award-winning pet essentials, visit http://www.skoutshonor.com. For national & international distribution and retail opportunities please contact Shannan Morlas, National Sales Manager, at shannan@skoutshonor.com.
About Skout's Honor
Skout's Honor is an award-winning company based in Oceanside, Calif. that offers everyday pet essentials. Founded by a team of animal lovers and proud pet owners, the company created its "Skout's Paw Pledge," and donates a day's worth of food for a shelter animal in need with every product sold. For more information on the products and for specific retailers, please visit SkoutsHonor.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Researchers from the Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) are among the presenters during the 2020 San Antonio Breast Cancer Symposium, which will take place virtually Dec. 8-11. This internationally renowned symposium is owned and operated by the Mays Cancer Center.

SAN ANTONIO (PRWEB) DECEMBER 03, 2020
This year's San Antonio Breast Cancer Symposium (SABCS) will take place virtually from Dec. 8 through Dec. 11. One of the largest breast cancer meetings in the world, the four-day conference was founded and is owned and operated by the Mays Cancer Center, part of The University of Texas Health Science Center at San Antonio.
Members of the media who wish to register or to learn more about the symposium can visit sabcs.org.
This year's conference will feature an oral presentation by Manjeet Rao, PhD, about a possible FDA-approved anti-depressant being studied that may block breast cancer growth by preventing breast cancer cells from repairing themselves.
Dr. Rao has been studying the unique ability of cancer cells to repair DNA damage caused by either unchecked growth or chemotherapy and radiation. Even though breast cancer cells can't repair all the damage themselves, they recruit back-up DNA repair systems in the body to help damaged cells survive and continue replicating. These back-up DNA repair systems can cause previous treatments not to work if cancer returns. "Our pre-clinical and clinical data show that a drug that can inhibit the alternate DNA repair pathway signaling may promote immune surveillance, and therefore may serve as a novel treatment option for treating breast cancer patients," Dr. Rao said.
He will be presenting preliminary results from a clinical trial that is being conducted exclusively at UT Health San Antonio to evaluate the anti-depressant drug Imipramine that may inhibit breast cancer growth by stopping the alternate repair programs. The presentation will be given during the afternoon session on Tuesday, Dec. 8, between 1 and 3 p.m.
Dr. Rao is a professor of cell systems and anatomy, deputy director of the Greehey Children's Cancer Research Institute based in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, and is co-leader of experimental and development therapeutics at the Mays Cancer Center.
Poster sessions
A sampling of the posters offered by UT Health San Antonio faculty members are as follows:
Andrew Brenner, MD, PhD, a medical oncologist and associate professor in the Division of Hematology and Medical Oncology, studies breast cancer, including breast cancer that has spread to the brain. The blood-brain barrier, a specialized rim of cells around the outside of the brain, allows nutrients in but prevents many substances from entering, including many cancer treatments; therefore, it has been difficult to treat brain tumors in the past. Scientists have been studying how to piggyback potent drugs onto specially designed molecules that are capable of entering the brain.
Dr. Brenner's poster is based on a clinical trial conducted only at the Mays Cancer Center that evaluated the ability of an FDA-approved antibody called sacituzumab govitecan (SG) to carry a highly potent chemotherapy drug, SN-38, to the tumors without injuring healthy tissue.
He tested this theory in two groups of patients: one group of 11 patients with highly aggressive triple-negative breast cancer that had spread to the brain, and a second group of 10 patients with glioblastoma, another form of aggressive cancer that originates in the brain or spinal cord. After receiving an initial dose of SG carrying SN-38, both sets of patients had tumors surgically removed for analysis.
Early results showed that most patients with metastasized breast cancer showed improvement, while all glioblastoma patients still showed some measurable disease. Final results of the trial will be revealed in the poster session.
Patricia Chalela, MPH, DrPH, is an associate professor in UT Health San Antonio's Institute for Health Promotion Research. She is working on a smartphone app to encourage patients to continue using hormone therapy, which has been proven to contribute to the reduction of recurrence and death from breast cancer long term, as high as a 50% reduction into the second decade after breast cancer diagnosis.
The purpose of her app is to promote continued adherence to hormone therapy among breast cancer patients while increasing patient education, enhancing self-efficacy, facilitating communication with the medical team and helping patients develop self-care skills to promote optimal adherence to hormone therapy.
Virginia Kaklamani, MD, is a professor and leader of the breast cancer program at the Mays Cancer Center, and one of three co-leaders of the SABCS. She has been studying new ways to classify subtypes of triple-negative breast cancer.
"We evaluated the relationship between the tumors' unique gene expression signatures to the known tumor subtypes using a tumor characterization tool called BluePrint," she said. The new technology describes the "chain reaction" of chemical processes within the tumor to more specifically characterize the tumor. "These data suggest that molecular classification by BluePrint adds further precision in classifying triple-negative breast cancer in patients and sheds new light on the differences among these tumors," she said. This information is valuable to cancer physicians in matching the tumor subtype to the most effective treatment.
Kate Lathrop, MD, breast medical oncologist and associate professor of medicine at the Mays Cancer Center, also is studying triple-negative breast cancer. In collaboration with Ausio Pharmaceuticals, she is exploring a new oral medication that targets the cancer's estrogen beta receptor. This medication, S-equol, was given to women with triple-negative breast cancer for two to three weeks.
"Tumor samples from before and after taking the medication were compared, and on average, the speed of tumor growth was decreased. This is encouraging as there are relatively few treatments for triple-negative breast cancer," Dr. Lathrop said. The medication was well tolerated and had few side effects. Additional studies are currently being planned for S-equol, she said.
# # #
The Mays Cancer Center, part of The University of Texas Health Science Center at San Antonio, is one of only four National Cancer Institute-designated Cancer Centers in Texas. The Mays Cancer Center provides leading-edge cancer care, propels innovative cancer research and educates the next generation of leaders to end cancer in South Texas. Visit cancer.uthscsa.edu.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Key West is the 17th new MÜV location this year alone, for a total of 28 dispensaries across the state, bringing jobs and award-winning products to the southernmost point in the continental U.S.

SARASOTA, FLA. (PRWEB) DECEMBER 03, 2020
AltMed Florida, one of the fastest growing medical cannabis companies in Florida, continues its statewide expansion with a three-day opening in Key West starting Saturday December 5, 2020 at 10am (pending final approvals) for its newest MÜV Medical Cannabis Dispensary.
Location: 519 Duval Street, the most popular street in Key West.
"Having MÜV on iconic Duval Street is a feather in our cap. Residents and visitors will now have access to our award-winning products and top-notch service," said John Tipton, AltMed Florida CEO. "Being in such a high traffic destination, this newest location is a great fit for us. We're excited about becoming part of the Key West community and building lasting relationships with our patients there."
With millions of visitors each year, Duval Street is lined with retail shops, restaurants and nightlife hotspots like Sloppy Joe's Bar, which is a designated National Historic Landmark. Running north to south from the Gulf of Mexico to the Atlantic Ocean, Duval Street is the epicenter of Key West's famous party atmosphere.
The Key West MÜV is the southernmost dispensary in the continental U.S. - just around the corner from the famous Mile-0 marker and near the Southernmost Point Buoy, both bustling tourist landmarks. MÜV is also located on the same block as the popular Margaritaville Key West Restaurant.
During the opening, staggered over three-days (Dec.5-Dec.7) for crowd mitigation, all licensed Florida medical cannabis patients will receive a one-time use only, one per patient, 25 percent off their entire first purchase. Patients can order online for express pickup at muvfl.com where they will see real-time live inventory including specific strains and potencies of products.
Deemed an essential service during the pandemic, AltMed Florida has been able to expand its workforce to over 700 employees with additional teams coming onboard at each of its 17 new dispensaries this year. With higher demand for products from 28 total dispensaries, AltMed has also generated additional construction employment and staffing with the expansion of its 220,000-square-foot cultivation facility in Apollo Beach.
The newest state-of-the-art MÜV dispensary will offer an extensive selection of award-winning products including flower, pre-rolls, a wide range of vaporizer pens, metered dose inhalers, topicals, oral sprays, patent-pending encapsulation formulations in its tinctures, 72-hour transdermal patches and transdermal gels. MÜV also has one of the widest selections of concentrates for patients needing macro-dosing options.
Like AltMed Florida's 27 other locations (Apollo Beach, Bradenton, Bonita Springs, Cape Coral, Clearwater, Deerfield Beach, Fort Myers, Gainesville, Jacksonville/San Marco, Jacksonville Beach, Lady Lake, Lakeland, Longwood/Orlando, Lutz, North Port, downtown Orlando, Ormond Beach, Pensacola, Port St. Lucie, Sebastian, Sarasota, St. Petersburg, Shalimar, Tallahassee, Tampa, Wellington and West Palm Beach) MÜV Dispensaries are designed to provide a premium experience – think Apple Store, with a modern design and expert staff that undergoes extensive training.
The MÜV brand already has a wide following in other legal medical cannabis markets, including Arizona, where it has won five Best of Arizona medical cannabis awards. MÜV products are sold exclusively in Florida at MÜV dispensaries because, unlike other states, Florida does not allow wholesale of product between license holders - only products that license holders make themselves can be sold in their dispensaries.
For more information about the new ADA-compliant MÜV Medical Cannabis Dispensary at 519 Duval Street in Key West, including hours and available MÜV products, visit muvfl.com.
AltMed Florida is on pace to open 40 MÜV Medical Cannabis Dispensaries across the state, all supplied by its 220,000-square-foot, state-of-the-art cultivation facility. Visit this link for images of AltMed Florida's cultivation operations and watch this brief video to see what makes AltMed Florida and its MÜV Medical Cannabis Dispensaries stand out.
About MÜV - The MÜV brand of medical cannabis infused products launched in Arizona in 2016 and quickly gained international attention and recognition. MÜV Dispensaries by AltMed Florida was formed a year later through the partnership of AltMed Enterprises and Plants of Ruskin, a multi-generational Florida agricultural leader. Through continual research and development, MÜV has received multiple patents for its award-winning MÜV Products line that provides quality, consistent and reliable medical cannabis products to patients at all 29 locations (one in Arizona muv-az.com, 28 in Florida muvfl.com, and more added each month). Patients are encouraged to place reservations online at muvfl.com for in-store pickup, order for delivery, or visit any one of the MÜV Dispensaries for alternative medical cannabis medicine you can trust.
About Plants of Ruskin, LLC - d.b.a. AltMed Florida, LLC - With a focus on quality and attention to detail, Plants of Ruskin has more than 35 years of experience in providing seedlings to farmers for vegetable and medical product production. Plants of Ruskin founders, the Dickman Family, are 4th generation farmers with a long history of working in conjunction with the University of Florida, including an endowed chair specifically dedicated to plant improvement.
About AltMed Enterprises - Alternative Medical Enterprises, LLC, headquartered in Sarasota, FL and doing business as AltMed Enterprises, is a fully integrated medical cannabis company that brings compassion, community engagement and pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.
Forward-Looking Statements - To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as "may," "should," "estimates," "predicts," "continues," "believes," "anticipates," "plans," "expects," "intends," "potential," "strategy" and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

With Covid-19 Vaccines on the Horizon, Churches Can Organize Socially Distanced Events with TouchPoint's Ticketing Feature

DALLAS (PRWEB) DECEMBER 03, 2020
TouchPoint, a church management system (ChMS) used by congregations nationwide, now includes a feature for ticketing individual seats that will help houses of worship plan events and responsibly reopen while maximizing available space.
An engaged community of fans and users of the ChMS regularly suggest new additions or features to the platform, making it purpose-built for the very audience it serves. This latest change is no different. Commissioned by Bellevue Baptist Church in Tennessee, the ticketing feature folds directly into both the desktop and mobile versions of TouchPoint. The integration means churches no longer need to migrate data from third-party vendors like Eventbrite or Brushfire to their church management systems, saving both time and effort.
The new feature also reduces costs. Churches can save over 75% vs. what competitors charge, with even greater cost savings for buying in bulk. According to MarketWatch, these savings will be a welcome boon to congregations, many of which have seen their budgets shrink during the pandemic.
So, while local and statewide closures start and stop until a majority of the public can be vaccinated, TouchPoint users can enjoy the platform's ticketing feature, which includes customizable social distancing rules that churches can use to maximize their facilities while keeping congregants safe.
Village Bible Church in Illinois especially appreciates the ability to apply social distancing parameters when using the TouchPoint ticketing feature. "It worked flawlessly, and people loved it," says executive pastor Keith Duff. "Much more efficient use of our space too, which is critical right now. Big win."
The feature has added functionalities that churches applaud. Unlike other event management and ticketing systems, TouchPoint allows users to build their own venues within the platform while giving churches the flexibility to offer a hybrid of in-person and virtual ticketing. In addition, churches can provide discount codes and services such as childcare during the same ticket-sales process.
"We're proud to debut a feature that meets a demonstrated need identified by our community of church leaders," says Andrew Triplett, director of consulting at TouchPoint. "These partnerships guide the platform's development and ensure its offerings are aligned with what churches truly require, not just what technologists think they need."
To schedule a demo of the TouchPoint platform and its robust ticketing feature, please email brian.bishop@touchpointsoftware.com.
About TouchPoint
TouchPoint is a powerful, cloud-based church management system that equips leaders to grow fully devoted followers of Christ. TouchPoint is designed for midsize to large churches looking for a ChMS solution that's ready to use and customizable. Its best-in-class, fully integrated mobile app helps users with contact records, membership management, volunteer management, child check-in, discipleship groups, ministry engagement, contributions, events, media, and more.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Mahjoubi, leading board-certified Anesthesiologist and founder of the Ketamine Healing Clinic of Los Angeles, discussed ketamine IV treatment therapy in a newly published Business Insider feature essay, "Job diary: I'm an LA doctor who runs a ketamine infusion therapy program to help people overcome depression, anxiety and trauma."

LOS ANGELES (PRWEB) DECEMBER 03, 2020
Dr. David Mahjoubi is among a select group of physicians in the United States to use ketamine as a treatment for depression, anxiety, PTSD and chronic pain. In the informative Business Insider piece, Dr. Mahjoubi details ketamine's value in improving mental health conditions, such as depression and PTSD, and what a patient can expect when going through the treatment process. He explains how after working at surgical centers throughout Southern California, he quickly noted the beneficial mental effects of IV ketamine in many patients post-procedurally. As a result of this realization, he founded Ketamine Healing Clinic of Los Angeles. The article goes into depth regarding the protocol for ketamine IV treatment at Dr. Mahjoubi's clinic and the benefits that can lead to the alleviation of depression, including meaningful realizations, decreased anxiety and negative thinking, increased energy and the processing of past trauma. Patients who are not tolerating anti-depressants or are resistant to other forms of treatment often make ideal candidates for ketamine therapy. As a non-opioid and non-addictive treatment, ketamine has also shown valued efficacy for helping chronic pain and fibromyalgia. Dr. Mahjoubi is one of a handful of doctors in the country offering ketamine nasal spray as a supplementary, at-home treatment to help maintain and extend the benefits of IV ketamine treatments.
"I hope this article helps people further understand the remarkable benefits that ketamine IV infusion therapy can have in treating depression symptoms as well as anxiety and chronic pain," says Dr. David Mahjoubi of Ketamine Healing Clinic of Los Angeles.
Link to Article: https://www.businessinsider.com/anesthesiologist-in-la-who-runs-ketamine-infusion-clinic-2020-11
More About Dr. David Mahjoubi of Ketamine Healing Clinic of Los Angeles:
David Mahjoubi, M.D., is a Diplomate of the American Board of Anesthesiology. He earned his medical degree at The Chicago Medical School and carries over a decade of experience with intravenous ketamine, beginning from his residency training at the University of Southern California (USC) + Los Angeles County Medical Center. Following his residency, Dr. Mahjoubi joined the Anesthesia Group at Northridge Hospital Medical Center and became the most active user of IV ketamine for both conscious sedation and general anesthesia cases. He then founded Ketamine Healing Clinic of Los Angeles, providing a highly effective option for patients with treatment-resistant depression and chronic pain. He is the author of multiple publications in the medical field.
Ketamine Healing Clinic of Los Angeles is located at 1762 Westwood Boulevard, Suite 320. To learn more about Dr. Mahjoubi and the Ketamine Healing Clinic of Los Angeles, please visit http://www.ketaminehealing.com or contact the clinic at (424) 278-4241 or (866) 987-7874.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it is investing $10 million in isolator capabilities at its sites in Malvern, Pennsylvania and Dartford, U.K., to expand its micronization capabilities for highly potent drug compounds.

SOMERSET, N.J. (PRWEB) DECEMBER 03, 2020
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it is investing $10 million in isolator capabilities at its sites in Malvern, Pennsylvania and Dartford, U.K., to expand its micronization capabilities for highly potent drug compounds.
The investment will allow flexible jet milling operations to be carried out at both sites under containment to a working occupational exposure limit (OEL) of 0.05 micrograms per cubic meter, enabling micronization of potent and highly potent compounds, at less than 10 and less than 1 microgram per cubic meter respectively. Additionally, the capability to operate under an inert nitrogen environment offers enhanced manufacturing safety, eliminates the risk of dust explosion for compounds with low minimum ignition energy (MIE) values, and enables the processing of humidity, light and oxygen-sensitive materials. Work is underway at both facilities, with installation and validation activities likely to be completed by mid-2021.
At Dartford, the isolator will encompass a K-Tron gravimetric feeder with KT35 hopper and feed screws, suitable for 8-inch and 12-inch jet mills. The DEC Group designed system will be fully automated and allow product and waste to be collected within a safe, controlled environment. At the Malvern facility, the nine-chamber isolator will be housed within a new extension at the site, and will be one of the biggest isolators installed in the United States. The multi-chamber design, undertaken by FPS Architects & Engineers Limited, offers superior ergonomics and is optimized to significantly reduce cleaning and maintenance time.
"Catalent offers multiple tools and technologies to drug innovators to improve the characteristics and efficacy of new molecules, and micronization is an important engineering step for many materials to help improve the solubility of oral drugs and optimize inhaled therapies," commented James Walter, Vice President Operations, Oral and Specialty Delivery at Catalent. "This investment allows us to ensure that access to this technology is not limited, as we see the development of highly potent molecules becoming more prevalent in the small molecule R&D pipeline against a number of disease targets."
The Dartford and Malvern sites offer world-leading expertise and experience in particle size reduction capabilities including micronization, jet milling, mechanical milling, cryogenic milling and associated analytical services, and work alongside Catalent's network of commercial-scale facilities. The company recently announced the launch of its OneXpress solution to integrate and accelerate a program's transition from early-phase development to commercial-ready manufacturing by leveraging its phase-appropriate scale, technologies, extensive oral dose form network and expertise to reduce risk, complexity and cost between phases.
About Catalent
Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs approximately 14,000 people, including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com
More products. Better treatments. Reliably supplied.

Catalent offers multiple tools and technologies to drug innovators to improve the characteristics and efficacy of new molecules



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In a first from iaedp's International Chapter, an eating disorders treatment training course is presented in all Spanish virtually by its renowned collective of experts including Dra. Rosanna Mauro, MS, CEDRD-S, Dra. Julieta Velez-Belmonte, PsyD, CEDS, NCC-OPCA, Dra. Juanita Gempeler Rueda, MD, FAED, Dr. Rodrigo León, PsyD, Dr. Antonio Tena, PsyD, Dra. Aridia Vásquez, MD, MS, RD, Dra. Eva Trujillo, MD, F.iaedp, FAED, Dra. Zuleika Morillo, MD, and Dr. Emmett Bishop, MD, FAED, F.iaedp, CEDS.

PEKIN, ILL. (PRWEB) DECEMBER 03, 2020
In a first from iaedp's International Chapter, an eating disorders treatment training course is presented in all Spanish virtually by its renowned collective of experts including Dra. Rosanna Mauro, MS, CEDRD-S, Dra. Julieta Velez-Belmonte, PsyD, CEDS, NCC-OPCA, Dra. Juanita Gempeler Rueda, MD, FAED, Dr. Rodrigo León, PsyD, Dr. Antonio Tena, PsyD, Dra. Aridia Vásquez, MD, MS, RD, Dra. Eva Trujillo, MD, F.iaedp, FAED, Dra. Zuleika Morillo, MD, and Dr. Emmett Bishop, MD, FAED, F.iaedp, CEDS.
The International Association of Eating Disorders Professionals (iaedp) is a premiere provider of educational programs and training standards for eating disorder treatment specialists and other healthcare professionals. Its International Chapter proudly serves a global community.
"This is a very special and rare opportunity for healthcare professionals who need this training in Spanish from the very best in the field of eating disorders treatment," said Blanche Williams, iaedp Director of International Development.
The cost for 11 expert sessions with two roundtable discussions is $130; students with credentials is $100; those who register with a friend is $100 each and registrants must include the name of each person in the registry. A Certificate of Participation will be awarded at completion of the training.
The training program presenters and workshops available in the course presentations include:
Brief Introduction to the Integrative Treatment of Eating Disorders - Dra. Julieta Velez-Belmonte, PsyD, CEDS, NCC-OPCA and Dra. Rosanna Mauro, MS, CEDRD-S
Functional Body: A Comprehensive and Novel Alternative to Managing Body Distortion on Eating Disorders - Dra. Juanita Gempeler Rueda, MD, FAED
Eating Disorders Prevention Model Based on Risk Level - Dr. Rodrigo León PsyD
Study and Clinical Practice of Binge Eating Disorder, Proposals Towards Its Comprehensive Care - Dr. Antonio Tena, PsyD
Beyond Food: Integrative Nutrition Therapy for Eating Disorders - Dra. Aridia Vásquez, MD, MS, RD
Eating Disorders from a Preventive Medical Perspective - Dra. Eva Trujillo, MD, F.iaedp, FAED
Roundtable- Feeding Disorders, Pica, Rumination Disorder - Dra. Aridia Vásquez, MD, MS, RD; Dra. Julieta Vélez-Belmonte, PsyD, CEDS, NBCC-OPCA; Dra. Zuleika Morillo, MD; Dra. Juanita Gempeler Rueda MD, FAED
From Theory to Practice: Role of the Psychiatrist in Eating Disorders - Dra. Zuleika Murillo, MD
ACT as a Strategy for Managing Personality Traits in Patients with Eating Disorders - Dr. Emmett Bishop, MD, FAED, F.iaedp, CEDS
Psychological Aspects of Eating Disorders and Body Image - Dra. Julieta Vélez-Belmonte, PsyD, CEDS, NBCC-OPCA
Reconstructing Eating Identity in Eating Disorders: A Key Factor for Recovery - Dra. Rosanna Mauro, MS, CEDRD-S, NBC-HWC
Round Table: ARFID - Dr. Emmett Bishop, Dra. Eva Trujillo, Dra. Rosanna Mauro.
REGISTRATION: https://iaedp.site-ym.com/event/ElCuerpoTerritorioDeLaImagen
Learn more about our International Chapter:
https://membershare.iaedp.com/international-chapter/
https://membershare.iaedp.com/international-chapter/en-espanol/
About the iaedp Foundation: Since 1985, the International Association of Eating Disorders Professionals has provided education and training standards to an international and multidisciplinary group of various healthcare treatment providers and helping professions. MemberSHARE.iaedp.com is an iaedp business journal and online member resource to learn about noteworthy member achievements, continuing education webinars and U.S. and International Chapter activity and events; for more information, visit MemberSHARE.

"This is a very special and rare opportunity for healthcare professionals who need this training in Spanish from the very best in the field of eating disorders treatment," said Blanche Williams, iaedp Director of International Development.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Food Industry Organizations Collaborate With Industry Stakeholders To Support the New Era of Smarter Food Safety

CHICAGO (PRWEB) DECEMBER 03, 2020
A group of six industry organizations today released a report outlining four months of leafy green traceability pilots with supply chain partners, including growers, distributors and both independent and chain retailers, offering a detailed response to the request by the U.S. Food and Drug Administration (U.S. FDA) for improved traceability in the food system. The three pilots, conducted July through October, showed that investigations into foodborne illness outbreaks could be streamlined and conducted more effectively when supply chain partners provided extended product information during tracebacks. Additionally, the use of a standard template called the Produce Traceback Template to exchange pertinent product information was found to enhance the speed of tracing procedures. All of the pilots were successful in tracing the source of the affected product.
The six organizations that led this industry activity included: FMI-The Food Industry Association; GS1 US; the International Foodservice Distributors Association (IFDA); the Institute of Food Technologists (IFT); Produce Marketing Association (PMA) and United Fresh Produce Association (United Fresh). The pilots tracked romaine lettuce through three separate supply chains, starting with actual consumer purchases made with loyalty cards or credit cards. Small teams of industry experts mimicked the U.S. FDA's role in conducting the traceback, including determining the data to be requested and how to format the requests for such data. Supply chain members, starting with the point-of-sale or point-of-service, used the template to provide key data elements that allowed an item to be traced back to its source. The expert groups conducting the traceback analyzed the information provided by each supply chain node to determine next steps.
Although the participants stated they would adopt the template in the future, the pilots revealed opportunities to refine the template and highlighted the need for a greater focus on education. The pilot report provides guidance on a path forward for future use of the template including additional industry training and modifications to maximize effectiveness and increase ease of use.
Notably, the data that enabled each of the teams to independently and successfully identify the finished product lot purchased by the consumer is not currently captured by the template. These data included business intelligence such as sales data, stock rotation, inventory controls and delivery schedules. These were critical in bracketing the scope of the traceback.
"As outlined in the New Era of Smarter Food Safety Blueprint, pilots like these are necessary to determine what is needed for traceability to further scale, such as testing interoperability and public and private data sharing," said Bryan Hitchcock, executive director of IFT's Global Food Traceability Center, on behalf of the six organizations.
"The pilots provided valuable insights that will inform future outbreak response and recall protocols, helping industry to work together to support the FDA's focus on tech-enabled traceability."
For more information on the pilots, please visit https://ift.org/leafygreens.
###
About FMI-The Food Industry Association - As the food industry association, FMI works with and on behalf of the entire industry to advance a safer, healthier and more efficient consumer food supply chain. FMI brings together a wide range of members across the value chain — from retailers that sell to consumers, to producers that supply food and other products, as well as the wide variety of companies providing critical services — to amplify the collective work of the industry. https://www.fmi.org
About GS1 US - GS1 US, a member of GS1 global, is a not-for-profit information standards organization that facilitates industry collaboration to help improve supply chain visibility and efficiency through the use of GS1 Standards, the most widely used supply chain standards system in the world. Nearly 300,000 businesses in 25 industries rely on GS1 US for trading partner collaboration that optimizes their supply chains, drives cost performance and revenue growth, while also enabling regulatory compliance. They achieve these benefits through solutions based on GS1 global unique numbering and identification systems, barcodes, Electronic Product Code (EPC)-based RFID, data synchronization, and electronic information exchange. GS1 US also manages the United Nations Standard Products and Services Code (UNSPSC). https://www.gs1us.org
About IFDA - The International Foodservice Distributors Association (IFDA) is the premier trade organization representing the $303 billion foodservice distribution industry and the 350,000 people it employs. This industry ensures a safe and efficient supply of food and products to more than one million restaurants and foodservice outlets in the U.S. every day. For more information, visit https://www.ifdaonline.org.
About IFT - The Institute of Food Technologists (IFT) is a global organization of approximately 13,000 individual members from 95 countries committed to advancing the science of food. Since 1939, IFT has brought together the brightest minds in food science, technology and related professions from academia, government, and industry to solve the world's greatest food challenges. Our organization works to ensure that our members have the resources they need to learn, grow, and advance the science of food as the population and the world evolve. We believe that science is essential to ensuring a global food supply that is sustainable, safe, nutritious, and accessible to all. For more information, please visit https://www.ift.org.
About PMA - Produce Marketing Association (PMA) is the leading trade association representing companies from every segment of the global produce and floral supply chain. PMA helps members grow by providing business solutions that expand business opportunities and increase sales and consumption. For more information, visit https://www.pma.com.
About United Fresh - Founded in 1904, the United Fresh Produce Association brings together companies across every segment of the fresh produce supply chain, including growers, shippers, fresh cut processors, wholesalers, distributors, retailers, foodservice operators, industry suppliers and allied associations. We empower industry leaders to shape sound government policy. We deliver the resources and expertise companies need to succeed in managing complex business and technical issues. We provide the training and development individuals need to advance their careers in produce. Through these endeavors, we unite out industry with a common purpose – to build long-term value for our members and grow produce consumption. For more information, visit https://www.unitedfresh.org.
Media Contacts:
FMI: Heather Garlich, hgarlich@fmi.org, 202-220-0616
GS1 US: Kaitlin Friedmann, kfriedmann@gs1us.org, 609-620-8074
IFDA: Meghan Cieslak, mcieslak@ifdaonline.org, 703-962-9950
IFT: Jennifer Garcia, JGarcia@ift.org, 312-604-0273
PMA: Cassidy Taylor, ctaylor@pma.com, 860-716-5586
United Fresh: Mary Coppola, mcoppola@unitedfresh.org 202-303-3425

"The pilots provided valuable insights that will inform future outbreak response and recall protocols, helping industry to work together to support the FDA's focus on tech-enabled traceability."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

This extended 30-minute "Special Edition" of Behind the Mystery: Rare and Genetic will air on December 9 and January 26 on Lifetime TV and will then stream online at: https://thebalancingact.com/rare.

DEERFIELD BEACH, FLA. (PRWEB) DECEMBER 03, 2020
"Behind the Mystery: Rare and Genetic" (BTM) is a recurring health segment on the national, award-winning morning show, The Balancing Act, that highlights the emotional, scientific and medical aspects of rare and genetic diseases. For the past nine (9) years, BTM has been bringing these often undiagnosed, misdiagnosed and complex medical conditions to the forefront by partnering with pharmaceutical and biotechnology companies who are on a mission to educate the public, leading to earlier diagnosis and treatment. To date, the show has featured over 100+ disease states and is an invaluable resource to people suffering from these disorders and the entire rare disease community.
This extended 30-minute "Special Edition" of Behind the Mystery: Rare and Genetic will air on December 9 and January 26 on Lifetime TV and will then stream online at: https://thebalancingact.com/rare.
Featured rare diseases:

Sickle Cell Disease - is a lifelong debilitating disease, affecting an estimated 100,000 people in the U.S. Patient's with sickle cell have an inherited mutation in their hemoglobin gene causing red blood cells to become hook-shaped or crescent-shaped every time they give up oxygen. As a result, they clump and clog blood vessels, limiting blood flow, causing intense pain and organ damage. Patients with severe Sickle Cell have frequent pain episodes and trips to the hospital; they typically only live to their 40's. In this special episode, you will meet Carla, a sickle cell patient who has outlived the average life expectancy, and learn about a new, one-time potentially curative investigational gene therapy by Dr. Malik of The Comprehensive Sickle Cell Center at Cincinnati Children's. For more information, visit momentumtrials.com or clinicaltrials.gov.

IgA Nephropathy (IgAN) – is a progressive kidney disease in which up to 50% of patients end up at risk of developing end stage kidney disease and possible kidney dialysis. Although it manifests in the kidneys, most scientific studies have found that the cause of IgAN begins in the gastrointestinal track. Currently there are no approved treatment options; however, clinical trials are currently being conducted to target the abnormal IgA production thought to be the cause of the inflammation and scaring which causes the kidneys to decline. In this special episode, IgAN Researcher and Nephrologist Dr. Jonathan Barratt of the University of Leicester, UK, discusses this complex kidney disease. John, an IgAN patient, also shares the journey of his shocking diagnosis and how he is determined to help others suffering with the disease. For more information, visit igan.org.

###
About The Balancing Act: The Balancing Act is a morning show created and produced by BrandStar that offers sensible solutions and essential information in a fun, entertaining format; providing resources to help people do life better. Now in its 19th season, The Balancing Act features everything from delicious recipes, style makeovers and dream getaways to parenting tips and the latest news in health and wealth. Tune in to The Balancing Act weekdays at 7:30 a.m. (ET/PT) on Lifetime, and find all previously aired episodes on TheBalancingAct.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Wellness visionaries honored for achievements in leadership and innovation

MIAMI (PRWEB) DECEMBER 03, 2020
The Global Wellness Summit (GWS), the foremost gathering of international leaders in multitrillion-dollar global wellness economy, today announced details about the individuals who took top honors in four award categories announced during the 2020 GWS, an annual event that is recognized as the leading conference on the business of wellness. In this unique year, winners received their honors during the Summit's first-ever hybrid conference, which connected in-person delegates at The Breakers Palm Beach with hundreds of virtual attendees over three days of the Summit.
Videos of each award presentation can be viewed via the 2020 Global Wellness Summit ON DEMAND package, which features all 73 main-stage keynotes, interviews, and panels with world experts on the future of wellness. In addition, ON DEMAND subscribers receive access to the Global Wellness Institute's new research report, "Defining the Mental Wellness Economy." Preview ON DEMAND here.
The Debra Simon Award for Leader in Furthering Mental Wellness was presented to Lynne and Victor Brick by Susie Ellis, chair and CEO, Global Wellness Summit, on behalf of Lauren Wright. The Bricks were honored for creating the John W. Brick Mental Health Foundation, honoring Victor's brother John, who suffered from mental illness for many years. The Foundation's mission is to fund and promote evidence-based research on how healthy lifestyle choices—such as exercise, nutrition and mind-body practices—benefit mental health. The Debra Simon Family Foundation sponsors the award.
After receiving a standing ovation from delegates at the 14th annual GWS, Victor Brick said, "My brother's passing was tragic at the time (and) I never cried so hard in my life. But...if his life is an agent for change, then it was a successful life. And I have a feeling that this is how we're going to look at the pandemic and the coronavirus, as an agent for change."
The Global Wellness Award – Leading Woman in Wellness, was presented to Veronica Schreibeis Smith, a pioneer in the wellness architecture movement and founder of Vera Iconica Architecture, by GWS Chief Creative Officer and Executive Director Nancy Davis. The award honors a woman who is making an extraordinary contribution in any of the wellness sectors, whether as an entrepreneur or a health and wellness champion. Schreibeis Smith was recognized for designs that are in complete harmony with nature, along with the aesthetic, science and technology that makes her an industry leader. Hyatt Hotels & Resorts sponsored the award.
Accepting her award, she said, "Being recognized for the impact we want to have on the industry is an incredible honor and brought tears to my eyes. Thank you so much for all of the support that you have given to me. This is such an amazing community."
The Inaugural Global Wellness Summit Prize for Innovation was awarded to Amai Proteins, an Israel-based innovator focused on fixing the global food system one protein at a time. The competition entries were reviewed by an impressive panel of international CEOs, business leaders and venture capitalists in the wellness space. Amai's innovation, Sweet Designer Proteins sugar substitutes—a healthy sustainable alternative to sugar—faced stiff competition with 84 companies from all sectors of wellness responding to the inaugural "Call for Wellness Innovations" competition and a dozen making the impressive finalists list. The competition was sponsored by WellTech1, a wellness fund and innovation hub in Tel Aviv.
Accepting the award from Amir Alroy, WellTech1 co-founder, Dr. Ilan Samish said, "The competition was challenging, and I am humbled by this vote of confidence."
Shark Tank of Wellness Global Student Competition. Krysta Silva, from Atlanta, Georgia's Savannah College of Art and Design, took first place honors ($5,000) for her allergy sensing fork, Samii. The runners up each received $2,500 and were Balazs Csatlos, from Hungary's University of Pannonia, for the Sleeping Beauty sleep mask, a new high-tech solution for getting a good night's sleep, and Liam James Campbell, also from the Savannah College of Art and Design, for Melo, a multifunctional pregnancy pillow to enhance sleep/rest.
The Shark Tank of Wellness awards were presented by Frank Pitsikalis, founder and CEO of ResortSuite (Canada), on behalf of fellow judges Julia Sutton, COO, Exhale Enterprises, and Karen Campbell, business development consultant at Chiva-Som (Thailand). Silva's innovation uses nanotechnology and the cellulose nanocrystals inside the fork to attract the allergenic proteins and detect them. The app then notifies the user that the food is not safe to eat, saving time, money, and a potential trip to the emergency room.
About the Global Wellness Summit: The Global Wellness Summit is an invitation-only international gathering that brings together leaders and visionaries to positively shape the future of the $4.5 trillion global wellness economy. Held in a different location each year, Summits have taken place in the US, Switzerland, Turkey, Bali, India, Morocco, Mexico, Austria, Italy and Singapore. The 14th annual Summit took place at The Breakers Palm Beach, FL, from November 8–11, 2020. The 2021 GWS will be held in Tel Aviv, Israel, November 15–20.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Healthcare Leaders to Partner on the Advancement of Patient Experience in Ambulatory Care

NASHVILLE, TENN. (PRWEB) DECEMBER 03, 2020
In expanding its commitment to elevate the human experience in healthcare, The Beryl Institute introduces its inaugural Ambulatory Care Council. The Council consists of professionals committed to supporting expansion of the experience conversation in ambulatory care environments, defined as care provided in outpatient settings without admission to a hospital or other facility.
"There are unique challenges and opportunities specific to delivering exceptional experience in ambulatory care environments," said Michelle Garrison, CPXP, Vice President, Membership, The Beryl Institute. "This Council will work collaboratively with the Institute's staff to build programs and resources to elevate and support members of our community working in these environments."
Complementing the Institute's other boards and councils, Ambulatory Care Council members have demonstrated passion in patient experience within a healthcare provider organization. Members of the inaugural Council include:
Co-Chairs:

Nicole Allen, Assistant Vice President, Patient Experience, HCA

Nancy Stueland-Adamski, Patient Experience Director, Marshfield Clinic Health System

Council Members:

Uriel Aguirre, Project Manager, University of Alabama at Birmingham Health System

Kristie Andrews, Director, Customer & Physician Engagement, Emory Healthcare

Anita Brazill, Healthcare Quality/Comms, Tandigm Health

Anne Brown, Executive Director, Patient Experience, Cone Health

John Cunningham, Senior Vice President, Operations and Experience, Premise Health

Sondi Fiegel, Director, Patient Care, Methodist Health System

Amanda Fox, Manager, Ambulatory Customer Experience, Tampa General Hospital

Nicolette Kerns, Service Line Director, Children's Hospital & Medical Center

Christina Martin, Director, Service Strategy, Kaiser Permanente Georgia

Cynthia Mento, Director of Operations, Crystal Run Healthcare

Sharmi Mukherjee, Director of Rehab, Outpatient, Washington Hospital Healthcare System

Tiffany Rooks, Director, Clinical Initiatives, OneOncology

Ashley Schmit, Ambulatory Clinical Practice Specialist, Children's Hospital & Medical Center

Garrett South, Patient Experience Lead, NewYork-Presbyterian

Natalie Whitlock, Ambulatory Care Experience Leader, Kaiser Permanente

Mary Wilkins, Patient Experience Consultant, CoxHealth

Stewart Williams, Senior Regional Manager, Patient and Care Experience, Providence St. Joseph Health

Debbie Young, Manager, Service Excellence, Sutter Health

For more information on the Ambulatory Care Council of The Beryl Institute, visit:
https://www.theberylinstitute.org/AMBULATORYCOUNCIL
For more information on the Ambulatory Care Community of The Beryl Institute, visit:
https://www.theberylinstitute.org/AmbulatoryCareCommunity
###
About The Beryl Institute:
The Beryl Institute is the global community of practice committed to elevating the human experience in healthcare. We believe human experience is grounded in experiences of patients & families, those who work in healthcare and the communities they serve. We define patient experience as the sum of all interactions, shaped by an organization's culture, that influence patient perceptions across the continuum of care.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

NDA Partners President Earle Martin announced today that John Godshalk, MSE, MBA, a former Reviewer and Investigator in the FDA Division of Manufacturing and Product Quality in the Center for Biologics Evaluation and Research (CBER), has joined the firm as an Expert Consultant. Mr. Godshalk is an expert in CMC, quality systems, product development, manufacturing, and cGMP for biologics.

ROCHELLE, VA. (PRWEB) DECEMBER 03, 2020
NDA Partners President Earle Martin announced today that John Godshalk, MSE, MBA, a former Reviewer and Investigator in the FDA Division of Manufacturing and Product Quality in CBER, has joined the firm as an Expert Consultant. As an FDA Reviewer, he was responsible for reviewing CMC sections of BLA submissions, leading pre-approval inspections for new biologics, device, and biotechnology products, conducting meetings with industry, and developing regulatory strategies. He is an expert in CMC, quality, and facility issues for cell and gene therapies and has experience with biologics, vaccines, drugs, drug/device combinations, biologic devices, and in vitro diagnostics.
In addition to his FDA experience, Mr. Godshalk has also consulted with small to large biopharma companies on CMC, quality strategy, quality assurance, product development and manufacturing, GMP systems for the US and EU, and auditing and training. Early in his career, he was a Research Engineer at Westvaco Corp. and Pilot Plant Manager at Energy BioSystems Corp.
According to Dr. Ellen Feigal, Manager of NDA Partners' biologics practice, "We are pleased to welcome Mr. Godshalk to NDA Partners as an Expert Consultant. His FDA and industry experience and expertise in CMC, quality, product development, manufacturing, and cGMP, make him a valuable resource to our clients developing biologics, including cell and gene therapies, vaccines, and biologic devices."
Mr. Godshalk earned his master's degree in chemical and biochemical engineering from Johns Hopkins University and MBA in marketing and finance from the University of Maryland, College Park and the Merrick School, University of Baltimore. He received his bachelor's degree in chemical engineering from North Carolina State University.
About NDA Partners
NDA Partners, a part of The Planet Group, is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.
Contact
Earle Martin, President
Office: 540-738-2550
MartinEarle@ndapartners.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Titanium Healthcare group plans statewide expansion with programs to support Medicaid patients

LOS ANGELES (PRWEB) DECEMBER 03, 2020
Titanium Healthcare Inc, a leading provider of programs designed to help patients with multiple, chronic conditions, is opening an office in Seattle, Washington to serve the Washington market with solutions for members that need exceptional care.
The company, headquartered in Los Angeles, CA, is bringing care management and its proven physician model to the market. The group intends to build programs of care management and primary care over the course of 2021 with the intention of being able to cover the entire Washington state by the end of the year.
"We believe that many patients will benefit from our program of care coordination and primary care. Our expectation is that our model, which will span 7 counties in California by early 2021, will port to the Washington market well." said Titanium CEO, Gray Miller. "We are excited to enter the Washington market in an effort to help more patients through statewide availability".
Titanium Healthcare Inc is a cutting-edge healthcare organization that delivers exceptional care though exceptional care coordination, telehealth and clinical intervention. We currently service major healthcare entities throughout California and have achieved less than 5% readmission rates and over 99% patient satisfaction. Patients may visit us at any one of our Titanium Healthcare clinics. For more information about our innovative model, please visit the Company's website at http://www.tihealthcare.com.
Contact:
Investor.relations@tihealthcare.com

The Titanium Model will help thousands of people in the State of Washington



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Comprehensive platform for all clinical trial data enables a proactive, data-driven approach to conducting more efficient clinical trials

MANSFIELD, MASS. (PRWEB) DECEMBER 03, 2020
eClinical Solutions LLC, a leading global provider of cloud-based products for clinical research and software driven clinical data services, announced that Celsius Therapeutics has selected the elluminate clinical data platform for use in their research programs. elluminate is used by Life Sciences companies to aggregate, standardize and analyze data from numerous systems and sources across trials, providing clinical teams with rapid data insights, improved data quality and reduced cycle times.
Celsius Therapeutics is developing a new model of target and drug discovery that leverages a systematic approach to single-cell sequencing. A key component of their strategy is building a database of single-cell genomic and patient clinical information to discover precision medicines for patients with autoimmune diseases and cancer, and other complex diseases. Celsius is using the elluminate platform and Mapper application to:

Aggregate clinical metadata within and across studies, without the time and costs associated with relying on programmers to aggregate and standardize data

Integrate numerous different and disparate data sources for rapid clinical and translational insights

"We are inspired by the work of clients like Celsius Therapeutics who are taking innovative approaches to the discovery of new medicines," said Raj Indupuri, eClinical Solutions Co-Founder and CEO. "The elluminate platform and Mapper application are designed to help life sciences companies like Celsius unlock the value of their data faster, replacing manual processes with automated insights."
About eClinical Solutions LLC
eClinical Solutions is a leading provider of cloud based enterprise software and software-driven clinical data services. The elluminate platform provides life sciences companies with greater control of their clinical trial data. elluminate software and data driven services have been used by more than 100 life sciences companies on more than 500 trials. For more information, visit http://www.eclinicalsol.com.
About Celsius Therapeutics
Celsius Therapeutics is charting a new course of target and drug discovery by applying a systematic approach to single-cell sequencing of patient tissue, combining massive datasets, complex algorithms, and machine learning to discover first-in-class precision therapies with a transformative impact on the lives of patients with autoimmune diseases and cancer. Celsius was launched in 2018 and is based in Cambridge, Mass. For more information, please visit http://www.celsiustx.com.

"The elluminate platform and Mapper application are designed to help life sciences companies like Celsius unlock the value of their data faster, replacing manual processes with automated insights," said Raj Indupuri, eClinical Solutions Co-Founder and CEO.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The integration of technology and medical care has become even closer in the post-pandemic era, and the pace of smart transformation is accelerating in the medical care industry. As part of its focus on the smart medical care sector, AUO will showcase its premium 3D surgical display solutions at the Healthcare Expo Taiwan at the Nangang Exhibition Center in Taipei from December 3 to 6.

HSINCHU, TAIWAN (PRWEB) DECEMBER 03, 2020
Issued by: AU Optronics Corp.
Issued on: December 2, 2020
Hsinchu, Taiwan, December 2, 2020–
The integration of technology and medical care has become even closer in the post-pandemic era, and the pace of smart transformation is accelerating in the medical care industry. As part of its focus on the smart medical care sector, AUO will showcase its premium 3D surgical display solutions at the Healthcare Expo Taiwan at the Nangang Exhibition Center in Taipei from December 3 to 6. These AUO-developed solutions include the 32-inch 4K polarized 3D display solution integrated with MedicalTek's world-leading 3D endoscope and minimally invasive surgery (MIS) visualization system, and a 15.6-inch 4K naked-eye 3D display with AUO's proprietary eye-tracking system for use in surgery rooms. AUO also leads the industry(*) in presenting the 32-inch 4K hyper-realistic surgical display set equipped with medical-grade mini LED technology, and a range of medical panel computers designed for medical institutions in partnership with ADLINK, all demonstrating AUO's accumulated strengths over the years to help accelerate the transformation of the medical care industry.
Expertise in High-end 3D Display Technology Taking Surgical Applications to the Next Level
AUO has years of profound experience in the development of 3D display technologies. The history goes back to the times of polarized 3D TV LCDs, large 3D interactive gaming displays, and naked-eye 3D display technologies for a variety of applications, many of which were the industry's firsts and represented key technological milestones. Newly developed 3D display technologies are now introduced for surgical applications. The 32-inch 4K polarized 3D display solution to be exhibited represents an integration of AUO's latest 3D display technology with the advanced 2D-to-3D stereoscopic endoscopy visualization technology developed by MedicalTek. Its use with MedicalTek's DARWIN3D endoscopy visualization system provides physicians with stereoscopic imagery that incorporates depth of view information. The improvement to hand-eye coordination effectively enhances the precision and quality of minimally invasive surgeries. The 15.6-inch 4K naked-eye 3D display also developed for use in surgery rooms incorporates AUO's proprietary eye-tracking system to effectively increase the 3D field of view and image quality. Physicians can then view crystal-clear 3D imagery from different angles during surgery without wearing 3D glasses to quickly establish the relative position and depth of organs and tissues.
High-end Medical Displays with High Resolution and Mini LED Backlighting Leading the Charge
The 32-inch 4K hyper-realistic surgical display set will also be showcased for the first time at the expo. AUO's medical-grade mini LED driver technology with the highest zone-count, along with advanced Deep Red technology for optimized display of red colors provide physicians with the most realistic colors and details. Improved distinction between minute differences in human body tissue and blood will help physicians make more accurate judgment. To meet the infection prevention and control needs in non-contact or multi-field applications in the post-pandemic era, AUO's high resolution, low reflection and touch technologies have now been applied to a range of All-in-One (AIO) hygienically-designed medical panel computers and monitors launched by ADLINK, the global leader in industrial computers. The screwless, fanless, fully sealed aluminum housing and anti-bacterial coating on ADLINK hygienically-designed medical panel computers satisfy the highest health standards. The easy and faster cleaning and disinfection procedures help ensure the safety of patients and operators. The medical-grade touch displays have edge-to-edge glass surface and on-screen buttons that can be operated with gloved hands and are resistant to bacteria to prevent transmission of infections.
AUO is focusing on the smart medical care sector and actively investing in the development of user-centric medical-grade displays that solve the pain points of users in the field. AUO is now one of the top three global suppliers for applications such as medical-grade displays and X-ray sensors, with products extensively adopted by international medical device makers. AUO's future strategy in the smart medical care market will focus on three areas: surgery room, medical management and medical testing. Professional display technologies will underpin the integration of pioneering AI and 5G technologies, while partnerships with customers and partners will serve to drive the smart transformation of the medical care sector. The progressive refinement of the field eco-system will enable the continued delivery of even better medical services to the general public.

Based on the available market research information as of December 2, 2020.

AUO photos can be downloaded at the Company's website:
https://auo.com/en-global/Download_Photos
Any use of photographs must cite the source thereof as AU Optronics Corporation.
ABOUT AU OPTRONICS
AU Optronics Corp. ("AUO") is one of the world's leading providers of optoelectronic solutions. Based on its profound R&D and manufacturing experience, AUO offers a full range of display applications and smart solutions integrating software and hardware, and leverages its core expertise to enter new business areas such as solar, smart retail, general health, circular economy and smart manufacturing service. Additionally, AUO has also been named to the Dow Jones Sustainability World Index since 2010. AUO's consolidated net revenues in 2019 were NT$268.79 billion. For more information, please visit AUO.com.
Safe Harbour Notice
AU Optronics Corp. ("AUO" or the "Company"), a global leader of TFT-LCD panels, today announced the above news. Except for statements in respect of historical matters, the statements contained in this Release include "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on our management's expectations, projections and beliefs at the time regarding matters including, among other things, future revenues and costs, financial performance, technology changes, capacity, utilization rates, yields, process and geographical diversification, future expansion plans and business strategy. Such forward looking statements are subject to a number of known and unknown risks and uncertainties that can cause actual results to differ materially from those expressed or implied by such statements, including risks related to the flat panel display industry, the TFT-LCD market, acceptance of and demand for our products, technological and development risks, competitive factors, and other risks described in the section entitled "Risk Factors" in our Annual Report on Form 20-F filed with the United States Securities and Exchange Commission on March 27, 2020. In addition, our SEC reports, including our Annual Report on Form 20-F contains other information on these and other factors that could affect our financial results and cause actual results to differ materially from any forward-looking information we may provide. We undertake no obligation to update or revise any forward-looking statements to reflect subsequent events, new information or future circumstances.
For more information, please contact:
Corporate Communication Division
Jessie Lee    Tel: +886-3-5008800 ext 3206    Email : jessie.jc.lee@auo.com
Katie Chen    Tel: +886-3-5008800 ext 3615    Email : katie.chen@auo.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Digital therapeutics company attracts global consumer investor and leading women's health expert as Chief Medical Officer

BOSTON (PRWEB) DECEMBER 03, 2020
Embr Labs, the breakthrough thermal technology company and creator of the Wave Bracelet, today announced a strategic investment by Joy Ventures and the appointment of Dr. Pamela Peeke as Embr Labs' Chief Medical Officer. Both moves help to solidify the company's leadership in women's health, wellness and digital therapeutics. The state of Massachusetts and the National Science Foundation recently recognized Embr Labs' role as a life sciences innovator by funding Artificial Intelligence for Menopause Symptoms, a collaboration between Embr Labs and UMass Institute for Applied Life Sciences that will produce the largest physiological dataset for natural menopause and advance the state of the art for detecting and predicting vasomotor symptoms, also known as hot flashes.
Dr. Pamela Peeke joins Embr Labs as Chief Medical Officer and will oversee clinical trials of the company's cutting-edge wearable that helps to improve women's stress, sleep and menopause symptoms. Dr. Peeke is a nationally renowned physician, scientist and expert in preventive and lifestyle medicine. She is also a Pew Foundation scholar in metabolism and a fellow of both the American College of Physicians and the American College of Sports Medicine, the latter of which she is a board member. As a three-time NY Times bestselling author and host of HER, the top women's health show on iTunes, Apple, and RadioMD, Dr. Peeke's message of health and wellness touches the lives of millions of women in the US and globally.
"As a physician and scientist, I am excited to be joining the Embr Labs' team. I look forward to creating clinical research opportunities and partnerships that will further the development and validation of this groundbreaking technology. At Embr Labs, we share a profound passion to improve people's health and wellbeing through our thermal digital technology. I'm honored and thrilled to be a part of this revolutionary new science," noted Dr. Pamela Peeke, Embr Labs' Chief Medical Officer.
As Embr Labs solidifies its leadership as a digital therapeutic company, the company has attracted global investors such as Joy Ventures, who are committed to advancing the growing category of consumer products for wellbeing. Joy Ventures' investment insight reflects an understanding that today's complex world combined with intense lifestyles has created stress, anxiety and life challenges that demand accessible and holistic solutions.
"At Joy Ventures, our mission is to counterbalance today's challenges by advancing the science of everyday joy. We work to identify the world's most talented entrepreneurs, innovators and scientists to evolve their ideas into products that will help us all live more joyfully - and we see Embr Labs as a company that is succeeding in this area," noted Miri Polachek, CEO of Joy Ventures.
Started in 2013 by three MIT materials science engineers, Embr Labs was founded upon a basic insight: temperature is an untapped pathway to the brain that can deliver therapeutic benefits. Embr's patented technology harnesses the power of thermal sensations to deliver safe, non-invasive, and beneficial therapies that leverage the body and mind's natural response to temperature to promote relief from hot flashes, manage stress, and improve sleep.
Embr Labs has sold tens of thousands of Embr Waves that have found their way into over 160 countries despite only being available through Embr Labs' US website. This digital thermal solution has also been clinically validated in partnership with Johnson & Johnson, and the Embr Labs' Science and Innovation team continues to explore new ways to enhance the efficacy and impact of Embr's technology for the nearly 1.1 billion women who will be experiencing menopause by the year 2025.
"The addition of Dr. Peeke to our leadership team and the investment from Joy Ventures, combined with our collaboration with UMass IALS and support from the Massachusetts Life Sciences Center/NSF have significantly accelerated our development and validation of innovative digital thermal solutions for women's health," said Elizabeth Gazda, CEO of Embr Labs.
For more information, please contact Heather Ritchie or press@embrlabs.com, or visit embrlabs.com.
About Embr Labs
Embr Labs is the first thermal wellness technology company, pioneering a new pathway to unlock the therapeutic power of temperature. Its first product, Embr Wave, is an intelligent bracelet that uses temperature to activate and balance the body and mind. Despite only being sold in the United States, the Wave is being used in over 160 countries. The company's patented technology harnesses the power of thermal sensations to deliver a brand new category of safe, non-invasive, and natural therapies that leverage the body and mind's natural response to temperature to help people feel more comfortable, fall asleep faster, and be less stressed. Embr Labs was founded by MIT-trained engineers and is backed by investors including DigiTx Partners, Joy Ventures, Bose Ventures and Joyance Partners.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Nashville-based Keystone Behavioral Health recently announced the formation of a committee to assess the urgent need for Psychiatric Residential Treatment Facilities.

NASHVILLE, TENN. (PRWEB) DECEMBER 03, 2020
Nashville-based Keystone Behavioral Health recently announced the formation of a committee to assess the urgent need for Psychiatric Residential Treatment Facilities. The committee will be led by Mike McCulla and Al Smith, pioneers in the behavioral health industry with extensive experience developing psychiatric hospitals, residential treatment programs and continuums of care for young people and their families. Consisting of mental health professionals, child welfare and juvenile justice experts, managed care/Medicaid leaders, and investors the committee will explore the value that access to PRTFs would bring to communities actively engaged in implementing the initiatives of the Family First Preservation Services Act.
In 2001, the federal government's Center for Medicaid and Medicare Services (CMS) passed into law the certificate of participation (CoP) for Psychiatric Residential Treatment Facilities (PRTFs) to operate as inpatient psychiatric treatment facilities for individuals 21 years old and under. The CoP establishes PRTFs as an acute psychiatric level of care whose treatment model, like that of a psychiatric hospital, is physician/psychiatrist led. The law established criteria of medical necessity to enter treatment, processes for verifying continuance of treatment, and a pathway for states to federally match funding of PRTF treatment through their state Medicaid plan.
The CMS classification of PRTFs allowed for willing residential treatment programs to adopt PRTF regulatory requirements and evidenced-based treatment practices in order to become credentialed and enrolled in Medicaid and most commercial insurance plans. Unfortunately, adoption of PRTFs by residential programs and state youth serving agencies did not keep pace with the expansion of residential treatment programs throughout the United States. It is estimated that there are 7 residential treatment beds to every 1 PRTF bed in the US today.
Not long after the enactment of PRTFs in 2001, Keystone Behavioral Health's founders, Mike McCulla and Al Smith, introduced the use of PRTFs through their development of new PRTF programs and conversion of many existing residential treatment programs to PRTFs. "Having developed and managed many psychiatric hospitals and residential treatment programs, we thought the PRTF model established by CMS was the perfect model for ensuring quality care and safety for young people whose treatment needs met the criteria for admission," says Mike McCulla. "We discovered that the PRTF model was very similar to the services we were providing in psychiatric hospitals, and that because the model allowed for longer lengths of stay than a hospital does, a PRTF was better positioned to transition young people back into their homes. We also discovered that because young people could access treatment at PRTFs through Medicaid and their parents' insurance, many young people did not have to be committed to state custody just to access out of home treatment, as they had to with residential treatment," continued McCulla.
The Family First Act became effective on January 1, 2020, but because of the many complexities involved with full implementation of the law, most states have been granted 2-year waivers to complete full compliance. The Family First Act was implemented in part to ensure that all or at least most of federal funding earmarked to keep families together (Title IV-E) was not to be used by child welfare agencies to fund the residential treatment programs in their state. As most states had become reliant on Title IV-E funding to pay for residential treatment, many states are struggling to develop evidenced-based family preservation programs and simultaneously reduce their need/use of residential treatment. "We believe the PRTF model is the perfect solution to replace residential treatment needs for young people who truly require out of home treatment, and that PRTFs have the capacity to become the basis for a continuum of lower level services that will be needed for effective family preservation," says Al Smith. "We launched Keystone and are organizing the committee to evaluate the validity of our assumptions, as well as how Keystone could use its experience with PRTFs and psychiatric hospitals to offer this very practical solution for keeping kids with their families and community."
Keystone Behavioral Health specializes in providing psychiatric and behavioral health services to young people 21 and under. Its mission is to reduce the number of young people having to enter state custody in order to access out of home treatment by optimizing the capacities of PRTFs to provide a full continuum of care. More info can be found at http://www.keystonebh.com, or by calling 615-973-5503.

Having developed and managed many psychiatric hospitals and residential treatment programs, we thought the PRTF model established by CMS was the perfect model for ensuring quality care and safety for young people whose treatment needs met the criteria for admission



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Dentist Entrepreneur Organization (DEO) is committed to providing emerging dental group leaders access to the connections, education, and resources they need to grow. So, The DEO is excited to announce its joint venture with Share Moving Media to form DEO Media, LLC, publisher of Efficiency In Group Practice Magazine, a resource for dentist entrepreneurs and DSO leaders.

PORTLAND, ORE. (PRWEB) DECEMBER 03, 2020
The Dentist Entrepreneur Organization (The DEO) of Portland, Oregon and Share Moving Media of Lawrenceville, Georgia announce the formation of a new entity called DEO Media, LLC, a joint venture between the two organizations to publish Efficiency in Group Practice, a bi-monthly dental trade magazine focused on DSOs (dental service organizations) and group dentistry.
"We're extremely excited to give emerging dental group leaders even more access to the people, education, and resources they need to grow," said Jacob Puhl, CEO of The DEO. "This partnership further enables us to continue our mission to help dentist entrepreneurs and their executives fulfill their visions. We hope to have a continued positive impact on the dental community."
Efficiency In Group Practice provides an informational and educational link between manufacturers, distributors, service providers, and dental group practices. Each issue of Efficiency covers emerging trends in dentistry, and provides content to enable group practices to capitalize on their distinct strengths and differences to reach new heights of efficiency and become more profitable.
"This new partnership positions Efficiency in Group Practice with the leadership and direction so dearly needed for a publication to thrive in these dynamic times," said Share Moving Media CEO John Pritchard. "Now more than ever, dental group practices need insight, understanding and community to grow their practices. We are excited to partner with Jacob Puhl and the entire DEO team to help provide just that!"
Under the partnership, The DEO and Share Moving Media will collaborate on editorial, sales, marketing and distribution of the industry-leading publication. Jacob Puhl, partner and CEO of the Dentist Entrepreneur Organization, will be Efficiency's publisher.
The first issue from DEO Media, LLC will be the January-February 2021 edition of Efficiency In Group Practice.
About
The Dentist Entrepreneur Organization (DEO) provides a context, a professional resource, and a peer-to-peer network within a well-managed organizational structure. For more information, visit https://deodentalgroup.com/.
Share Moving Media is a leading publishing and content company providing information, communication and educational services to providers, manufacturers and distributors involved in the business of healthcare. For more information, visit https://sharemovingmedia.com/.
For more information on Efficiency in Group Practice, visit https://www.dentalgrouppractice.com/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The FSB Companies, the private investment firm of Frank Brumfield, is pleased to announce the sale of its portfolio company, Pinnacle Medical Solutions LLC to AdaptHealth Corp (NASDAQ: AHCO).

CHICAGO (PRWEB) DECEMBER 03, 2020
The FSB Companies ("FSB"), the private investment firm of Frank Brumfield, is pleased to announce the sale of its portfolio company, Pinnacle Medical Solutions LLC ("Pinnacle" or "the Company") to AdaptHealth Corp (NASDAQ: AHCO).
Pinnacle is a high-growth direct-to-patient provider of diabetes management supplies serving patients primarily in the Southeast United States. Pinnacle's offering includes continuous glucose monitors (CGMs), insulin pumps and other diabetic supplies. Pinnacle's efficient operations and multi-state service footprint have enabled rapid growth and positioned the Company well for continued expansion with AdaptHealth. Pinnacle will continue to operate under its current name and location in Southaven, MS.
"It was an honor to be a part of the Pinnacle team and build something special," said Frank Brumfield, CEO and Owner of FSB. "The Pinnacle-FSB Teams were able to work together to create an exceptional company that provides outstanding quality service to patients, payors, and manufacturers. We were able to leverage technology, perfect workflows, and build an incredible culture that we are proud to transition to AdaptHealth."
Lincoln International acted as the exclusive investment banking representative for Pinnacle and The FSB Companies, working closely with Pinnacle's management team and ownership. Terms of the transaction were not disclosed. Hughey Business Law served as Pinnacle's legal counsel in connection with the transaction.
About Pinnacle Medical Solutions
Pinnacle Medical Solutions LLC ("Pinnacle") is a leading patient-centric provider of technology-enabled diabetes management devices, including continuous glucose monitors and insulin pumps. Based in Southaven, MS, Pinnacle is recognized as a market leader in the Southeastern U.S. Driven by its patient-first mindset, Pinnacle is committed to offering the latest technology and best customer experience available. For more information, visit: http://www.pinnaclemedicalsolutions.com.
About The FSB Companies
The FSB Companies is an operationally oriented private investment firm, funded and lead by Frank Brumfield. FSB focuses on acquiring and building outstanding companies by partnering with management teams and providing high-level resources across a portfolio of companies. These resources include operational support, strategic leadership, financial acumen, and custom technology development. FSB has a permanent base of capital that provides flexibility and allows for a long-term perspective on value creation. For more information, visit
http://www.fsbcompanies.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

miBrite announces a new paradigm-shifting reformulation for its take-home tooth whitening products ilustra plus and luminite teeth whitening pens. The new ilustraplus formulation is the first teeth whitening product to combine the two most effective whitening agents, Hydrogen Peroxide and Phthalimidoperoxycaproic Acid (better known as PAP), with a dual-barrel syringe. When the two gels combine, the whitening results are out of this world with no tooth sensitivity.

BOCA RATON, FLA. (PRWEB) DECEMBER 03, 2020
miBrite the teeth whitening brand that sparks confidence, announces the reformulation of its flagship home tooth whitening kit miBrite ilustra plus along with both miBrite luminite teeth whitening pens. The new formulations include never seen before dueling teeth whitening gel technology with a dual-barrel syringe that dispenses and combines two powerful teeth whitening ingredients: hydrogen peroxide and Phthalimidoperoxycaproic Acid - more commonly known as PAP.
miBrite ilustra plus doesn't stop at just combining the two effective whitening ingredients; their oral care R&D team formulated the gels to be near sensitivity-free with the natural enamel fortifying and remineralization ingredient hydroxyapatite.
Since they know hydrogen peroxide and PAP to be effective teeth whitening ingredients separately, miBrite reformulated its touch up options to offer customers a choice between the whitening agents. miBrite upgraded the luminite blue pen to a pH-neutral tooth whitening gel containing medical-grade hydrogen peroxide. Next, miBrite upgraded the luminite pink teeth whitening pen with the peroxide alternative, PAP.
Hydrogen peroxide is the professional choice as a teeth whitening agent for decades. The way hydrogen peroxide whitens teeth is by the hydrogen peroxide (H2O2) breaking down water (H2O) and releasing an oxygen free radical that changes the optical properties of tooth stain, changing it from having color to transparent. This reaction with hydrogen peroxide is commonly demonstrated with hair bleach products.
Phthalimidoperoxycaproic Acid, or PAP, is a new teeth whitening ingredient formulated as an effective alternative to hydrogen peroxide. While the ingredient is very effective for whitening teeth, it is also a challenging ingredient to integrate into products because of its dynamic nature. The miBrite research and development team has spent years unlocking PAP's full potential, eventually creating a very carefully stabilized active formulation.
"miBrite's reformulated ilustra plus dueling teeth whitening technology will undoubtedly disrupt the entire teeth whitening industry," says Dr. Martin Giniger, Ph.D., DMD, Chief Scientist at Smash Labs, "for the first time we have a single teeth whitening treatment that uses a dual-barrel syringe to combine the two most effective teeth whitening agents - hydrogen peroxide, and PAP together - along with remineralizing the teeth at the same time with hydroxyapatite."
Dr. Giniger continues, "Our testing has shown that not only does ilustra plus work twice as fast with twice the some of the best results I have seen. What's more, there has been almost no reported sensitivity during or after the whitening treatment. I have never seen a teeth whitening product work this well in all my years developing teeth whitening products."
To learn more about the new revolutionary miBrite ilustra plus and luminite teeth whitening products, please visit http://www.mibrite.com.
About Smash Labs, LLC and miBrite
Smash Labs, LLC is a multi-faceted oral care product innovation international firm based in Boca Raton, Florida, and Amsterdam, The Netherlands. Dr. Martin Giniger, Ph.D., DMD heads the company as Smash Lab's Chief Scientist and works together with Oral Care R&D formulator Matt Spaid. Smash Labs works closely with companies worldwide and helps them formulate the products of their dreams. For more information, visit http://www.smash-labs.com and http://www.mibrite.com
###



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Genetic wellness brand addresses immunity at the level of the genome; assembles scientific team, with Dr. Steve Henig as Chief Science Officer

LOS ANGELES (PRWEB) DECEMBER 03, 2020
Caligenix, a leading genetic wellness brand, has just launched Immunotype, a DNA-based supplement that addresses the human immune system at the level of the genome. Immunotype combines the most heavily researched bioavailable vitamins, minerals, and herbs in an immunity supplement and is backed by years of clinical trials and lab testing to confirm efficacy. It utilizes only the most trusted, highly absorbable vitamin forms and optimally doses them to precisely target and elevate immune systems. This immunity supplement is the company's foray into the nutritional supplement space and is backed by years of DNA research and data. The company also announces the establishment of their scientific team and has brought on board as Chief Science Officer, Dr. Steve Henig, a nationally recognized expert in the health, wellness and supplement industries.
As a biotech company innovating wellness solutions personalized to one's lifestyle and genomic data, Caligenix has long been a pioneer in the genetic testing industry. Funded by angel investors, the company is on a mission to personalize nutrition and skincare with advanced genomic technologies and actionable products that can be measured.
"Our mission is rooted in our collective experience dealing with a one-size-fits-all approach when it came to wellness, which we found did not fully meet the individual needs of most consumers. In the journey to transform ourselves, we envisioned a world of wellness guided by the unique data hidden within our genes," said Dr. Tzur Gabi, Caligenix Co-Founder. "By pairing years of anonymized genetic data and diagnostic testing in real time, Caligenix is positioned to deliver next-generation wellness supplements and skincare solutions while simultaneously measuring their effectiveness on the individual—giving consumers a solution that is truly unique to them."
Caligenix's 'science first' approach led Gabi and fellow Co-Founder, Eliad Josephson, to recruit esteemed and cutting-edge scientists, dietary clinicians and industry experts in the fields of molecular biology and chemistry. They have recently appointed Dr. Steve Henig as the company's Chief Science Officer to lead the scientific team. Henig has over 30 years of experience in executive leadership roles at leading food, beverage and supplement companies, including Herbalife Nutrition, Ocean Spray Cranberries, Conagra Grocery Products, Hunt-Wesson Foods, Land O'Lakes, Pilsbury Co., and General Foods.
"We are fortunate and proud to have leading scientists, innovators and experts, such as Dr. Henig, that can help us continue to leverage technology, science and AI to provide cutting-edge solutions that bring personalized genetic wellness solutions to people everywhere," said Josephson. "It's a big reason why Caligenix has been selected by leading multi-national CPG corporations to perform personalized nutrition pilots with real consumer data. We're excited to unveil new discoveries in the form of more personalized products in the coming months."
Learn more at getimmunotype.com
About Caligenix:
Headquartered in Los Angeles, Caligenix is a genetic-based health and wellness company innovating customized solutions in the fields of nutrigenomics and dermagenetics, personalized to individual lifestyle and genomic data, so that people are empowered to take control over their overall health and well-being. Visit Caligenix.com.
Media Inquiries: media@caligenix.com




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Jennifer Hsu will take the helm at SGF's Woodbridge location, expanding excellence in fertility care to the Northern Virginia region.

FAIRFAX, VA. (PRWEB) DECEMBER 03, 2020
Shady Grove Fertility (SGF) announced today that reproductive endocrinologist, Jennifer Hsu, M.D., has joined the practice and will begin seeing patients in SGF's Woodbridge location late December 2020. As a University of Virginia Cavalier alumna, Dr. Hsu is proud to return to the state where her medical journey began.
"The 85,000 babies and counting born at SGF is nothing short of a miracle," says Dr. Hsu. "I am immensely proud to be a part of this team of people who are all 100% dedicated to the goal of building families and making dreams a reality."
Dr. Hsu will provide comprehensive fertility services to patients, including:

fertility and ovarian reserve testing and diagnosis;

semen analysis;

hysterosalpingogram (HSG);

low-tech fertility options;

in vitro fertilization (IVF);

donor egg, sperm, and embryo;

genetic screening and testing;

gestational carrier;

egg freezing;

fertility preservation for patients with cancer;

and LGBTQ family building.

Dr. Hsu earned a full undergraduate merit scholarship from UVA, where she continued her graduate studies and earned a medical degree. As a medical student, Dr. Hsu extended her research efforts abroad in Quetzaltenango, Guatemala, and was ultimately honored with the Medical Alumni Association (MAA) Outstanding Medical Student Award. Her time in Central America allowed Dr. Hsu to exercise her fluency in Spanish.
She then completed her residency at Columbia University Medical Center, followed by a move to Boston where Dr. Hsu completed her fellowship in reproductive endocrinology and infertility at Massachusetts General Hospital. Today, she is board eligible in obstetrics and gynecology as well as reproductive endocrinology and infertility.
"When patients are hurting, my vow is to stay by their side and help them through it," shares Dr. Hsu. "Whether they need someone to listen, grieve with, or help them make a plan, I will be there. The journey to parenthood can be difficult, but I hope my patients never feel that they are alone."
Dr. Hsu is very active in the medical community. She is an experienced lecturer and oral examiner at Harvard Medical School and has spent time in Appalachia providing free medical and women's health services to residents. Additionally, Dr. Hsu is an accomplished researcher, having contributed to more than 15 presentations across the country on topics including intrauterine insemination (IUI), anti-Mullerian hormone (AMH), and polycystic ovary syndrome (PCOS). She has also served as a peer-reviewer for several publications including the Journal of Assisted Reproduction and Genetics.
"Dr. Hsu is a very bright and compassionate physician who, on behalf of SGF, we're very thankful to have part of our team," says Eric Widra, M.D., Chief Medical Officer at SGF.
Patients may schedule a new patient virtual physician consultation with Dr. Hsu by calling 1-877-761-1967 or submitting this brief form. Patients also have access to SGF Woodbridge's unique financial options, such as the 100% refund program for IVF, that help make fertility treatment more affordable.
About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and 5,000+ 5-star patient reviews. With 37 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients virtual physician consults, deliver individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including 100% refund guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Experienced industry leader will serve as part of company's global leadership team

SOUTH RIDING, VA. (PRWEB) DECEMBER 03, 2020
Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of John Leite as Chief Business Officer at InterVenn Biosciences. In his new role, Leite will direct all business operations for the company as part of its global leadership team.
Over the past six years, Leite served as Vice President of Oncology, Market Development & Product Marketing for the oncology business unit at Illumina. Prior to joining Illumina, Leite was Vice President of Commercial Strategy and Market Access for Genoptix Inc., where, from 2008 until 2014, he drove several functions including marketing and business development, building the portfolio of oncology diagnostic services. Leite began his career as a scientist for Invitrogen (now Thermo Fisher Scientific), before transitioning to the business team as a marketer overseeing product management of the proteomics portfolio.
"John Leite is an experienced and highly accomplished business development and marketing specialist in the biotechnology and diagnostics sectors," said Slone Partners President Tara Kochis-Stach. "He brings a keen strategic sensibility and an extremely successful track record to the InterVenn executive team."
"We are thrilled to bring John on board at a very exciting time for our company," said Aldo Carrascoso, Chief Executive Officer at InterVenn. "He and the rest of our global leadership team are poised to move us forward as we continue to make tremendous progress in the diagnosis and treatment of various diseases through the use of glycoproteomics."
Leite earned his PhD in Biochemistry at the University of Pittsburgh School of Medicine. He also served his post-doc in Neuroscience at the California Institute of Technology.
ABOUT SLONE PARTNERS
Slone Partners delivers the leaders who build amazing and diverse life sciences organizations – People Are Our Science. Founded in 2000, Slone Partners specializes in delivering world-class C-suite leadership, executive, and upper management talent to the most promising and established biotech, diagnostics, research tools, healthcare, precision medicine, CRO, and laboratory services companies. With coast-to-coast presence in the most active healthcare industry hubs of Boston, San Francisco, New York, Los Angeles, San Diego, Austin, Research Triangle Park NC, and Washington DC, Slone Partners uniquely and precisely provides an array of executive search and advisory services, including diversity, equity, and inclusion strategy, to innovative life sciences companies. To learn more about Slone Partners' value proposition and processes, visit http://www.slonepartners.com or call 888.784.3422.
ABOUT INTERVENN BIOSCIENCES
Based in South San Francisco, InterVenn Biosciences utilizes a proprietary glycoproteomic biomarker interrogation platform using AI and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression. For more information, please visit the company's website at https://intervenn.bio/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The partnership is supported and accredited by the Postgraduate Institute for Medicine

ALLENTOWN, N.J. (PRWEB) DECEMBER 03, 2020
COVID-19 has revealed several things about the U.S. health and medical industry. Among them is the lack of response and empathy for people of color, specifically African Americans. Already at higher risks due to pre-existing conditions, the Black community requires a unique and informed response from medical professionals to address the specific needs of those who contract Coronavirus. Announcing today, CE Health Interactive (CEHI), a leading provider of cutting-edge medical educational programs launches a certified educational video to support medical professionals servicing the African American community during the COVID-19 pandemic. The educational video is accredited by the Postgraduate Institute for Medicine(PIM).
According to a National Urban League study, based on data from John Hopkins University, Black Americans are twice as likely to die from COVID-19 related illness than white Americans. With an infection rate of 62 for every 10,000 people, Black Americans are three times as likely to be infected with the virus than their white counterparts.
"Although co-morbidities are a factor," says Kenneth R Alleyne, M.D., orthopedic surgeon and chair of Connecticut Health Foundation Board. "We know that there are gaps in knowledge, education and practice when it comes to managing the needs of the African American community during this time as it relates to the pandemic. Current treatment options focus on addressing symptomatology. We believe a physician-led program may be beneficial for capturing a larger audience of HCPs. The provision of newer methods for implementing diagnostic and treatment options into the clinicians armamentarium for addressing the symptom and disease progression of COVID-19, as well as the morbidity and mortality rates of Black Americans, are tantamount to achieving improved outcomes."
"We will be able to use our award-winning MedXchange Live Studio platform to create and feature impactful faculty didactic presentations," said Calvin L. Butts Jr., board member, CE Health Interactive. "In addition, we will use our platform to moderate panel discussions that will allow for engaging conversation between clinicians and clinical experts."
In addition to Alleyne, the panel discussion will be led by Reginald Eadie, president and CEO, Trinity Health of New England, and Cheryl R. Whitaker, MD, MPH, FACP, president, Institute of Medicine Chicago and CEO, NextLevel Health.
Topics will include:

Meeting the medical needs of African American patients with COVID-19

Data limitations on COVID-19 and African American patients

Meeting the social determinants of Health needs of At-Risk African American Patients during the Pandemic

Watch the discussion here.
###
About CE Health Interactive
CE Health Interactive (CEHI) designs and executes innovative, compelling and interactive continuing medical education (CME) programs. In the past 15 years, our engaging programs have educated 800k clinicians to improve patient care in cardiology, rheumatology, diabetes, psychology, oncology and other areas of medicine. Our proprietary and award-winning MedExchange Live platform fosters communications among practitioners, caregivers and patients. We also identify proven solutions and technologies from other industries and use them to create novel education programs. CE Health Interactive is minority-owned and operated. For more information, visit http://www.cehealthinteractive.com and contact us at Info@cehealthinteractive.com.
About Postgraduate Institute for Medicine (PIM)
In support of improving patient care, PIM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. PIM is one of a very select group of jointly accredited providers that has been awarded the highest level of a 6-year term, placing PIM among the top echelon of CME/CE providers that have demonstrated the highest levels of educational acumen in providing healthcare professionals with relevant, effective, practice-based continuing education that supports US health care quality improvement.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Event to Feature Brad Paisley, Sara Evans, Cece Winans, Trace Adkins, Scott Hamilton, and more

NASHVILLE, TENN. (PRWEB) DECEMBER 03, 2020
Shriners Hospitals for Children, in collaboration with Circle Network, is excited to present an evening at the historic Grand Ole Opry on Saturday, December 5, at 9/8 pm CT to raise awareness and support for the mission of providing The Most Amazing Care Anywhere.
Stories of Love will feature performances by country music favorites like Brad Paisley, Sara Evans, Cece Winans, and Shriners Hospitals for Children's own, Kechi Okwuchi. Opry members Trace Adkins and The Oak Ridge Boys will grace the stage for this event as well, in a show of their ongoing support for Shriners Hospitals for Children.
The evening, which will be hosted by Olympic Gold Medalist Scott Hamilton, along with several Ambassadors for Shriners Hospitals [Alec, Hadley, Karolina, Kechi, Lily, and Marius], will also feature inspiring stories from some incredible patients and their families.
"We are so excited to collaborate with the Circle Network to present Stories of Love, benefiting our incredible patients," said Jim Smith, Chairman of the Board of Directors, Shriners Hospitals for Children. "We are looking forward to a fantastic evening full of great music and inspiring stories, all in support of the world-class care provided by Shriners Hospitals."
"Circle is honored to join Shriners Hospitals for Children in sharing the Stories of Love Telethon with our audience," said Drew Reifenberger, General Manager at Circle Media. "The evening will shine a very important light on the work Shriners is doing to help change the lives of children in need this holiday season and beyond."
Circle recently announced streaming distribution partnerships with The Roku Channel, Samsung TV Plus, VIZIO SmartCast and XUMO, bringing the network's country lifestyle original programming to millions more worldwide. Check CircleAllAccess.com for complete programming information and to see how you can be a part of the Stories of Love Telethon.
Enjoy, be inspired, and consider sending your Love to the Rescue for children in need.
About Shriners Hospitals for Children:
Shriners Hospitals for Children is changing lives every day through innovative pediatric specialty care, world-class research and outstanding medical education. Our health care system provides advanced care for children with orthopaedic conditions, burns, spinal cord injuries, and cleft lip and palate. All care and services are provided regardless of the families' ability to pay. Shriners Hospitals for Children is a 501(c)(3) nonprofit organization and relies on the generosity of donors. All donations are tax deductible to the fullest extent permitted by law. For more information, please visit ShrinersHospitalsforChildren.org.
About Circle:
Circle is a media network dedicated to celebrating the country lifestyle and putting fans inside the circle of everything country. Circle offers entertainment news, documentaries, movies, archival, new and licensed programming, Grand Ole Opry performances, and more. Circle is a joint venture between Opry Entertainment Group, a subsidiary of Ryman Hospitality Properties, and Gray TV.
For more details and to find out if Circle is available in your market, please visit http://www.circleallaccess.com.
Media Contacts:
For SHC - Mel Bower, mbower@shrinenet.org
For Circle - Sunshine Sachs, circle@sunshinesachs.com
Teresa George, tgeorge@circleplus.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The free tool is a modified System Usability Scale that can measure the experiences of those who use assistive technologies, for example people living with blindness who use screen readers.

TORONTO (PRWEB) DECEMBER 04, 2020
Today Fable Tech Labs Inc. ("Fable"), a leading accessibility testing platform powered by people with disabilities, announced the launch of the Accessible Usability Scale (AUS) and made it freely available to all. ­­­ It is a tool that quantifies and measures the perceived user experiences of assistive technology users, to improve the usability of websites and apps and make them more accessible.
The AUS is based on the System Usability Scale (SUS). SUS was originally developed in 1986 and is a common psychometric tool to assess user experience. However, it doesn't effectively measure the experiences of assistive technology users, such as people with disabilities who use screen readers or voice navigation.
Developed based on thousands of hours of engaging people with disabilities across more than 25 assistive technology configurations on Fable's crowdtesting platform, the AUS adapts the original framework to measure usability issues for those who are impacted by accessibility.
Fable CEO Alwar Pillai said: "We made AUS free for everyone – because it can help. Regardless of what industry we are in, we can all agree that the experiences of people with disabilities on the internet can get a lot better. But we won't get there unless we quantify the quality of those experiences."
The Accessible Usability Scale consists of a brief survey of 10 alternating statements related to the user experience of an assistive technology user. AUS assigns a scale position for each possible response. The output of AUS is available after completion of the survey.
Samuel Proulx, blind since birth and now Fable's Community Manager, said that "AUS is a critical step on the path to ensuring that people with disabilities are fully represented in digital product development. AUS enables designers and researchers to have a useful baseline tool to collect feedback from assistive technology users. Thanks to AUS, our voices can be included and considered in ways that were previously lacking."
To learn more, go to https://makeitfable.com/AUS.

We made AUS free for everyone – because it can help. Regardless of what industry we are in, we can all agree that the experiences of people with disabilities on the internet can get a lot better. But we won't get there unless we quantify the quality of those experiences.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Results include faster ROI, better outcomes and improved patient experiences

HOUSTON (PRWEB) DECEMBER 04, 2020
Element Blue, a twenty-year technology consultancy in the healthcare sector and expert in robotic process automation (RPA), is partnering with DRUID, specialists in conversational AI, to serve the emerging ecosystem of conversational AI technology in the healthcare industry. The two companies will collaborate on the implementation of AI-driven virtual assistants in hyperautomation projects across North America.
Element Blue will provide support to healthcare organizations in the design and implementation of conversational automation projects through AI-powered chatbots and RPA technology, deployable on multiple digital communication channels in various deployment scenarios. DRUID conversational technology may be implemented either on the most secure cloud infrastructures, or can run entirely on a client's infrastructure, without the interference of external AI providers or risk to highly confidential patient's data. Hybrid deployments -- with the chatbot running in cloud and securely connected with the on-premises systems -- are also available, to stay flexible enough to offload insensitive data to cloud servers to reduce processing costs.
"Partnering with DRUID will help our healthcare system clients and their patients experience the self-service benefits of AI-driven conversational technology. The platform produces an enhanced customer service driven approach while providing important analytics to providers, increasing their case resolution, billing inquiries, and other valuable conversation flows (services)," said Steven Gerhardt, CEO and managing partner of Element Blue.
The collaboration will help large healthcare organizations realize the value of conversational automations while improving digital engagement and patient insights. DRUID brings conversational capabilities to RPA robots, adds enhanced cognitive services, and simplifies the completion of automated tasks. DRUID AI-powered virtual assistants can communicate and trigger actions with both attended and unattended bots to simplify complex end-to-end hyperautomation projects in a natural, human-like manner.
"We believe combining robotic process automation with conversational technology provides incredible value and efficiency for the healthcare industry. Together with Element Blue's deep expertise in accelerating digital transformation of this sector, we will help healthcare organizations reimagine what is possible with conversational artificial intelligence" stated Adrian Smith, U.S. Senior Director of Sales and Alliances, DRUID.
With a proprietary natural language processing (NLP) engine available in more than 45 languages, DRUID offers 600 predefined conversational templates targeting specific roles and processes. Element Blue will provide healthcare providers with support in designing and implementing chatbot flows, easily deployable on digital communication channels such as WhatsApp, MS Teams, Skype, Facebook Messenger, Slack or corporate webpages.
About DRUID
DRUID (http://www.druidai.com) is a global leader in Conversational AI Automation. Druid's no code platform enables enterprises to automate customer and employee communications using AI-driven chatbots. 600 predefined conversational templates and award-winning native connector with UiPath bots offer 3x-5x faster deployments. DRUID is available in any deployment scenario and supports conversations in any language and on any digital channel. DRUID client portfolio includes Raiffeisen, BRD, Orange, Telekom, Carrefour, Servier and many more.
About Element Blue
Element Blue enables healthcare systems to transform the patient experience and reduce costs through increased personalization and robotic process automation (RPA). The practice's Blueprint Services Framework impacts patient access, referrals, digital marketing and the revenue cycle at the most critical stages of the customer journey, resulting in a seamless encounter across the system.
By empowering patients and employees to actively manage their unique healthcare experiences, Element Blue increases the satisfaction of every health system consumer: customers, patients and members.
Houston-based, Element Blue has offices in Dubai, Hyderabad, Nairobi, Lima, and San Jose. For more information, please go to https://elementblue.com.

"DRUID produces an enhanced customer service driven approach while providing important analytics to providers, increasing their case resolution, billing inquiries, and other valuable conversation flows," said Steven Gerhardt, Element Blue CEO



START your own Wordpress site, business or personal website, or online store at www.siteground.com

AHN's Center for Inclusion Health was established as of the nation's first programs focused on meeting the comprehensive health needs of patients from underserved or marginalized populations.

PITTSBURGH (PRWEB) DECEMBER 04, 2020
Allegheny Health Network (AHN) has named Elizabeth Cuevas, MD, as Division Chief of its Center for Inclusion Health. A board-certified internal medicine physician, Dr. Cuevas most recently served as Division Chief of Academic Internal Medicine at AHN, as well as Director of Primary Care Transformation for the Internal Medicine Residency Clinics.
As part of Dr. Cuevas' nearly 10-year tenure with AHN, she was instrumental in launching the Center for Inclusion Health (CIH) in 2014. CIH was established as one of the nation's first programs focused on meeting the comprehensive health needs of patients from underserved or marginalized populations.
Since its inception, the Center has significantly grown in the number of caregivers that are dedicated to delivering a coordinated and compassionate care delivery model using evidence-based interventions, as well as expanded programs to address heath issues and health care barriers such as addiction, food insecurity, HIV/AIDS, homelessness, immigrant/refugee health and transgender health. As Division Chief, Dr. Cuevas will work to ensure consistent delivery of CIH's mission to provide compassionate, accessible care to the region's high-risk patients.
Stuart Fisk, CRNP, who has served as the Center's director for the past six years, has taken on the role of Director of Strategic Operations for CIH. Patrick Perri, MD, will continue to serve as the center's Medical Director and lead the Program for Homeless and Urban Poverty Medicine.
"This year, many of us have developed a deeper sense of appreciation for the selfless, courageous ways in which caregivers serve our communities. I am confident that this level of appreciation has long been held by those who utilize the many extraordinary services provided by the Center for Inclusion Health," said Susan Manzi, MD, Chair, AHN Medicine Institute. "Dr. Cuevas is extremely well-suited to lead this team of heroic caregivers, and we look forward to her many contributions as division chief."
A University of Notre Dame graduate, Dr. Cuevas received her medical degree from the University of Pittsburgh in 2001. She completed her internship and residency training in internal medicine at Massachusetts General Hospital. While in Boston, she also served as a medical director in the Boston Health Care for the Homeless Program.
To learn more about the AHN Center for Inclusion Health, visit http://www.ahn.org/services/medicine/center-for-inclusion-health.
###
About Allegheny Health Network
Allegheny Health Network (AHN.org), a Highmark Health company, is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 13 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home and community based health services, a research institute and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, cardiovascular disease, cancer care, orthopedic surgery, neurology and neurosurgery, women's health, diabetes and more. AHN employs approximately 21,000 people, has more than 2,500 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Specific Diagnostics today announced that it has successfully received its ISO-13485 certification through the International Organization for Standardization. A QMS conforming to ISO-13485 meets the highest FDA standards applicable to businesses operating in the medical device sector.

MOUNTAIN VIEW, CALIF. (PRWEB) DECEMBER 04, 2020
Specific Diagnostics today announced that it has successfully received its ISO-13485 certification through the International Organization for Standardization. A QMS conforming to ISO-13485 meets the highest FDA standards applicable to businesses operating in the medical device sector.
Specific, which manufactures the Reveal rapid antimicrobial susceptibility testing system and associated disposables, has already started its European market launch. While not required for European sales, the ISO-13485 quality management system certification will give European hospital customers the added assurance that Specific's instruments and disposables have been manufactured under the highest standards applicable to medical devices.
"Our team has worked incredibly hard to implement our ISO-13485-compliant quality system," said Dr. Paul A. Rhodes, Specific's CEO. "This designation, along with our CE-IVD registration, have made us a better engineering and manufacturing organization, and will continue to positively impact the Company's operations as we begin to supply the Reveal rapid AST system to our customers in Europe."
Specific's Reveal furnishes a phenotypic MIC directly from a positive blood culture sample in an average of less than 5 hours, as reported in a to-be-published preclinical study of 104 patient samples conducted at the Henry Ford Health System in Detroit, Michigan. Based upon arrays of printed sensors responsive to the volatiles emitted by growing microorganisms, the Reveal system has the high throughput, low cost, antibiotic menu, and ease of use to prompt wide adoption.
"As we move to make Reveal available to clinics in Europe, we were determined to complete the ISO-13485 certification process to ensure we meet the highest standards applicable to medical device manufacturers, and we have done-so," said Specific COO Raymond Martino. "The Reveal system, which is currently available in Europe, will rapidly make an impact on clinical best practice for bacteremia and other time-sensitive infections."
About Specific
Specific Diagnostics has developed in vitro diagnostic systems based upon a unique, patented metabolomic signature technology that enables rapid detection and identification of microorganisms as they grow in culture. Its first commercial application applies this fundamental new platform to the rapid determination of antimicrobial susceptibility directly from positive blood cultures, as well as isolate dilutions. Specific is based in Mountain View, CA.
For press inquiries, please contact: press@specificdx.com

Specific Diagnostics today announced that it has successfully received its ISO-13485 certification through the International Organization for Standardization. A QMS conforming to ISO-13485 meets the highest FDA standards applicable to businesses operating in the medical device sector.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

America's Pharmacy has just published a 2021 eBook full of information designed to assist people who have lost their health benefits (and often their jobs) due to COVID-19 understand their options to finding inexpensive health coverage. This free resource is designed to help individuals and families easily navigate the various healthcare options available in 2021.

NORWALK, CONN. (PRWEB) DECEMBER 04, 2020
America's Pharmacy (https://www.americaspharmacy.com) has just published an updated 2021 eBook full of information designed to assist people who have lost their health benefits (and often their jobs) due to COVID-19 understand their options to finding inexpensive health coverage.
The free eBook "COVID-19, Medicaid, Health Insurance, and You. New Rules Survival Guide 2021" covers such topics as:

What's new for Medicaid in 2021?

What about COVID-19?

Who is eligible for Medicaid?

How do you apply for Medicaid?

Do you need to lose your job to be eligible for Medicaid?

Where do you get a Medicaid application?

What are the cheapest forms of health insurance?

What is CHIP?

Is it too late in my state to sign up for the Affordable Care Act (Obamacare)?

"Rules change every year," said Jon Jensen, General Manager of America's Pharmacy. "And with the on-going effects of the COVID-19 pandemic, government sites can be trickier to navigate than ever. We've reviewed these government Medicaid sites for you and updated our consolidated data and links for 2021."
"This free new-for-2021 eBook includes information data on kinds of insurance that no everyone knows about, such as short term medical, and Affordable Care Act options available through state marketplaces," Mr. Jensen continued. "In this uncertain time, people deserve whatever help they can get making sense of our government and private health care systems."
To get the eBook, simply go to https://www.americaspharmacy.com/Plan2021. The eBook is free and does not require registration.
About America's Pharmacy
America's Pharmacy is a free prescription discount program created to help United States residents save money at more than 62,000 pharmacies nationwide. Consumers can save up to 80% instantly, with no limitations, registrations, and no member fees. Patients can check prices at most pharmacies in any zip code with a single click.
Our Lowest Prices on Prescription Medications
Consumers looking to save on their medication can go to https://www.americaspharmacy.com/card to download a free pharmacy discount card. The card is honored at more than 62,000 pharmacies nationwide, including CVS, Walgreens, Walmart, Rite Aid, Target, and Kroger stores (just to name a few). The free America's Pharmacy app is available for iOS and Android at https://www.americaspharmacy.com/download.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Nalu Medical, Inc. ("Nalu"), a company that provides miniaturized neuromodulation implants for the treatment of chronic pain, has received FDA 510(k) clearance for expanded labeling that allows for full-body 1.5 Tesla (T) magnetic resonance imaging (MRI) in individuals with select Nalu Spinal Cord Stimulation (SCS) implants.

CARLSBAD, CALIF. (PRWEB) DECEMBER 04, 2020
Nalu Medical, Inc. ("Nalu"), a company that provides miniaturized neuromodulation implants for the treatment of chronic pain, has received FDA 510(k) clearance for expanded labeling that allows for full-body 1.5 Tesla (T) magnetic resonance imaging (MRI) in individuals with select Nalu Spinal Cord Stimulation (SCS) implants. This clearance is retroactive to currently implanted SCS patients and considered MRI-Conditional. With a conditional classification, MRI scans can be safely administered under certain conditions, such as the type of MRI scanner, implant configuration and anatomical location. The MRI safety labeling also includes 1.5T and 3T scans of the head and extremities for SCS and Peripheral Nerve Stimulation (PNS) Systems.
In today's medical practice, MRI scans are necessary and routinely performed for diagnosis and clinical care. It is very likely that a patient with chronic pain will require a future full-body MRI scan.(1,2) The clearance for full-body MRI labeling removes a potential barrier for eligible patients to select the Nalu Neurostimulation System as a means to help manage their chronic pain.
"Expanding our MRI label from head and extremity only to full-body is a significant factor for extending our reach across the United States," said Earl Fender, Nalu's President and CEO. "With this clearance, clinicians can now recommend our life-changing therapy to eligible patients with fewer concerns about future imaging. It also underscores Nalu's ongoing commitment to advance medical devices with miniaturized technology to provide meaningful differences in patients' lives."
"When evaluating neurostimulation systems best suited for my patients, I always consider their immediate and long term needs with regards to disease progression and imaging," said Dr. Dawood Sayed, MD, Associate Professor University of Kansas School of Medicine and Division Chief of Pain Medicine. "The small size and broad capabilities of the Nalu implant is something that is especially important to many of my patients. Adding full-body conditional MRI allows me to offer this effective therapy to an even greater number of patients with chronic pain, while maintaining more of my patients' available imaging options".
References:
1. Sayed D, et al. Neuromodulation. (2020) 23:893–911.
2. Desai MJ, et al. Spine. 2015;40(9):E531–E537.
About Nalu Medical
Nalu Medical, Inc. is a privately-held, early-stage medical device company located in Carlsbad, California. Our team of seasoned entrepreneurs, engineers and scientists are developing the next generation of miniaturized medical devices. Our novel devices are designed and developed upon a proprietary, versatile technology platform that will allow us to address several poorly treated clinical conditions. Our mission is to modernize, improve, and broaden the therapeutic capabilities in miniaturized medical devices, thus improving lives of people now and to meet the demands of medicine tomorrow.
About the Nalu Neurostimulation System
The Nalu Neurostimulation System is a micro-implantable pulse generator for treating individuals with chronic pain. The System, up to 26X smaller than other IPGs, utilizes the powerful nPower microchip to deliver treatment equal to larger implantable pulse generators but with additional waveforms, programming modes and upgradability. Uniquely battery-free and minimally invasive, the System offers a distinct advantage over bulky devices powered with implantable chemical batteries. The System is currently cleared by the FDA for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS). To learn more, visit http://www.nalumed.com.
Nalu, the Nalu logo and nPower are trademarks of Nalu Medical, Inc.

Adding full-body conditional MRI allows me to offer this effective therapy to an even greater number of patients with chronic pain, while maintaining more of my patients' available imaging options.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Drive through clinics offer rapid testing to diagnose infection caused by one of three viruses and supports proper course of treatment

HOUSTON (PRWEB) DECEMBER 04, 2020
As winter approaches and colder weather brings more people indoors, the risk of spreading viruses increases dramatically. A bad flu season can strain healthcare resources, and with this year's double-whammy of flu season coinciding with the raging coronavirus pandemic, healthcare workers are preparing for an overwhelming number of patients. To help accurately diagnose patients who are suffering from a range of symptoms, GMED Global, LLC, an international institution specializing in medical education and health care workforce development and solutions, today announced that it is offering 3-in-1 COVID-19 and flu testing at its three Rapid COVID Clinics. The rapid test accurately detects infection caused by COVID-19 and Influenza A and/or B viruses, helping the patient to determine the proper course of treatment.
"Infection rates for COVID-19 have been steadily rising across the United States for several weeks, and we expect the spread of the virus to spike following the Thanksgiving holiday," said Dr. Ramin Ahmadi, Co-founder and Chief Medical Officer of GMED. "Since symptoms of the coronavirus often overlap with those caused by the seasonal flu, this rapid test serves as an important diagnostic tool by identifying whether a patient has been infected and by what illness. Armed with accurate information, patients can seek appropriate medical treatment and follow appropriate precautions to prevent further spread of these viruses."
GMED's Rapid COVID Clinic utilizes the rapid Sofia 2 Flu + SARS Antigen FIA test manufactured by Quidel, one of the few rapid antigen tests in the country, and approved for emergency use by the U.S. Food and Drug Administration. The test includes a pain-free nasal swab that can be self-administered - minimizing the exposure between test takers and health care providers. This highly accurate test directly detects the presence of COVID-19 and Influenza A and/or B and test results are returned the same day.
GMED's Rapid COVID Clinic testing locations and hours are as follows:
Houston/Westbury (5556 Gasmer Dr, Houston, TX 77035)
Monday-Friday 9 am – 7 pm
Saturday and Sunday 10 am - 4 pm
Houston/Kirby (3773 Southwest Fwy, Houston, TX 77027)
Monday-Friday 7 am – 6 pm
Saturday and Sunday 10 am - 3 pm
Phoenix/Old Town Scottsdale (6940 E. Indian School Rd., Scottsdale, AZ 85251)
Testing by appointment only
Monday - Friday 8 am – 7 pm
Saturday and Sunday 9 am - 4 pm
The test does not require a doctor's referral. Individuals must schedule an appointment for the Phoenix testing site; Houston locations offer testing by appointment and on a drop-in basis.
GMED's Rapid COVID Clinic also offers on-site 3-in-1 COVID-19 and Influenza A and/or B screening to assisted living and nursing homes, area businesses, federal health clinics, and schools. Discounted rates are available to healthcare workers, dentists, law enforcement, first responders, flight crew, postal workers, and school employees with proper identification and children under the age of 17 years old.
For more information about testing locations, rules, procedures, and hours of operation, or to schedule an appointment visit http://www.rapidcovidclinic.com.
About GMED Global
GMED Global LLC is a healthcare network that works across the globe to support NGOs, hospitals, medical schools, and governments to establish training and development programs in health care and medical education. Based in Houston, the GMED network has a global reach, with offices in San Francisco, New York, New Haven, Toronto, Monaco, and Riyadh. Through a unique partnership with the Royal College of Canada, GMED's Kazan State Medical University offers a pathway for future doctors to practice medicine in North America. GMED's subsidiary businesses span the scope of the health care industry, including mobile hospital development, healthcare logistics and supply chain staffing, contact tracing, and education and testing. For more information visit https://www.globalhealthresponse.com/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss strategic options for comparator sourcing in China and critical factors to consider in designing a clinical trial program. Attendees will learn about the considerations and hurdles for running trials in China, and how to overcome them, as well as three key things to look for when choosing a sourcing partner for China.

TORONTO (PRWEB) DECEMBER 04, 2020
China is now the second-largest pharmaceutical market in the world, and with a more harmonized and efficient clinical trial approval process, it is seeing a large increase in clinical trial activity – even during the COVID-19 pandemic. Ensuring that a clinical trial supply strategy is in line with current market requirements, and that a sponsor has considered all of their sourcing options, is essential to save time, resources and reduce costs. This webinar will provide two unique insights into this strategy and the key areas to focus on for success.
The featured speakers will address sponsors' common concerns when establishing a clinical trial supply strategy in China, and provide solutions to problems that sponsors have experienced in the past, including:

Have the regulatory requirements cost time and money and delayed the clinical trial plan?

Have time, language, and cultural differences affected the efficiency of a project?

Are there concerns about quality and reliability when initiating a trial in China?

Is there uncertainty about how to assess sourcing options and determine what the best solution may be?

The challenges of running successful trials in China can be daunting, and getting comparator sourcing right from the start is essential. This webinar will focus on the key areas for success as participants hear both the pharmaceutical and service provider views on how to navigate the Chinese landscape effectively.
Join Chan Liu, Comparator Strategist Lead, Pfizer; and Philip Gregory, Vice President, Asia Pacific, Clinical Trial Services, Inceptua, in a live webinar on Monday, December 14, 2020 at 10am EST (3pm GMT/UK).
For more information, or to register for this event, visit Strategic Comparator Sourcing in China: Optimizing the Clinical Supply Chain.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Convergint Technologies, a global leader in service-based systems integration, announced the acquisition of Innovative Medical Systems (IMS), a leading value-added reseller of select acute care and technical products for hospitals. BlueWater Partners acted as the exclusive financial advisor to Innovative Medical Systems for this transaction.

GRAND RAPIDS, MICH. (PRWEB) DECEMBER 04, 2020
Convergint Technologies, a global leader in service-based systems integration, announced the acquisition of Innovative Medical Systems (IMS), a leading value-added reseller of select acute care and technical products for hospitals. This acquisition will further deepen and expand Convergint's presence within the healthcare market in the United States.
BlueWater Partners acted as the exclusive financial advisor and Miller Johnson acted as the legal counsel to Innovative Medical Systems for this transaction.
IMS brings over thirty years of critical industry expertise, an enduring dedication to serving customers with integrity, and a strong commitment to fostering innovative solutions. As part of Convergint Technologies, IMS will have access to Convergint's global network of expertise, allowing them to broaden their service offerings and solutions to current and future clients.
"What made Innovative Medical Systems such an easy decision for Convergint was their unwavering commitment to company culture and being their customers' best service provider," said Ken Lochiatto, CEO of Convergint Technologies. "We are excited to work with their colleagues, customers, and partners and to expand the work we provide in the healthcare industry with the addition of this exceptional company."
"IMS is truly excited to become a part of the Convergint family. This will be an exceptional marriage of Convergint's global reach with IMS' expertise in acute care patient safety and real-time locating capabilities," said Dan De Jong, CEO of IMS. "Our cultures complement one another, and we share the same basic approach to customer satisfaction and after-sale support. We look forward to the new opportunities we can now bring to our customers."
About Convergint Technologies
Convergint Technologies is a $1 billion global, industry-leading systems integrator that designs, installs, and services electronic security, fire alarm, and life safety systems. To learn more about Convergint, visit http://www.convergint.com.
About Innovative Medical Systems
IMS is a specialized integrator in the healthcare market, providing solutions for complex hospital hardware and software systems requiring a multi-departmental "buy-in" and after-sale support. The company offers several innovative technology solutions to healthcare facilities, including Real-Time Location Systems (RTLS), EMR battery management software, and security. IMS technology solutions are custom-designed to help healthcare facilities reduce complexity by integrating their electrical, mechanical, network, and software components, further reducing costs and streamlining workflow management processes. To learn more about IMS, visit http://www.innovative-medical.com.
About BlueWater Partners
BlueWater Partners is a middle market investment banking and consulting firm. As strategic advisors to business owners and management, BlueWater Partners works with companies to create, manage and realize business value, frequently before or through a sale or acquisition. BlueWater Partners' services include advice on mergers and acquisitions, divestitures, capital sourcing, performance improvement, restructuring and turnaround. To learn more about BlueWater Partners, visit http://www.bluewaterpartners.com




START your own Wordpress site, business or personal website, or online store at www.siteground.com

The VIC Investor Network (VIN) makes investments into companies based on technologies that can have substantial impact on human health and well-being.

FAYETTEVILLE, ARK. (PRWEB) DECEMBER 04, 2020
A newly introduced feature of the VIC Investor Network is a Secondary Market that provides VIN Standard Members early liquidity options via sales of shares to other VIN members. Learn more about VIN by registering for any of the upcoming webinars: https://hubs.li/H0BJHrc0
VIN operates as one element of a complete, nationally comprised, innovation ecosystem that mitigates the normal risk in investing in these types of high return-on-investment opportunity companies.
Every investment opportunity presented to VIN members is in a company based on an innovative technology with large commercial opportunity that has been thoroughly vetted by an experienced, successful team, following a proven business model. Each investment is offered to VIN members at an attractive investment valuation. VIN co-invests alongside VIC Technology Venture Development, which provides additional protection to VIN members compared to investing in a typical angel investor network.
The new Secondary Market provides a simple, low-overhead means for VIN Standard Members to offer their shares from VIN investments they have made for sale to other VIN members. Any VIN Standard Member may offer any portion or all of their investments for sale on the VIN Secondary Market. The VIN member sets the sale price. Other VIN members may then either select to purchase the offered shares or may make a counter-offer via the website. VIC Technology Venture Development provides regular guidance on the current valuations for portfolio companies, allowing investors to tailor their offers properly.
VIN places all individual member investments into separate holding companies for each new investment round in each VIC portfolio company being invested in. The holding companies are set up to facilitate the exchange of shares from one VIN member to another. Thus, the exchange of shares from a VIN Secondary Market transaction occurs solely within the VIN holding company and not within the given VIC portfolio company. This greatly simplifies the overall process and keeps transaction costs extremely low.
The VIC Investor Network provides important advantages for investors interested in placing investments in high-impact, high-upside companies. The addition of the VIN Secondary Market is another compelling feature of VIN membership.
About VIC Investor Network:
VIN is a nationally comprised network of accredited investors. VIC's portfolio companies are based on the most commercially promising technologies exclusively licensed from top research institutions around the world. From breakthrough medical devices to lifesaving therapeutics, VIC companies develop commercially promising products and technologies that address important problems facing society and the world. For more information, please visit http://www.vicnetwork.com
About VIC Technology Venture Development:
VIC Technology Venture Development, LLC is a technology venture development firm that creates innovative new companies with world-changing science- and engineering-based technologies. VIC carefully selects and licenses technologies from universities and research institutions around the world, then partners technology entrepreneurs with VIC's team of business and technology experts and allocates seed capital through the national VIC Investor Network. VIC provides its portfolio companies with senior management expertise, extensive knowledge of technology startups, and proven processes to execute business strategies, including legal, financial, operations, marketing, capital acquisition, and technology management. For more information, please visit http://www.victech.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

CISCRP (Center for Information and Study on Clinical Research Participation), a non-profit, is hosting a free webinar about clinical research with local partners, non-profit advocates and international organizations. The webinar has a Miami focus.

MIAMI (PRWEB) DECEMBER 04, 2020
CISCRP (Center for Information and Study on Clinical Research Participation), a non-profit, invites members of the Miami community to attend AWARE for All – Miami, a free, interactive webinar that:

demystifies clinical trials

reveals what the experience is like for participants

reviews the role and responsibilities of involved medical professionals

reinforces the critical role that individuals who participate in clinical trials play in advancing new medicines and treatments

The webinar is scheduled for Tuesday, December 8th, from 4-6pm EDT via a customized, secure online platform.
"The idea of participating in clinical trials is an unfamiliar one, for the vast majority of individuals," said Joan Chambers, Senior Director CISCRP. "Most people first learn about them at the same time they've been diagnosed with a serious illness for which no medication is adequate, or available. There's a rush for patients and their loved ones to navigate this unfamiliar terrain, in order to make the decision to participate – or not. They have to discuss options with their health care providers. Our AWARE for All programs provide vital information and insight, with a local focus, that can help."
During the free webinar, attendees learn about clinical trials straight from the patients and researchers who take part in them with a facilitated conversation and will be able to submit questions via a chatbox during the program. Dr. Rishi Kakar, Chief Scientific Officer & Associate Medical Director, Segal Trials, will be the overview speaker. There will be two 5-minute health assessments, including a breast cancer assessment offered by the Florida Breast Cancer Foundation and a mental health/depression exercise offered by Segal Trials.
A virtual health fair with over 30 local and national health and wellness organizations providing educational resources is also part of the platform.
CISCRP's AWARE for All – Miami program comes at a critically important time. Public interest in learning about clinical trials is high and the need for study volunteers in all disease conditions—including COVID-19 clinical trials—has increased significantly. Led by CISCRP and supported by local research organizations, advocacy groups and a consortium of biopharmaceutical and service provider companies, the educational program is open to all members of the public.
Paulette McDaniels shared that she participates in clinical trials because as an African American woman, she thinks it is important to bring parity to health care. She has participated in studies that focus on osteoporosis, asthma and breast cancer research. "I want to contribute to making health care better for all African Americans," she said.
"At CISCRP, helping patients and the public learn about the importance of clinical research participation is at the heart of our mission. We're extremely excited to be presenting this event with support from a diverse team of stakeholders from the Miami community," said Joan Chambers.
The AWARE for All – Miami supporters include Allergy & Asthma Network, American Kidney Foundation, Arianna's Center, k, Clinical Pharmacology of Miami, Clinical Site Partners, LLC, Debbie's Dream, Florida Breast Cancer Foundation, JDRF, Lupus Research Alliance, Myovant, NAMI, National Kidney Foundation, National MS Society, Pals for Health, Peoples Science, Segal Trials, Susan G. Komen, and the AWARE Industry Consortium.
AWARE for All – Miami Clinical Research Webinar will be held Tuesday, December 8th, from 4-6pm EDT. Attendance is free, but please register today here: https://www.eventbrite.com/e/virtual-aware-for-all-miami-2020-registration-115502951437?aff=ciscrpawarepage To learn more, visit awareforall.org or call 877-633-4376.
About CISCRP
The Center for Information and Study on Clinical Research Participation (CISCRP) is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. CISCRP provides free education and outreach to the general public and patient communities. Visit http://www.CISCRP.org for more information or to participate in CISCRP's educational initiatives. For additional questions about AWARE for All, contact awareforall@ciscrp.org or call 877-633-4376.
###

"We're extremely excited to be presenting this event with support from a diverse team of stakeholders from the Miami community," said Joan Chambers, Senior Director, CISCRP.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Online glasses supplier Bowdenopticians.co.uk has launched a new specialist range of snooker glasses specifically designed for snooker players who require corrective lenses.

BOLTON, UNITED KINGDOM (PRWEB) DECEMBER 04, 2020
Bowden Opticians have been supplying prescription snooker glasses online since 1997.
The very first pair sold was to a professional snooker player from Hong Kong, before Google days and ecommerce.
Upside Down Snooker glasses were popularised in the 80's by Dennis Taylor, they are designed in such a way as to allow optimum table top performance for snooker players requiring a prescription.
With very limited choice in the market and lack of products available, Bowden Opticians have now launched their very own brand, designed with Snooker Players and Pool Players in mind.
The Bowden Opticians Snooker Glasses Model Mark, comes in two colours gold and gunmetal, with a semi rimless construction at the top to prevent distractions from the frame.
Currently available with an anti reflective coated lens, this prevents excessive glare from the bright lights above the snooker table.
Bowden Opticians has already received great feedback from thankful snooker players who now have crystal clear vision whilst playing snooker and gives them an edge over their competitors.
For more information on the snooker glasses visit Bowden Opticians at https://www.bowdenopticians.co.uk



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Find out why this Holiday Season might be the best time to get a cosmetic procedure. Discounted prices and working from home may make this December the perfect time to give yourself a gift.

LOS ANGELES (PRWEB) DECEMBER 04, 2020
This December might be an unexpected time to get a cosmetic procedure. But with everyone encouraged to stay inside this winter, a lot of people are jumping at the opportunity to enhance their appearance while they recover comfortably at home. Working remotely makes recuperation even easier as plastic surgery patrons opt to switch off their Zoom cameras and continue working from the privacy of their homes.
Winter has historically been considered the best time of year to get Plastic Surgery because bulky clothes, turtlenecks, and scarves allow patients to conceal swelling after their procedure. The cooler weather also helps keep inflammation in check. Shorter days make staying out of direct sunlight easier, which is typically recommended after surgical procedures to minimize the pigmentation of scars.
To make this opportunity even more alluring, renowned plastic surgery practices like Wave Plastic Surgery are offering a variety of special offers on both surgical and non-surgical cosmetic procedures. Throughout the month of December, Wave is offering deals on popular non-surgical procedures like Juveau. Neuromodulators like Juveau use a purified form of botulinum toxin to relax the facial muscles and get rid of frown lines. This wrinkle-reducing treatment is the perfect way to cap off a rough year that gave a lot of us some extra age lines.
Others may want to take full advantage of working remotely and having a clear social calendar by getting a facelift. There are a number of different types of facelifts offered at most Plastic Surgery practices. Wave is offering 30% off of their Curelift procedure during the month of December. The Curelift is a Wave-exclusive mini face and neck lift that serves as an alternative to a traditional facelift. The Curelift offers natural-looking results with dramatically reduced recovery time and virtually no scarring. This winter, the ubiquity of facial masks can keep any post-surgery puffiness private.
December 2020 may seem like a hard end to a harder year, but many people are choosing to give themselves a gift this holiday season by taking years off of their appearance. This Christmas people across the country are pampering themselves with an age-defying cosmetic procedure to give them the confidence to take on the new year.
Have any questions? Schedule a Virtual Consultation at WavePlasticSurgery.com or Call 888-674-3001Today!



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Trusted online guide highlights the most efficient solutions for dental practices

SEATTLE (PRWEB) DECEMBER 04, 2020
Digital.com, a leading independent review website for small business online tools, products, and services, has announced the best dental software of 2021. The top firms were selected based on key features and reporting capabilities.
Each software company was required to offer appointment management tools that can automate scheduling and send reminders to patients. The guide also examined solutions that support integration with accounting, customer relationship management, and other systems. Additional qualifications include reporting functions that track inventory and identify the most profitable services.
"Many successful practices use dental software to save time, increase efficiency and prevent no-shows or late arrivals," says Josephine Miller, PR Manager of Digital.com. "This guide provides an in-depth review of the most reliable solutions for dental offices."
Researchers at Digital.com conducted a 40-hour assessment of over 60 companies from across the web. To access the complete list of best dental software, please visit https://digital.com/dental-software/.
Best Dental Software of 2021
-Curve Dental
-Denticon
-DentiMax
-Dentrix
-Dentrix Ascend
-Dovetail
-Lighthouse 360
-MatrixRay & TeleRay
-OpenEMR
-Planmeca Romexis
-RevenueWell
-RXNT
-Solutionreach
-tab32
-Weave
ABOUT DIGITAL.COM
Digital.com reviews and compares the best products, services, and software for running or growing a small business website or online shop. The platform collects twitter comments and uses sentiment analysis to score companies and their products. Digital.com was founded in 2015 and formerly known as Review Squirrel. To learn more, visit https://digital.com/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Published in the new issue of JOI, an AAID white paper outlines guidelines and recommendations for mitigating the risk of COVID-19 for dental implant patients.

LAWRENCE, KAN. (PRWEB) DECEMBER 04, 2020
Journal of Oral Implantology – The coronavirus pandemic has caused a major effect on the utilization of dental services which could not only impact patient's oral health but systemic health as well. In 2020, during the outbreak of COVID-19 infections, dentists had been advised to only perform dental treatment in a "dental emergency" to prevent the spread of the SARS-CoV-2 virus. In a recent white paper, published in the Journal of Oral Implantology (JOI), the authors detail the SARS-CoV-2 virus, its potential harm to patients and practitioners, recommendations and guidelines for mitigating the risk of infection, and what constitutes a dental implant emergency.
Individuals infected with COVID-19 display symptoms up to 14 days after infection with upwards of 60% of carriers never displaying symptoms at all. Therefore, all patients must be treated as if they were a potential spreader of the virus. The SARS-CoV-2 virus is spread through saliva in the form of breathing, speaking, coughing, or sneezing with transmission dependent on quantity, size, distance, and environmental factors such as air circulation, humidity, etc. Due to the nature of their work, dental professionals are at a high risk of contracting or passing an infection on to patients.
The authors of this study, James L. Rutkowski, DMD, PhD, Editor-in-Chief of JOI, Daniel P. Camm, DDS, and Edgard El Chaar are all distinguished members of the dental community and belong to the American Academy of Implant Dentistry. Using peer-reviewed clinical studies, Centers for Disease Control and Prevention, World Health Organization, Occupational Safety and Health Administration, and United States Environmental Protection Agency guidelines, the authors provide general recommendations for practices specializing in implant dentistry including prevention, patient prioritization, air filtration, patient assessment, disinfectants, and more; finding that hypochlorous acid (HOCl) is an inexpensive and efficient method of disinfectant. The white paper also reviews ideal dental treatment guidelines and mitigation consideration specific to implant practice including invasive implant procedures, procedural preparation of the patient, simple implant procedures, Personal Protective Equipment, and more.
When the term "dental emergency" is not clearly defined by governmental leaders, dental specialty associations should define what constitutes an emergency and subsequent emergency care. In the case of implant dentistry, procedures are generally regarded as elective and do not qualify as an emergency however, long term delay of implant treatments may lead to implant failure and negatively impact the patient's health. In this white paper, the authors describe a dental implant emergency as "an issue involving the teeth, dental implants, and/or supporting tissues that would be, if left untreated, harmful to the patient's oral or systemic health in the near-term."
While delayed dental care is sometimes necessary, it is only recommended in areas of heightened outbreaks of COVID-19. When proper precautions are taken, including proper PPE and facility protection, infection prevention is highly successful for both practitioner and patient.
Full text of the article "AAID White Paper: Management of the Dental Implant Patient During the Coronavirus Pandemic and Beyond," Journal of Oral Implantology, is available at https://doi.org/10.1563/aaid-joi-D-20-00316.
###
About the Journal of Oral Implantology
The Journal of Oral Implantology is the official publication of the American Academy of Implant Dentistry and of the American Academy of Implant Prosthodontics. It provides valuable information to general dentists, oral surgeons, prosthodontists, periodontists, scientists, clinicians, laboratory owners and technicians, manufacturers, and educators. The JOI distinguishes itself as the first and oldest journal in the world devoted exclusively to implant dentistry. For more information about the journal or the AAID, please visit http://www.joionline.org



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Renowned Houston plastic surgeon has received this honor every year since 2016

HOUSTON (PRWEB) DECEMBER 04, 2020
Showcasing his dedication to the craft of plastic surgery and patient care, board-certified Houston plastic surgeon Paul Vitenas, Jr., M.D., F.A.C.S. has been named a Castle Connelly Top Doctor in 2020, for the fifth consecutive year. Dr. Vitenas continues to impress colleagues and patients, resulting in his inclusion on the Top Doctors list for five years in a row. Only about 60,000 doctors (of around 850,000) in the United States are selected for this honor each year, across all specialties.
The Top Doctors selection process is rigorous and is designed to recognize only the best of the best. Doctors are nominated by their peers before a physician-led committee reviews the nominations and selects the doctors who will make the list. Doctors who are ultimately included are experienced yet innovative and have made an ongoing commitment to providing quality care.
The Castle Connelly Top Doctors list is extremely prestigious because it is unbiased. Doctors cannot pay to be on the list and the selection process is free from conflicts of interest. The committee evaluates each nominee using a huge number of factors, from education and research history to professional reputation, disciplinary history and outcome data. Prospective patients can enjoy peace of mind when looking for a new physician through Castle Connelly because only the top doctors in each state make the list. It is a reliable source of information for anyone who needs medical care.
Dr. Vitenas prides himself on his approach to cosmetic medicine. At Vitenas Cosmetic Surgery, he has been offering patients customized procedures since 1990. Although Dr. Vitenas has decades of experience in private practice, he is committed to staying on the cutting edge of aesthetic medicine and introducing advanced technology to his practice whenever necessary.
Known as one of the top plastic surgeons in Texas and the country as a whole, Dr. Vitenas offers patients a range of effective procedures. He is known for his incredible breast surgery results, from breast augmentation to breast lifts and reductions. He offers a range of body contouring and rejuvenation procedures such as liposuction, mommy-makeover and vaginal rejuvenation. Dr. Vitenas is also an extremely skilled facial surgeon, performing facelifts, rhinoplasty, fat transfer, blepharoplasty and more.
Dr. Vitenas was trained at Tulane University and is board-certified by the American Board of Plastic Surgery. Over the years, he has earned a huge number of awards through his work at Vitenas Cosmetic Surgery. He also runs and oversees a state-of-the-art medical spa, Mirror Mirror Beauty Boutique, which is known for incredible non-surgical treatments like CoolSculpting. Dr. Vitenas works with top medical professionals to deliver unparalleled, customized care at both facilities.
Patients at Vitenas Cosmetic Surgery and Mirror Mirror Beauty Boutique know just how dedicated Dr. Vitenas is to their results and well-being. If you would like to learn more about any of the procedures Dr. Vitenas offers, visit the Vitenas Cosmetic Surgery website or call 281.484.0088 today.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Gwinnett Family Dental Care is pleased to announce that Dr. Dafna Lapidot has become the newest member of their skilled dental team.

LAWRENCEVILLE, GA. (PRWEB) DECEMBER 04, 2020
Gwinnett Family Dental Care is located at 3455 Lawrenceville Highway in Lawrenceville, GA. This well-respected practice is an established and trusted provider of complete dental care, including general and preventative services, as well as restorative and cosmetic dentistry for all ages. The team of dental professionals at Gwinnett Family Dental Care are excited to welcome Dr. Dafna Lapidot to the practice. She graduated from Georgia State University and then received her MBA from Augusta University. Dr. Lapidot earned her dental degree from the Dental College of Georgia. She is a member of the Georgia Dental Association, American Dental Association and the Academy of General Dentistry. Dr. Lapidot feels it is very important to be involved in many different aspects of continuing education, since dentistry is an ever-changing field. Staying up to date on procedures allows her to provide the best service possible to patients. She believes that overall health is closely tied to oral health, and as a result, her goal as a dentist is to provide for her patients' general wellbeing. Dr. Lapidot adds an additional benefit to her patients with being fluent in both English and Hebrew.
"I am looking forward to providing compassionate, comprehensive and individualized dental care to my new patients," says Dr. Dafna Lapidot
More about Gwinnett Family Dental Care:
Gwinnett Family Dental Care's team of dentists are trained in multiple facets of dentistry and provide a full menu of dental services under one roof. From routine dental cleanings and emergency dental care to oral surgery, smile makeovers and other advanced treatments, the team maintains an unwavering commitment to delivering patient-centered dental care in a comfortable and rewarding environment. With patient satisfaction as a top priority, the Lawrenceville practice has invested in some of the latest dental technologies available, including the Druformat scan machine for customized mouth-guards and on-site whitening, soft tissue laser devices and CEREC one-visit dentistry for crowns and bridges. The practice offers flexible scheduling, easy financing options and a multi-lingual staff to ensure dental visits are as stress-free as possible.
For more information about Dr. Dafna Lapidot or the services offered at Gwinnett Family Dental Care, please visit http://www.gwinnettfamilydentalcare.com or call (770) 921–1115.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

LRF Scientific Advisory Board Members Joined by Current and Former Grantees at the 62nd ASH Annual Meeting & Exposition

NEW YORK (PRWEB) DECEMBER 04, 2020
The Lymphoma Research Foundation (LRF) – the nation's largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive portfolio of education programs, outreach initiatives, and patient services – will return to the American Society of Hematology (ASH) Annual Meeting and Exposition, with nearly 70 LRF affiliated scientists, including past and present members of LRF's world-leading Scientific Advisory Board (SAB) and grantees, presenting abstracts at this year's conference.
Widely regarded as the premier event in malignant and non-malignant hematology, the virtual ASH Annual Meeting, taking place December 5-8, 2020, will provide a critical forum for leading hematologists /oncologists to present their findings to over 20,000 of their peers. Among the distinguished scientists attending, more than 50 percent of LRF Scholars – participants in LRF's Lymphoma Scientific Mentoring Program – will present abstracts at the 2020 ASH Annual Meeting.
In addition to the Foundation's representation through presentations, more than 40 percent of LRF grantees (including 90 percent of LRF Scholars) are authors on abstracts selected for this year's meeting alone. In addition, LRF is represented in 596 abstracts through grantees, Lymphoma Rounds Steering Committee members, Mantle Cell Lymphoma (MCL) Consortium members, and current and former SAB members.
"The fact that we have nearly 90 percent of LRF's Scientific Advisory Board members and more than 40 percent of LRF grantees involved in abstracts at this year's ASH Annual Meeting speaks to the caliber of LRF's world-class scientists and research investment," said Andrew D. Zelenetz, MD, PhD, Chair of the LRF Scientific Advisory Board. "As Chair of this prestigious board, I am encouraged and proud of the incredible research being presented by the early career scientists we support."
The 2020 ASH Annual Meeting also featured 10 abstracts and presentations stemming from LRF-funded research and 15 COVID-19-related research authored by LRF-affiliated scientists.
"We are incredibly proud to work with and support scientists who are making strides in advancing lymphoma research," said Meghan Gutierrez, Chief Executive Officer of the Lymphoma Research Foundation. "We are grateful to have the expertise of our Scientific Advisory Board to guide our research investment and make a meaningful impact on the future of lymphoma research, which is evident in the number of investigators supported by LRF presenting at this year's ASH."
Throughout each ASH Annual Meeting, members of the Lymphoma Research Foundation Executive Team will be available for comment on ongoing ASH presentations and findings. For requests for comment, please contact Kinya Harte, Director of Communications and Marketing at kharte@lymphoma.org or 518-505-3173, or Emily Nauseda at lrf@allisonpr.com or 408-688-7227.
To learn more about the Lymphoma Research Foundation research program, visit lymphoma.org/research.
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation's largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $63 million in lymphoma-specific research. For additional information on LRF's research, education and services, visit lymphoma.org.

The fact that we have nearly 90 percent of LRF's Scientific Advisory Board members and more than 40 percent of LRF grantees involved in abstracts at this year's ASH Annual Meeting speaks to the caliber of LRF's world-class scientists and research investment.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Kenall Manufacturing and Clear-Vu Lighting have agreed to dismiss their ongoing litigation concerning visible light disinfection technology

KENOSHA, WIS. (PRWEB) DECEMBER 04, 2020
Kenall Manufacturing and Clear-Vu Lighting have agreed to dismiss their ongoing litigation* concerning visible light disinfection technology.
Clear-Vu Lighting has ceased offering for sale all products using visible light disinfection technology.
Patrick Marry, President of Kenall stated, "Kenall is pleased to resolve this long-running litigation against Clear-Vu with the removal of disinfection lighting from their product offerings. With the dismissal of this litigation Kenall has successfully concluded all outstanding complaints concerning visible light disinfection technology."
*Kenall Mfg. Co. and University of Strathclyde v. Clear-Vu Lighting LLC, Case No. 2:18-cv-01337-WFK-SIL, in the Eastern District of New York
About Kenall
Kenall is a leading manufacturer of specialized solid-state lighting equipment and controls for challenging applications in healthcare, pharmaceutical, laboratory/research, education, transportation, public access and correctional market segments.

Kenall is pleased to resolve this long-running litigation against Clear-Vu with the removal of disinfection lighting from their product offerings. With the dismissal of this litigation Kenall has successfully concluded all outstanding complaints concerning visible light disinfection technology.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Linda E. Stone of Gentle Caring Dentistry is committed to providing her patients with an enjoyable dental experience.

SCOTCH PLAINS, N.J. (PRWEB) DECEMBER 04, 2020
Providing patients with a new outlook on life is what drives NJ Top Dentist, Dr. Linda E. Stone of Gentle Caring Dentistry every day.
"As a dentist, there is no greater feeling than knowing you have truly helped someone," she says. "We have had patients tell us that they never could have imagined how much their life has improved, simply due to their smile."
Dr. Stone pays attention to the smallest details, which is something that helps set her practice apart from others. Patients are provided with 3D movie glasses during appointments, as well as complimentary nitrous oxide if needed. She has made it a point to create a hospitable environment, so going to the dentist can be an enjoyable experience for all.
Dr. Stone has put in a tremendous amount of effort to ensure patients feel safe coming to her office during the pandemic.
"We follow a thoughtful and cautious approach to interacting with patients," she says.
Dr. Stone has implemented new PPE protocols for all of her staff members. Maintaining a safe and protected environment is a priority and through extensive safety precautions, patients are comfortable and eager about scheduling office visits.
Even apprehensive patients find that Dr. Stone's added protocols are reassuring, and the staff strives to make them enjoy their experience as they receive the treatment they need and deserve.
"I strive to provide the best quality care and to show patients that going to the dentist can be an enjoyable experience," adds Dr. Stone.
To learn more about Dr. Linda E. Stone and Gentle Caring Dentistry, please visit: https://njtopdocs.com/nj-dentists/gentlecaringdentistry/
About Us
NJ Top Dentists is a division of NJ Top Docs. NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.
NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.
For more information, please click here to contact us or visit http://www.njtopdocs.com.
You can also follow us on Facebook, Twitter, & Instagram



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Environmentally and Socially-Conscious Everyday Pet Essentials Now Available 'Across the Pond' for UK-based Pet Specialty Retailers.

OCEANSIDE, CALIF. (PRWEB) DECEMBER 04, 2020
Skout's Honor, the award-winning US-based pet specialty brand known for its powerful, earth-friendly cleaning solutions and innovative, patent-pending probiotic grooming and wellness lines for pets, today announced that it is available for distribution in the United Kingdom, via a partnership with Vital Pet Group.
Vital Pet Group is the leading wholesaler and distributor for pet within the UK with a national reach of depots, cross docks and offices spanning from North Tawton in Devon to Glasgow in Scotland. The company prides itself on servicing its partners and their retail business every single day.
Through the new partnership with Skout's Honor, Vital Pet Group will supply pet specialty retailers across the UK with the popular brand's range of products including stain and odor solutions, probiotic grooming line, wellness products and pet-safe sanitizing solutions.
"With the UK's largest range of pet products and servicing thousands of independent pet shops, pet superstores, vets and e-retailers – Vital Pet was the clear partner of choice for us to cover this important region," said Shannan Morlas, Director of Sales at Skout's Honor. "We're excited to expand into the UK, which already has a strong fan-base for our brand – it will be great to finally offer our products to specialty retailers and pet parents there!"
The addition of the UK to Skout's Honor's international presence marks another milestone for the brand as it continues on a rapid growth path to reach a broader global audience of pet parents. Skout's Honor products are now available in thousands of pet specialty retailers across the United States, Canada, United Kingdom, Chile, India, New Zealand and South Africa and soon-to-be-more countries.
For national & international distribution and retail opportunities please contact Shannan Morlas, Director of Sales, at shannan@skoutshonor.com.
About Skout's Honor
Skout's Honor is an award-winning company based in Oceanside, Calif. that offers everyday pet essentials including stain and odor, grooming, wellness, training and safer sanitizing products. Founded by a team of animal lovers and proud pet owners, the company created its "Skout's Paw Pledge," and donates a day's worth of food for a shelter animal in need with every product sold. For more information on the products and for specific retailers, please visit SkoutsHonor.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Puritan Medical Products Company has been named Company of the Year, the highest honor given among Inc.'s first annual Best in Business list.

GUILFORD, MAINE (PRWEB) DECEMBER 04, 2020
Puritan Medical Products Company has been named Company of the Year, the highest honor given among Inc.'s first annual Best in Business list. Puritan was selected based on its achievements as one of two companies in the world that made the nasal swabs necessary for COVID-19 testing, as well as the rapid expansion it put in place to increase supply.
"The obstacles we faced this year have been unlike any other, and from bringing in extra workers to adding new infrastructure our team rose to the occasion time and time again," says Timothy Templet, co-owner and executive vice president of Puritan. "My grandfather laid the groundwork for Puritan in 1919 amid a global pandemic, and I couldn't be prouder to see the role we're playing today in meeting the growing need for COVID-19 testing supplies. Those of us at Puritan are ecstatic not only to receive this honor but also to continue meeting this historic challenge."
Inc. created the Best in Business Awards to honor companies that have gone above and beyond to make a positive difference. The list recognizes small- and medium-size privately held American businesses that have had a superlative impact on their communities, their industries, the environment, or society as a whole.
Instead of relying on quantitative criteria linked to sales or funding, Inc.'s editors reviewed the companies' achievements over the past year and noted how they made a positive difference in the world. The applicant pool was very competitive, with around 2,700 entries and an acceptance rate in the low single digits. Honorees for gold, silver, bronze, and general excellence across industries and categories are featured online at inc.com/best-in-business.
About Puritan Medical Products
Puritan Medical Products Co., LLC, is a 101-year-old, family-owned American company known worldwide as the trusted manufacturer of single-use products for controlled environments, diagnostics, and specimen collection, environmental, forensics, and genetics, medical, and microbiology media industries. Puritan is FDA-registered and ISO-certified. Its products help customers collect, analyze, and transport specimens with the utmost confidence in the products' clinical integrity. Puritan manufactures all of its patented flock swabs and related products in its headquarters in Guilford, Maine, USA.
https://www.puritanmedproducts.com
About Inc. Media
The world's most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across various channels, including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the Inc. 5000 allows these founders a chance to engage with their peers' in an exclusive community with the credibility to help drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

InData Labs, a data science consulting and custom AI-powered software development company, rolled out a beta version of InData Labs FaceSDK for fast and accurate face detection, recognition, and tracking. Face attribute detection feature is included.

NICOSIA, CYPRUS (PRWEB) DECEMBER 04, 2020
On the 1st of December 2020, InData Labs, a data science company with a heavy focus on computer vision, rolled out a beta version of InData Labs FaceSDK.
InData Labs founded its R&D center with a major focus on computer vision and AI in 2014. Ever since they've been developing custom AI and computer vision solutions for clients globally. The company provides solid and reliable solutions for surveillance and anti-spoofing, gaming and entertainment purposes.
InData Labs Face SDK enables real-time face detection, recognition and tracking, and now is available for integration on various devices and platforms. The AI-powered solution uses standard single or multiple cameras to detect and match faces in 0.03-0.6 seconds. The SDK is resistant to bad lighting and occlusions, which gives it a competitive edge on the market. The SDK supports any database and UI and gives software developers, manufacturers and business owners robust face recognition technology ready for use.
Face Recognition-based SDK has accurate face attribute detection — glasses, headwear, beard, moustache and masks. Mask detection feature is a healthcare-specific feature that was developed to combat the spread of the COVID-19. The feature enables real-time mask detection, and if the person isn't wearing a mask, it informs the company's management. The feature can be useful for hospitals, public transport, stadiums and other crowded places.
Other characteristics include: 1:1 and 1:N face matching, face size 112 px, face rotation up to 45⁰, face occlusion 35%, number of cameras supported – multiple (more cameras = more computing power), interpupillary distance >25 px, false acceptance rate < 0.0001%, configurable score thresholds.
The product is distributed under proprietary license and is available as a free to try beta version.
About InData Labs
InData Labs is a computer vision service provider with excellent repute on the AI and computer vision market. With 4 offices in the USA, Cyprus, Singapore and Belarus, InData Labs operates globally. The company develops bespoke solutions for Finance, Digital Health, Entertainment, Travel and E-commerce, and other industries. InData Labs helps its clients scale up their businesses with technology and take it to the next level.
You can visit the InData Labs website to learn more or try out the free demo to see how it works.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The renowned dental implant specialists at Austin Dental Implant Center offer permanent, life-changing dental implants for those suffering from bone loss in Round Rock, TX, now with or without a referral. Even patients who have been told they do not qualify for dental implants have been able to receive this treatment from Austin Dental Implant Center with zygomatic dental implants.

ROUND ROCK, TEXAS (PRWEB) DECEMBER 04, 2020
Austin Dental Implant Center provides zygomatic dental implants to Round Rock, TX and surrounding Austin, TX areas with or without a referral to help those suffering from extreme bone loss increase their eligibility for life-changing dental implants. Patients who have been told they are ineligible for dental implants have been able to receive treatment from the implant specialists at Austin Dental Implant Center because of zygomatic dental implants.
Austin Dental Implant Center is one of the few practices in the country to offer zygomatic dental implants. Their doctors not only place zygomatic implants on a regular basis, but they have also lectured on and published many scientific articles about the use of this revolutionary technology.
Because bone loss is a direct result of missing teeth, often there is not enough bone within the jaw for patients to receive dental implants. However, zygomatic dental implants are angled and longer than traditional dental implants. This allows the dental implant specialist to secure the implants into facial bones instead of the jawbone making it possible for patients with severe bone loss to receive the life-changing benefits of permanent dental implants.
"Nowadays, I can smile as much as I want to and I don't have to lift a hand in front of my mouth when I do that," says Susan, a recipient of zygomatic dental implants from Austin Dental Implant Center. "I like showing off my new teeth."
Austin Dental Implant Center not only offers specialized dental implant surgery from highly experienced implant surgeons, but also comprehensive implant dentistry from one location. Instead of requiring patients to visit multiple offices and have restorations sent to and from a laboratory, this practice brought multiple specialists together under one roof. Bone grafting, tooth extractions, dental implant placement, and high-quality restorations are all offered here. Patients receive one treatment plan from one team and one all-inclusive price that is highly competitive, if not more affordable, compared to others in the Austin and Round Rock area.
Those who have been told they are ineligible for dental implants in Round Rock and Austin, TX are encouraged to receive a complimentary second opinion from the dental implant specialists at Austin Dental Implant Center. To schedule an appointment, call 512-375-0050 or visit http://www.austindentalimplantcenter.com.
About the Dental Implant Practice
Austin Dental Implant Center was founded by Dr. Dan Holtzclaw, one of the world's leading authorities on full arch immediately loaded dental implant treatment. Using experience from thousands of dental implant procedures, Dr. Holtzclaw pioneered the DIAsmile implant teeth-in-a-day treatment concept, which allows patients to receive a new dental implant smile in just one day. With an in-house laboratory utilizing world-class Zirkonzahn technology, staff oral surgeons, staff prosthodontists, and experienced dental technicians, Austin Dental Implant Center is able to provide industry leading dental implant treatment in one convenient location, eliminating the need for patients to travel to multiple offices, as is required with most traditional dental offices. To learn more about the Austin Dental Implant Center advantage visit http://www.austindentalimplantcenter.com or call 512-375-0050.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dual-certified periodontist, Dr. Jin Kim, welcomes patients with a knocked-out tooth or missing tooth to experience the permanent benefits of a dental implant in West Covina, CA. He encourages patients unhappy with their smile to schedule a consultation with or without a referral at either of his practice locations in Garden Grove and Diamond Bar, CA.

WEST COVINA, CALIF. (PRWEB) DECEMBER 04, 2020
Dr. Jin Kim, esteemed dual board-certified periodontist, encourages patients with a missing tooth or knocked-out tooth to restore their smiles with a dental implant in West Covina, CA. He welcomes patients for award-winning care, with or without a referral, at one of his practice locations in Garden Grove and Diamond Bar, CA.
Patients who lose a tooth, especially in the "smile zone" (teeth that show when someone smiles), can experience a decline in their self-esteem and dental function. Even with a temporary fix like a flipper, bone at the site of the missing tooth will resorb and may cause adjacent teeth to shift out of place. Over time, a single missing or knocked-out tooth can lead to problems with occlusion, loosening teeth, and the increased risk of infection and gum disease. To halt or prevent these concerns, patients can choose a dental implant, which provides a permanent and functional replacement for a single knocked-out or missing tooth.
Dental implants are replacements for tooth roots that are surgically inserted into the jawbone. They provide stimulation to keep the bone healthy and dense while supporting an attached custom dental crown. A single dental implant can restore a complete smile and return proper smile aesthetics and dental function. Unlike a flipper or dental bridge, a dental implant is designed to last for decades without becoming loose, decayed, or falling out. With a restored smile, patients can once again experience greater self-confidence in teeth that improve eating, natural smile aesthetics, and oral health.
Dr. Kim is a renowned expert in dental implant treatment and is considered a worldwide leader in implant dentistry. He has placed thousands of dental implants and gained extensive experience as a periodontist and dental implant specialist. Board-certified by both the American Board of Periodontology and the American Board of Oral Implantology/Implant Dentistry, he remains at the forefront of advancements in implant dentistry. He routinely implements the latest proven technologies and techniques, such as digital x-rays and 3D dental planning software, to provide lasting treatment with stunning results. Especially for patients with a missing tooth in the smile zone, Dr. Kim's expertise in soft tissue treatments and dental implants ensures that treatment outcomes achieve optimal aesthetics as well as permanent function.
Patients with a missing tooth interested in receiving a dental implant in West Covina, CA from the world-renowned periodontist can contact either practice in Garden Grove and Diamond Bar, CA for a consultation. Appointments can be made by visiting http://www.drjinkim.com, calling 909-860-9222 for the Diamond Bar location, or calling 714-898-8757 for the West Garden Grove location.
About the Doctor
Dr. Jin Kim is a periodontist dedicated to providing personalized dental care in Diamond Bar and Garden Grove, CA. Dr. Kim attended the University of Sydney Faculty of Dentistry before furthering his education with an advanced degree in pathology from the Medical School of the same University. Dr. Kim completed a periodontics and implant surgery residency at UCLA School of Dentistry and is board-certified by the American Board of Periodontology and the American Board of Oral Implantology/Implant Dentistry. He is a past president of the Western Society of Periodontology and was also inducted to be a Fellow of the prestigious American College of Dentists and earned Fellowships in the International Congress of Oral Implantologists and the American Academy of Implant Dentistry. Dr. Kim lectures and holds faculty positions at a number of universities including UCLA School of Dentistry and abroad. He has spoken at no less than 36 different countries across the globe as well as national and international academic and clinical associations and universities including the International Association of Dental Research, American Academy of Periodontology and Academy of Osseointegration. To learn more about Dr. Jin Kim and the services he offers, visit his website at http://www.drjinkim.com or call 909-860-9222 for the Diamond Bar location or 714-898-8757 for the West Garden Grove location to schedule an appointment



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The oral surgeons of Lane Oral Surgery in Sandwich and Plymouth, MA raise awareness of the impact oral health has on the whole body. Drs. William F. Lane and William M. Lane now offer care with or without a referral to improve oral health, including dental implants and wisdom teeth extraction.

SANDWICH, MASS. (PRWEB) DECEMBER 04, 2020
Oral surgeons, Drs. William F. Lane and William M. Lane, raise awareness of the systemic impact of oral health in Sandwich, MA. They now welcome patients with or without a referral, at both their Sandwich and Plymouth, MA offices, to receive life-changing oral health care that can also improve whole-body health. These oral surgeons offer expert care to improve the health of the mouth including dental implants and impacted wisdom tooth extraction.
As oral surgeons, Drs. Lane are both passionate and experienced when it comes to oral health. Oral surgeons are medically trained doctors who spend years dedicating themselves to education on the mouth, jaw, and face. In addition to this advanced education, Drs. Lane are also highly experienced in providing care for those whose oral health is suffering. They provide expert oral care including oral pathology exams, impacted wisdom teeth extraction, and permanent dental implants.
Their education also fuels their concern for the oral health of their community. When a mouth suffers from disease and decay, it can lead to oral concerns, such as tooth loss, and systemic concerns such as diabetes or heart disease. When a mouth is missing teeth, this can cause the remaining teeth to shift, resulting in a misaligned jaw, teeth grinding, and headaches. Tooth loss can also impact the diet, preventing the ability to chew certain foods and maintain a healthy diet.
With the stress of the pandemic, new oral health concerns are arising as well. According to the American Dental Association, a majority of dental health professionals have seen a rise in stress-related oral health conditions since the onset of the COVID-19 pandemic. This includes teeth grinding, cracked or chipped teeth, and an increase in TMJ disorder symptoms. This research shows how closely the mind, body, and mouth are connected, and highlights the need for keeping the oral cavity in peak condition.
Drs. Lane provide expert oral care to keep their patients in peak overall health. For those suffering from tooth loss, they provide permanent and secure dental implants. With their own patented dental implant solution, SmileOn!, Drs. Lane can replace an entire mouth of missing teeth with beautiful, natural-looking dental implants in just one appointment. These compassionate oral and maxillofacial surgeons can also extract impacted wisdom teeth.
Patient health is the number one priority at Lane Oral Surgery. Drs. Lane not only provide leading oral health care in Plymouth and Sandwich, MA, but they maintain a safe and sanitized practice to help stop the spread of the coronavirus. The practice limits the number of patients in the office at a time and implements strict sanitization protocols. Drs. Lane are giving their best efforts to provide a comfortable and safe atmosphere to ensure that no one misses out on the oral health care they need.
Individuals looking for dental implants, wisdom tooth extraction, or other oral health care in Plymouth and Sandwich, MA can connect with the oral surgeons, Drs. Lane, for a consultation. To schedule an appointment, visit http://www.laneoralsurgery.com or call 508-746-8700.
About the Oral Surgeons
Lane Oral Surgery offers oral and maxillofacial surgical care at their offices in Plymouth, MA and Sandwich, MA. Renowned oral surgeon, Dr. William F. Lane graduated from Harvard University, received his doctorate from Boston University, and completed his residency training in oral and maxillofacial surgery in a combined program at Boston University and Tufts University. Dr. Lane created the revolutionary SmileOn! same-day full mouth dental implant solution to help patients with missing teeth regain their smile, confidence, and normal dental function. His son and esteemed associate, Dr. William M. Lane completed his medical degree from Boston University School of Medicine before graduating Summa Cum Laude from Tufts University School of Dental Medicine with his Doctor of Dental Medicine degree. He then completed his oral and maxillofacial surgery residency program at Boston University/Boston Medical Center. Together they offer a comprehensive list of high-quality oral surgical care including bone grafting, wisdom teeth removal, full mouth reconstruction, and cosmetic surgical treatments. The entire team at Lane Oral Surgery is devoted to restoring and enhancing the natural beauty of smiles. To learn more about these oral surgeons or the services offered at Lane Oral Surgery, visit http://www.laneoralsurgery.com or call 508-746-8700 to schedule a consultation.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Discover how technology is changing the way healthcare is delivered, processed, and paid.

JUPITER, FLA. (PRWEB) DECEMBER 04, 2020
Scheduled to broadcast Q1/2021, the award-winning series, Advancements with Ted Danson, will focus on recent breakthroughs in healthcare information technology.
Advancements will highlight how technology is innovating the healthcare sector as it explores Med Claims Compliance Corporation(MCC). Viewers will learn about RemitOne, its innovative documentation, coding, and claims processing platform for patient encounters which frees physicians from data entry and improves claim processing timelines – giving providers more time with patients, expanding access to quality care, and enabling the healthcare system to operate more efficiently.
"The innovative front-end clean claims processing platform, RemitOneTM, goes beyond the status quo of merely capturing the correct codes from a patient encounter. It frees the provider from the burdens that EHRs have put them under, while also freeing up the support staff that spend countless hours generating documentation and submitting claims for payments only to receive rejections due to minor edits or recently enacted changes to codes or regulations. The healthcare industry has been under extreme pressure in the past year not only due to the ever-increasing regulatory hurdles but also the strain of the pandemic. Being able to showcase a critical tool such as RemitOne and the efficiencies it provides gives us an opportunity to help our healthcare heroes breathe a little easier and get back to safely providing patient-centered care," said Julie Brown-Georgi, Chief Strategy Officer.
By capturing accurate and complete documentation at the point of care, audiences will see how the voice-enabled RemitOne removes providers from the burden of data entry, and paves the way for them to deliver higher quality, patient-centered care while also improving access for patients who need to obtain care.
The show will also explore how through increased accuracy and complete, reliable claims submission processes, RemitOne not only helps improve first-time payment rates, but also reduces pre-payment reviews. Together with improved patient access and reduced improper payments, healthcare dollars are spent in a more effective manner.
"By enabling providers to work at the top of their medical licenses, RemitOne reduces workflow burdens and increases patient engagement," said Senior Producer, DJ Metzer. "We look forward to shining a light on how technology is bringing a new level of care to patients."
About Med Claims Compliance Corporation:
MCC provides Health Information Management and Computer Assisted Clinical Documentation Improvement Services that pair with innovative technology which leverages Artificial Intelligence (AI) and Machine Learning (ML) to code claims and to analyze and interpret clinical documentation. MCC supports these efforts all the way through to medical claims remittance and payment by providing revenue cycle management services.
About RemitOne:
RemitOne is the only platform for compliant clinical documentation and coding that changes how healthcare is delivered, processed and paid. RemitOne works at the point of care as a front-end clean claims processing technology through voice-enabled AI and ML technologies that not only capture the patient encounter, but generates a structured medical record of the encounter and translates it into an electronic claim form that is submitted to the payor. This streamlined approach enables physicians to focus solely on their patients – without the burden of data entry and complex coding while knowing a high standard of regulatory compliance is upheld. For more information, visit: http://www.mccremitone.com.
About Advancements and DMG Productions:
The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today's consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.
Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.
For more info, please visit: AdvancementsTV.com or call DJ Metzer at 866-496-4065.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Lions Clubs in South and Central Texas donated equipment that will enable 1,500 more people a year to be screened for diabetic retinopathy at the Texas Diabetes Institute, a partnership of The University of Texas Health Science Center at San Antonio and University Health.

SAN ANTONIO (PRWEB) DECEMBER 04, 2020
The Lions Clubs International Foundation, in collaboration with South and Central Texas Lions Club members of District 2-A2, have increased their commitment to the prevention of blinding eye diseases with a $150,000 gift to UT Health San Antonio's Department of Ophthalmology.
The gift, augmented by $50,000 from UT Health San Antonio, recently expanded the Lion Dr. Eugene W. Eberlin Clinical Research and Imaging Facility at the Texas Diabetes Institute (TDI) Ophthalmology Clinic. The TDI, a partnership of University Health and UT Health San Antonio, is located at the University Center for Community Health, 701 S. Zarzamora St.
The 47 Lions Clubs in San Antonio and surrounding counties participated in raising funds for this vision-saving project, along with other clubs in District 2-A2.
The renovated Eberlin Facility now includes:

An ultra-wide retinal fundus camera that increases clinicians' ability to diagnose diabetic retinopathy, the leading cause of blindness in working-age adults. The retina is the tissue lining the back of the eye that senses light and sends visual information via the optic nerve to the brain, where an image is formed.

A unit to perform optical coherence tomography (OCT) angiography, which complements the fundus camera and makes it possible to non-invasively detect retinal blood circulation.

An additional eye examination lane, increasing by 1,500 the number of comprehensive evaluations that can be performed annually and decreasing patient wait time.

"We live by the phrase, 'Where there is a need, there is a Lion,'" said Lion Sam Pantusa, president and chief operating officer of the Lions Sight Research Foundation, which is supported by the 64 Lions Clubs in District 2-A2, Texas. "The most primary of our areas of service is to help the blind and visually impaired. The expansion of the Eberlin Facility is a wonderful project to help the highly regarded ophthalmic researchers and physicians serve our fellow community members who are suffering with diabetic retinopathy."
"This expansion through the great generosity of the local Lions, in collaboration with the Lions Clubs International Foundation, will allow us to continue our research, make eye care safer during the COVID-19 pandemic, and provide incredible diagnostics for our patients," said Daniel Johnson, MD, professor and chairman of ophthalmology in the UT Health San Antonio's Joe R. and Teresa Lozano Long School of Medicine.
The TDI is located in a medically underserved area of San Antonio's West Side with high prevalence of diabetes and diabetic retinopathy.
The TDI Ophthalmology Clinic conducted about 23,000 patient visits annually before the expansion and will now be able to reach 24,500.
Imaging of the eye is imperative to identify changes in blood vessels, including thickening of the vascular layers, capillary non-perfusion, leakage of plasma proteins, ischemia and proliferation of new vessels. One mode of imaging is called fundus color photography.
"The Lions' valuable support enabled the purchase of a wide-field fundus camera that allows a 200-degree view of the retina, compared to a 30-degree view afforded by our previous camera," said Jeong-Hyeon "John" Sohn, MD, director of the TDI Ophthalmology Clinic and the Retina Division of the Department of Ophthalmology.
"Not only can the new unit take images through a non-dilated pupil, but it can capture up to 82% of the retina in a single image," Dr. Sohn said. "This allows our clinicians to see at least 50% more of the retina, which is essential to diabetic retinopathy evaluation and management."
Both the fundus camera and the OCT angiography instrument enable earlier detection of diabetic retinopathy, which typically begins years before it is diagnosed, causing irreversible damage.
The imaging is easier and quicker for patients, because both pupil dilation and injection of dye to obtain images are no longer needed.
"Interestingly, we are starting a clinical study to see the effect of specific diabetes medications on diabetic retinopathy progression using the wide-field fundus camera," Dr. Sohn said.
"Words can't really express how grateful we are to the local and international Lions for providing this expansion, which will enhance our research and patient care missions," Dr. Johnson said.
The Long School of Medicine at The University of Texas Health Science Center at San Antonio is named for Texas philanthropists Joe R. and Teresa Lozano Long. The school is the largest educator of physicians in South Texas, many of whom remain in San Antonio and the region to practice medicine. The school teaches more than 900 students and trains 800 residents each year. As a beacon of multicultural sensitivity, the school annually exceeds the national medical school average of Hispanic students enrolled. The school's clinical practice is the largest multidisciplinary medical group in South Texas with 850 physicians in more than 100 specialties. The school has a highly productive research enterprise where world leaders in Alzheimer's disease, diabetes, cancer, aging, heart disease, kidney disease and many other fields are translating molecular discoveries into new therapies. The Long School of Medicine is home to a National Cancer Institute-designated cancer center known for prolific clinical trials and drug development programs, as well as a world-renowned center for aging and related diseases.
The University of Texas Health Science Center at San Antonio, also referred to as UT Health San Antonio, is one of the country's leading health sciences universities and is designated as a Hispanic-Serving Institution by the U.S. Department of Education. With missions of teaching, research, patient care and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have graduated more than 37,000 alumni who are leading change, advancing their fields, and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways "We make lives better," visit http://www.uthscsa.edu.
Stay connected with The University of Texas Health Science Center at San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.
To see how we are battling COVID-19, read inspiring stories on Impact.
About the Texas Diabetes Institute
Through a multidisciplinary approach to treatment, health promotion, patient education, professional training and research, the Texas Diabetes Institute, TDI, represents America's largest and most comprehensive center completely dedicated to the prevention and treatment of diabetes. As a collaboration between University Health and UT Health San Antonio, the Texas Diabetes Institute is directed and staffed by world-renowned specialists and equipped with the most advanced medical technology. This facility is designed to provide unsurpassed continuum of care for patients with diabetes mellitus and to conduct research to seek a cure for this debilitating disease. It is our mission to ensure healthier, happier and more fulfilling lives for thousands of men, women and children facing diabetes. Diabetes & Endocrinology Services | University Health

"This [gift] allows our clinicians to see at least 50% more of the retina, which is essential to diabetic retinopathy evaluation and management." -- Jeong-Hyeon "John" Sohn, MD, UT Health San Antonio



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dr. Eunice Wang presents results of early-phase studies of investigational targeted treatments for AML; novel menin-KMT2A inhibitor appears to be safe and well-tolerated, and FLT3 inhibitor plus low-dose chemotherapy shows promising efficacy and safety

BUFFALO, N.Y. (PRWEB) DECEMBER 05, 2020
Eunice Wang, MD, Chief of Leukemia and Director of Infusion Services at Roswell Park Comprehensive Cancer Center, is leading multiple research efforts focused on different treatment approaches for acute myeloid leukemia (AML) patients. Today, during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, which is being held virtually, she is presenting data on two ongoing studies incorporating new treatment options.
KOMET-001 (NCT04067336) is an ongoing phase I/IIA open-label study evaluating KO-539, a once-daily oral drug, in adult AML patients at Roswell Park and select other sites in the U.S. and Europe. KO-539 is a novel experimental inhibitor of the menin-KMT2A complex, which is dysregulated in acute leukemias characterized by rearrangements in the MLL gene and mutations in the NPM1 gene.
The phase I dose-escalation aims to assess safety and tolerability, characterize the pharmacokinetics, and determine a recommended phase II dose. Researchers will examine anti-leukemic activity, pharmacokinetics, safety and tolerability in patients with select genetic subtypes of AML during the phase IIA dose expansion.
"Preliminary results demonstrate that the drug appears to be safe and well-tolerated in adult patients with relapsed/refractory AML failing 3-7 prior lines of therapy," says Dr. Wang. "None of 12 patients treated to date have discontinued therapy due to toxicity. Moreover, six of eight evaluable patients to date have shown some evidence of anti-leukemic activity, with two individuals achieving complete remissions on therapy. This promising trial continues to enroll."
Dr. Wang will also present early findings from the randomized, multicenter, open-label phase III LACEWING study exploring the efficacy of gilteritinib, a FLT3 inhibitor, combined with low-dose chemotherapy compared to low-dose chemotherapy alone. Eligible patients include those with newly diagnosed FLT3 mutant AML who are considered unfit for intensive chemotherapy.
The primary objective of this study was overall survival. Secondary endpoints included event-free survival, best response, remission rates and duration, transfusion conversion and maintenance rates, leukemia-free survival, patient-reported fatigue, and safety/tolerability.
Patients in an initial safety cohort received gilteritinib (80-120 mg daily) plus the low-dose chemotherapy azacitidine. Mature data presented today show that 10 of 15 patients (67%) achieved a complete response or complete response, with incomplete count recovery on therapy with a median overall survival of 10.4 months. The adverse events observed by researchers were hematologic and no new safety signals have been associated with gilteritinib (120 mg daily) when combined with azacitidine.
Enrollment in the randomized portion of the LACEWING trial is ongoing, with 136 of 250 anticipated patients accrued to date. Patients in this group will be randomized 2:1 to receive oral gilteritinib in combination with azacitidine. Based on data from the safety cohort, patients will receive a gilteritinib dose of 120 mg daily alongside low-dose chemotherapy.
"It's encouraging to see signals of efficacy and evidence of good tolerability in these emerging treatment options, especially for subgroups of patients with AML whose cancers have been especially resistant to other therapies," notes Dr. Wang.
ASH 2020 Presentation Details:
Preliminary Data on a Phase 1/2A First in Human Study of the Menin-KMT2A (MLL) Inhibitor KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Abstract 115
Presenting author: Eunice Wang, MD, Roswell Park Comprehensive Cancer Center
Time/date: Saturday, Dec. 5, 10:30 a.m. PST
Session: 616, Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel promising therapies for relapsed/refractory AML
Phase 3, Multicenter, Open-Label Study of Gilteritinib, Gilteritinib Plus Azacitidine, or Azacitidine Alone in Newly Diagnosed FLT3 Mutated (FLT3mut+) Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Induction Chemotherapy
Abstract 27
Presenting author: Eunice Wang, MD, Roswell Park Comprehensive Cancer Center
Time/date: Saturday, December 5, 8:15 a.m. PST
Session: 616, Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel combination therapies in treatment of newly diagnosed AML
For an online version of this release, please visit: https://www.roswellpark.org/newsroom/202012-roswell-park-leukemia-chief-shares-promising-findings-new-treatment-options-ash
Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer's grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at http://www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@RoswellPark.org.

It's encouraging to see signals of efficacy and evidence of good tolerability in these emerging treatment options, especially for subgroups of patients with AML whose cancers have been especially resistant to other therapies.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Every Elf wrapping up a UV light wand has access to the QuantaDose UVC test card that takes the confusion out of spotting fake UVC light stocking stuffers. Gifting a genuine UV sanitization wand just got easier with QuantaDose's 2 part reusable UVC test card with toll-free UV test card technical support in the USA available to all holiday shoppers.

CHICAGO (PRWEB) DECEMBER 05, 2020
Quanta X Technology, the parent company of QuantaDose, CEO Katie Webb suggests, "Anyone in Santa's shoes gifting a UVC device to a friend or family member needs to make sure the UV-C device is real, and they also need to understand the potential dangers when using a UVC device for disinfecting objects and surfaces. Real UV-C lights aren't toys made by Santa's elves as UVC light can damage your eyes in seconds and burn your skin."
"In fact, UV-C light is a well-known carcinogen, and some UV light devices will produce ozone as a result of 184nm light from the mercury spectrum line escaping a quartz glass tube. Ozone producing UV lights require even more safety precautions that are worth checking twice — to see if your UV products being gifted this holiday season are naughty or nice," said Webb.
According to QuantaDose, "confusion has found the most fertile of breeding grounds as consumers attempt to weigh virus prevention advice coming at them from all directions during the COVID-19 pandemic."
The 1961 novel Catch 22, by author Joseph Heller, may have said it best: "In confusion there is profit." 2020 has been like no year in modern history as shoppers put their blind faith into the claims of untested personal protection devices sold online that can make the difference between life or death in an outbreak.
In this confusion, profits have soared for online retailers like Amazon that offer an almost unlimited selection of sanitizing products. Many devices sold by third-party sellers on these marketplaces make unverified claims regarding UV disinfecting power wavelengths used in these devices for virus protection. As it turns out, there is no shortage of fake UV disinfection products on the market.
The QuantaDose UVC light test card aims to reduce consumer confusion when choosing a real UV-C light solution capable of meeting their cleaning needs. World-class phone support is even available from a toll-free number on the back of the QuantaDose UV-C test card (1-800-713-9004) to help consumers spot fake UVC LEDs and Lamps.
"UV light is a valuable tool providing the UV wavelength, UV power, and UV duration are suitable for the application," notes John Coates, CTO and senior research scientist at Quanta X Technology.
"The reality is that with something like a handheld UVC light wand, it's the distance, it's the intensity of the UV light, it's the wavelength of UV-C light, and the duration of UV irradiance. That's not all, said Coates," It's the surface that you're waving this UV wand over. Is it marble? Is it glass? Is it wood? Is it your mail or a face mask? This all matters... and how often is a UV light wand tested to make sure it isn't a fake UV-C light? Consumers should always confirm the UV light manufacturers UV-C wavelength and UV-C power claims", said Coates, the American inventor behind the reusable QuantaDose UVC light test card.
When you purchase a QuantaDose UVC test card, you have access to highly trained professionals in the USA at 1 800 713-9004 that can help you through whatever UV light testing or UVC setup questions you have. QuantaDose doesn't have a vested interest in the UV lights you use, only that you have real UV lights and enough power to do the job in the time you require to stay safe.
There are hundreds of different style UVC lights on the market. QuantaDose will walk you through the process of validating any of them with a live real person. Many of the support calls are answered by the QuantaDose card's inventor, so no questions are too big or too small.
Webb emphasizes, "The only bad question about testing UVC lighting is the one that isn't asked to ensure consumers are not using fake UVC lighting to protect themselves and loved ones."
"QuantaDose is here to help take any confusion out of the equation when it comes to verifying that UVC lights are real and effective virus precautions. We're here to take the mystery and confusion out of the UVC disinfection process," said Coates.
QuantaDose is available on Amazon with same day delivery in many areas in the USA. Visit the QuantaDose Amazon Store
About QuantaDose
Designed and Engineered in the USA, QuantaDose uses molecular fluorescence and the quantum confinement effect for photochromatic WPV (Word Power Visibility) technology to provide reliable UVC intensity readings in 15 seconds with instant notification of optimal UVC germicidal wavelengths. The QuantaDose UVC intensity test card relies on calibrated word legibility starting > 300 µW/cm² when the word " ULTRAVIOLET" first becomes legible during exposure to optimal UVC germicidal wavelengths.
QuantaDose UVC test cards are a basic, reliable, low cost, simple, in-house, and right out of your pocket method of monitoring UVC intensity along with verifying that the optimal UVC light wavelengths are being used in your disinfection process without spending hundreds of dollars on fragile UV and UVC light meters.
When exposed to optimal UVC germicidal wavelengths, the QuantaDose UVC test card undergoes an instant color change to glow green, where fluorescence is directly related to the energy value of the UV wavelength received. Fluorescence stops instantly when excited electrons release all photons within nanoseconds after exposure.
QuantaDose has created this specially formulated ink chemistry sensitive to only optimal UV-C, which will not fluoresce to visible light or UVA and UVB. The QuantaDose test confirms that only wavelengths between 222nn-280nm are shown in glowing green letters UV-C. QuantaDose gives you instant verification of UV-C wavelengths to avoid an increasing number of fake UVC light products on the market today.
QuantaDose UVC test cards can be purchased online from the company's website at https://www.quantadose.com.
QuantaDose 1st Edition Reusable 300 µW/cm² UVC Intensity Test Card With UVC Wavelength Indicator Test
1st Edition Available on Amazon
QuantaDose 2nd Edition Reusable UVC Test Cards 300 µW/cm² Minimum Intensity w/UVC Wavelength Indicator
2nd Edition Available on Amazon



START your own Wordpress site, business or personal website, or online store at www.siteground.com

With increasing COVID-19 restrictions around the holidays, the Raymond A. Wood Foundation, a nonprofit organization providing quality of life support to child and adult brain tumor survivors, joins forces with Santa Claus to provide one-on-one Zoom sessions. Now children have an opportunity to let Santa know what they are hoping to find under their trees this year...virtually!

OCEAN CITY, MD. (PRWEB) DECEMBER 06, 2020
With increasing COVID-19 restrictions around the holidays, the Raymond A. Wood Foundation, a nonprofit organization providing quality of life support to child and adult brain tumor survivors, joins forces with Santa Claus to provide one-on-one Zoom sessions. Now children have an opportunity to let Santa know what they are hoping to find under their trees this year...virtually!
Parents are invited to visit ZoomtotheNorthPole.org,and book a 5 minute session with Mr. Claus for a small donation to the foundation. Santa will join via Zoom meeting straight from the North Pole, ready to hear wish lists from around the country. The sessions take place on Saturdays and Sundays, from 11am - 2pm EST through December 19th.
"Many of the patients we serve are children that fall in the COVID high risk category due to conditions caused by brain tumors or the treatment of them," said Amy Wood, RAWF executive director. "We wanted to keep up the holiday spirit for those kids that have been in quarantine for so long and figured it would be a great opportunity for all children to get some time with Santa, despite the pandemic."
Santa kicked off his virtual visits last weekend with meetings with boys and girls hoping for new Lego sets, virtual reality games and drones but Santa also fielded quite a few questions about how reindeer fly and if he could get caught on camera on Christmas Eve.
One mom wrote, "This is HANDS DOWN the BEST Santa visit we've ever had - thank you so much! Santa was perfect and so kind! Loved all his answers to the kids' questions."
Parents can book visits with Santa by going to ZoomtotheNorthPole.org. All proceeds benefit the Raymond A. Wood Foundation, a Maryland-based nonprofit organization that helps brain tumor survivors nationally and globally, who face challenging lifelong chronic conditions from tumor treatment while providing caregiver support. For more information, visit rawoodfoundation.org

"Many of the patients we serve are children that fall in the COVID high risk category due to conditions caused by brain tumors or the treatment of them," said Amy Wood, RAWF executive director. "We wanted to keep up the holiday spirit for those kids that have been in quarantine for so long."



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Emanate Health Queen of the Valley Hospital in West Covina has received certification as a Primary Plus Stroke Center (PSC+), which allows the hospital to provide complex stroke care including emergency thrombectomies to remove blood clots.

WEST COVINA, CALIF. (PRWEB) DECEMBER 06, 2020
Emanate Health Queen of the Valley Hospital in West Covina has received certification from DNV-GL Healthcare as a Primary Plus Stroke Center (PSC+), reflecting a high level of competence for treatment of complex and serious stroke events. DNV-GL is one of the two most prestigious stroke care certification entities in the country.
The PSC+ Program Certification includes all the requirements of the Primary Stroke Program (PSC) with the addition of thrombectomy capabilities, medical staff and metric requirements that are in a comprehensive stroke program. A thrombectomy is an interventional procedure for the removal of a blood clot from an artery or vessel.
"This designation demonstrates Emanate Health's commitment to provide stroke victims in the San Gabriel Valley with the best possible care in their immediate community," said Emanate Health CEO Robert H. Curry. "Time is brain and by offering this high level of care at Queen of the Valley Hospital allows stroke victims to receive emergency care far sooner instead of ambulance transport to a distant facility elsewhere."
According to the American Stroke Association, about 795,000 Americans each year suffer a new or recurrent stroke. That means, on average, a stroke occurs every 40 seconds. Stroke kills more than 137,000 people a year and is one of the leading causes of death. On average, every four minutes someone dies of stroke and is a leading cause of serious, long-term adult disability. Because stroke affects blood flow to the brain, response time and immediate treatment is crucial to limiting the extent of long-term damage.
DNV-GL's new stroke care certification is for organizations that meet the requirements of the primary stroke program and are fully thrombectomy capable but cannot quite meet the Comprehensive Stroke Center requirements due to reasons such as volume requirements or capability to provide full services, as required.
Queen of Valley Hospital received a rigorous on-site review in October 2020 to determine if it complied with stroke-care standards and requirements established by DNV-GL Healthcare. This certification from DNV-GL validates the hospital stroke program at the highest level of quality and capability to deliver optimal patient outcomes and safety.
"We're grateful for this certification because it's a critical step on our road for Emanate Health to become a Comprehensive Stroke Center and we're confident that we'll achieve this designation soon," Curry said.
Queen of the Valley Hospital is working to become a Comprehensive Stroke Center by demonstrating that it has the highest level of infrastructure, imaging capabilities, specially trained neurology specialist and staff ready at all times to treat complex strokes and provide specialized treatment options including medications and neuro-intervention procedures available 24/7.
About Emanate Health
Emanate Health, http://www.emanatehealth.org, is the largest nonprofit health care provider serving the one million residents of the San Gabriel Valley in California. The system provides specialized care in Behavioral Health, Cancer, Cardiovascular, Emergency, Neuroscience and Stroke, Orthopedics, Sports Medicine, and Women's Health. Its family of hospitals and hospice include Emanate Health Inter-Community in Covina, and Emanate Health Queen of the Valley in West Covina, Emanate Health Foothill Presbyterian in Glendora, Emanate Health Hospice and Emanate Health Home Care in West Covina, as well as other clinics throughout the region. Year after year the health care system has been voted "Best Hospital" and "Best Place to Work" and providers are consistently among the "Top Doctors" in Los Angeles County and hospitals are graded A for Patient Safety by The Leapfrog Group. Visit emanatehealth.org, our Newsroom and connect with us on LinkedIn │Twitter│ Instagram │ Facebook.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Tracy Lannan, a registered nurse for over three decades, has invented the Spike-Guard, a newsafety product that helps prevent dangerous IV fluid spills, thereby protecting patients and hospitalworkers alike.

DERRY, N.H. (PRWEB) DECEMBER 07, 2020
Tracy Lannan has recently conceived of the Spike-Guard, a unique protective device for intravenous (IV) units commonly found in hospitals, clinics and increasingly in remote/home use as well. As a longtime oncology nurse, Ms. Lannan is well aware of the day-to-day responsibilities and dangers faced by cancer patients and their caretakers. For many years, she has noticed that, by and large, the medical equipment industry has been neglecting the less-than-secure connection points between intravenous medication tubing and the bag or bottle containing medication/blood product.
The top of the IV drip structure has what's called a "spike end" that is then linked up to an IV bag or bottle. It is that point of connection, as well as the one further down extending to the drip chamber, that have been problematic in Ms. Lannan's experience. While other safety issues pertaining to IV therapy have been addressed to one degree or another, Ms. Lannan noticed that those particular points of connection remain as tenuous and unreliable as ever. As such, they continue to generate unpleasant, unsanitary and, considering that some of the treatment fluids in question cost over $20,000 per bag, costly surprises for her and millions of other healthcare workers and patients throughout the country.
Indeed, from messy spills of costly chemotherapy/immunotherapy/biotherapy fluids to safety-related complications that make remote IV therapy less viable and comfortable, Mrs. Lannan has witnessed the consequences of this problem firsthand. Unfortunately, it is not uncommon for cancer patients and others who undergo IV therapy to feel frail and lightheaded. When such incidents occur as they are walking with an IV structure beside them, they may grab the tube for support and inadvertently disconnect it from the IV bag or bottle, the contents of which may proceed to spill, as Lannan's patent application describes the hazard, "onto the patient, the furniture, the floor, the IV pump, and/or soaking the patient's clothing."
As suggested by its name, Lannan's patented Spike-Guard invention helps guard against such accidents. Consisting of an attachable clamp, the device is able to secure the spike by clamping it to the neck of a medication bottle or the stem of a medication bag. The Spike-Guard stabilizes the IV structure in a manner that can withstand the pressure of, for example, a patient grabbing on to a spike for support and does so for both connection points. Furthermore, as both the top and bottom clamps are removable, the Spike Guard is fully portable, versatile and suitable for use on multiple IV structures, if needed. As well, its application is simple enough for almost all patients to complete themselves, such as for cancer patients undergoing remote IV therapy of some sort.
Presently, Mrs. Lannan is communicating with various industry and regulatory stakeholders about the safety benefits of her breakthrough innovation. If you or your organization would like to reach out to her, you may do so through her new website, Spike-Guard.com (http://www.spike-guard.com). As well, through that site, you can gain access to additional Spike-Guard materials – including a brief demonstration video.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Annual competition gives ANCA customers a chance to build brand recognition and showcase their skills, innovation, and creativity globally.

BLOOMFIELD HILLS, MICH. (PRWEB) DECEMBER 07, 2020
ARCH Cutting Tools is the winner of the ANCA Tool of the Year 2020. The annual competition gives ANCA customers a chance to build brand recognition within the industry and to push the boundaries and showcase their skills, innovation, and creativity globally. It is an opportunity to share achievements with a community that appreciates the beauty that goes along with performance in cutting tools.
"We entered to present and showcase our capabilities as a cutting tool manufacturer and to demonstrate the complex capabilities of the ANCA Tool & Cutter Grinder," said Jim Gray, President and General Manager, ARCH Cutting Tools – Latrobe. "Additionally, we entered to share with customers our own custom capabilities with solid carbide tools.
"Our entry was based on what we provide for our customers," he added, "it's multi-functional, providing the customer a single high-performance tool that's multiple tools in one. A solution-driven tool, that reduces the need for tool changes and increases productivity."
Describing being a finalist in the Tool of the Year competition, Gray said, "We feel the opportunity to compete in this worldwide competition was exciting and being one of the finalists was quite humbling. At the same time, achieving finalist status was a validation of our capabilities."
Finalist entries were measured and evaluated rigorously, using Zoller device technology to measure the contour and accuracy of the tools, and Alicona device technology for dimensional surface roughness measurement. Judging criteria included best surface finish in Ra (roughness average) value on the flute or gash surface, closeness to the nominal tolerance as stated on the drawing in terms of diameter and profile, ground to the tightest tolerance per the drawing, and overall level of complexity.
Pat Boland, Co-Founder of ANCA said, "I think of ANCA's Tool of the Year as the 'Oscars for cutting tools' and am proud to take the time to recognize and reward the creativity and skill of manufacturers globally."
"The overall winner, the ARCH Cutting Tools, entry, demonstrated excellent use of multiple iGrind operations with several complex profiles. The tool came out in front of others when compared to the DXF and measured on the Zoller for Profile OD and Runout. The surface finish measurement on the Alicona produced a superb result. The tool also stood out in terms of complexity of grinding and was a large diameter (1") multi-functional cutting tool with many features. Overall, the tool was complete - ticking every box to be the Tool of the Year winner and was an exceptional effort from the team at ARCH Cutting Tools," Pat concluded.
ANCA CNC Machines, founded in 1947, is headquartered in Melbourne, Australia and is a leading worldwide manufacturer of of CNC grinding machines, motion controls and sheet metal solutions.
About ARCH Cutting Tools
ARCH Cutting Tools is the recognized world leader in high-performance solid round and indexable cutting tools. With manufacturing facilities located throughout the United States, the company's engineering and machining facilities are dedicated to the betterment of precision machined parts, products, tools, and related supply chain processes. ARCH Cutting Tools combines the expertise of leading American manufacturing professionals and expanding technologies to serve the medical, aerospace and defense, and industrial markets.

Our entry was based on what we provide for our customers ... it's multi-functional, providing the customer a single high-performance tool ... that reduces the need for tool changes and increases productivity.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Entry into Somerset County Continues EXCEL's Regional Expansion

HACKENSACK, N.J. (PRWEB) DECEMBER 07, 2020
Excel Physical Therapy ("EXCEL"), New Jersey's premier provider of orthopedic physical therapy since 1990, continues to expand its footprint with the opening of a clinic in Far Hills, NJ. This addition marks EXCEL's entry into the Somerset County market and the company's 19th New Jersey location.
"We are excited to introduce EXCEL's signature one-on-one patient experience to a new population in Somerset County," says Gary Flink, EXCEL's Chief Executive Officer. "Moreover, our team is proud to offer personalized care in the comfort of a safe, clean environment that exceeds CDC recommendations."
Conveniently located in Far Hills Center near Perotti's Deli, the Far Hills clinic boasts a bright, open-concept design with a functional training space and socially distant treatment area. It is easily accessible for patients commuting through the Far Hills Train Station, located just down the street.
Clinic Director Angelo Scarpati, PT, MSPT, CSCS, Cert. MDT has more than 25 years of experience specializing in orthopedic and sports injuries. He enjoys helping golfers, tennis players, and endurance athletes overcome physical limitations and achieve peak personal performance.
EXCEL Far Hills is now accepting new patients. To schedule an appointment, please call 908-748-4004 or submit a request via exceltherapy.com. The Far Hills office is located at US-202, Suite 5, Far Hills, NJ 07931.
ABOUT EXCEL:
Excel Physical Therapy specializes in the provision of comprehensive physical therapy to individuals following joint replacement, arthroscopic and reconstructive surgeries, as well as spine surgeries. In addition to post-surgical therapy, we pride ourselves in the treatment of patients with non-surgical orthopedic, sports, and spinal-related injuries.
We strive to offer an exemplary model of patient care in a professional and caring environment. Our skilled staff of highly trained physical therapists have extensive experience in treating advanced orthopedic injuries, and are referred by many of the area's and nation's top physicians.
We have treated many members of the New Jersey Devils and New York Giants and are the preferred provider for the NCAA Division 1 sports program at Fairleigh Dickinson University. At EXCEL we bring the same level of expertise, experience and care to all of our patients, ranging from school-aged children to seniors to high-level athletes.
Our foundation for success has been built upon providing exceptional quality care, while maintaining an unsurpassed level of professional standards and customer/patient service.

Our team is proud to offer personalized care in the comfort of a safe, clean environment that exceeds CDC recommendations.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Roswell Park Comprehensive Cancer Center's Francisco J. Hernandez-Ilizaliturri, MD, presented findings about a novel therapy for patients with relapsed or refractory B-cell non-Hodgkin lymphoma today at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition.

BUFFALO, N.Y. (PRWEB) DECEMBER 07, 2020
Roswell Park Comprehensive Cancer Center's Francisco J. Hernandez-Ilizaliturri, MD, along with a team of researchers from other institutions, has been investigating a novel therapy for patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Dr. Hernandez-Ilizaliturri will present the team's findings today at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, which is being held virtually.
TRPH-222-100 was a phase 1 open-label, multicenter, dose-escalation study that sought to determine the safety, tolerability, and pharmacokinetics of TRPH-222 monotherapy in patients with relapsed/refractory non-Hodgkin lymphoma. TRPH-222 is a novel antibody drug conjugate targeting CD22 — a receptor found in malignant B-cell lymphoma.
"TRPH-222 is generated using a novel technology that produces a very specific and stable bond between the antibody and the anticancer chemotherapy drug. The antibody binds to the cancer cells and delivers the chemotherapy agent inside the lymphoma cells," explains Dr. Hernandez-Ilizaliturri, who is Chief of Lymphoma, Professor of Medicine and Associate Professor of Immunology at Roswell Park. "Because of the novel engineering technology used to make TRPH-222, there is very small amount of free drug in the patients and, therefore, we expected that it could be given safely and with fewer side effects than other drug conjugates previously approved by the FDA to treat cancer."
The study included a dose-escalation stage followed by a dose-expansion stage. TRPH-222 was administered intravenously once every three weeks to the study population, which included patients with diffuse large B-cell lymphoma, follicular lymphoma, mantel cell lymphoma and marginal-zone lymphoma. Single-patient cohorts received doses of TRPH-222 beginning at 0.6 mg/kg until the occurrence of a dose-limiting toxicity or a nonhematologic adverse event (grade 2 or higher). The protocol then converted to a 3+3 design, where patients were added to the study in groups of three.
As of June 30, 2020, 22 patients were enrolled in the study. Two dose-limiting toxicities have occurred. Other treatment-related adverse events of grade 3 or higher included thrombocytopenia, neutropenia, hypertension and dry eyes. The researchers observed no treatment-related grade 5 toxicities or serious adverse events. Ten patients experienced grade 1 or 2 ocular events, which resolved to grade 1 or less with dose interruptions and reductions as well as lubricant eye drops.
The pharmacokinetic profile of TRPH-222 showed a long serum half-life. To date, no anti-drug antibodies have been found in analyzed samples, and peripheral B-cells were reduced at all TRPH-222 dose levels.
Eleven patients remain enrolled in the trial. Reasons for study discontinuation were progressive disease and investigator decision. At the end of cycle 6, the researchers reported five complete responses and one partial response. Four patients with complete responses at the end of cycle 9 are now off treatment, with ongoing follow-up for safety and durability of response.
"TRPH-222-100 is the first clinical trial to evaluate the safety and efficacy of TRPH-222 as a single agent in patients with relapsed/refractory B-cell lymphoma," says Dr. Hernandez-Ilizaliturri. "Our data demonstrated that TRPH-222 was well-tolerated at the dose levels tested and very effective at disease control among patients with different subtypes of B-cell lymphoma."
These findings support additional clinical trials of TRPH-222 alone and in combination with other agents for this patient population, he notes.
ASH 2020 Presentation Details
A Phase I Pharmacokinetic (PK) and Safety Study of Trph-222 in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R NHL): Dose-Escalation Results
Abstract 701
Presenting author: Francisco J. Hernandez-Ilizaliturri, MD, Roswell Park Comprehensive Cancer Center
Time/date: Monday, Dec. 7, 1:45 p.m. PST
Session: 623, Mantle Cell and Indolent B-Cell Lymphoma – CAR-T and immunotherapy clinical studies Hematology Disease Topics & Pathways: antibodies, Biological, Follicular Lymphoma, Diseases, Marginal Zone Lymphoma, Therapies, Mantle Cell Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, DLBCL, Lymphoid Malignancies
###
For an online version of this release, please visit: https://www.roswellpark.org/newsroom/202012-novel-therapy-safe-non-hodgkin-lymphoma-patients-roswell-park-led-study-finds
Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer's grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at http://www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@RoswellPark.org.

Our data demonstrated that TRPH-222 was well-tolerated at the dose levels tested and very effective at disease control among patients with different subtypes of B-cell lymphoma.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Announcing OrthoNOW Wins Award for its Mobile App

MIAMI, FLA. (PRWEB) DECEMBER 07, 2020
OrthoNOW, a network of orthopedic immediate care centers based in South Florida has won another award for its mobile app. "We are thrilled that our new app has been acknowledged by the Health Information Resource Center," noted Eric Rylander, VP Operations at OrthoNOW.
The Digital Health Awards competition, in its 22nd year, is held two times a year. The program is organized by the Health Information Resource Center (HIRC), a national clearinghouse for professionals who work in consumer health fields. A panel of 30 judges at the 2020 Digital Health Awards selects the winners based on content, format, success and overall quality in reaching the targeted health audience. The goal of the Awards is to recognize best in class digital health resources for consumers and health professionals.
OrthoNOW Founder and Chief Medical Officer Dr. Alejandro Badia is proud that the new app is receiving attention, and more importantly, that it is working well to offer patients a more convenient and efficient tool for seeing and being treated by an orthopedic expert.
According to HIRC, "hundreds of local, state and national health-related organizations and companies enter the competition each year. Recent winners have included AARP, Aetna, American Heart Association, Bayer, Blue Cross Blue Shield Plans, Centene, CGI Federal, Cigna, CMEducation, Coffey Communications, Edelman, Geonetric, GlaxoSmithKline, HealthEd, Healthwise, Hospitals & Health Systems, Humana, Johns Hopkins Medicine, Ketchum, Mayo Clinic, NIH, Quintiles, UnitedHealthcare, Walgreens, WebMD, Wellness Council of America, and more.
The initial version of the OrthoNOW app was released in 2013 and has gone through several iterations to achieve its current broad level of functionality. The 2nd version of the app won a national award for sports medicine innovation via "Orthopedics this Week" in 2017. https://ryortho.com/2017/08/the-ten-best-sports-medicine-technologies-for-2017/The newest version of the OrthoNOW Mobile App, v3.0, was first introduced in July 2020. This updated version is compatible with Android and is available in the Google Play store. The iPhone version of the app was also updated in July 2020.
The new app has been particularly useful due to the COVID-19 pandemic, where healthcare technology has become an essential tool for providing information and care. According to Rylander, "we know that technology and telehealth methods cannot replace traditional in-person examinations. However, our digital suite is a critical component of our mission to improve access to orthopedic specialists. The app helps consumers and businesses communicate with a clinician or track progression of an orthopedic problem or specific injury."
Dr. Badia adds that, "being able to see and access all of your orthopedic medical information in one place is just one of the benefits of the OrthoNOW Mobile App. Many of our patients appreciate the features in the application, which allow them to sidestep the traditional process for setting up an appointment. Instead, with the help of the app, they can make an appointment on their terms and at the most convenient time for them."
"Rylander goes on to say that for people who wake up with shoulder pain, get injured at work, or take a spill while biking or exercising, the OrthoNOW app is tremendously helpful." The app has numerous pioneering functions that distinguish it from other technologies and telehealth offerings. For example, included in the program is an option for parents and coaches of young athletes to input information for rapid game-time decision making. For example, Dr. Badia adds, "the OrthoNOW app will provide guidance and information for coaches and other sports enthusiasts, to decide when it's time to come off of the field."
Version 3.0 of the app includes:

On My Way NOW, a way to select a clinic, order a car from Uber or Lyft, and alert the medical team that you're on your way

Referrals functionality which allows patients to be referred to an OrthoNOW clinic from primary care doctors, general urgent care centers, and even hospitals

A live Link to OrthoNOWlive telemedicine for video visits

Driving directions and location information, including hours of operation

A way to take and store pictures of your injuries and share progress with clinicians

More information about services, social media links, Q&As and more

For more information and locations, visit http://www.orthonowmobileapp.com or call (305) 262-8665.
Bios: Alejandro Badia, MD, FACS, internationally renowned hand and upper-limb surgeon and founder of Badia Hand to Shoulder Center and OrthoNOW. Eric Rylander, VP Operations at OrthoNOW. http://www.drbadia.com http://www.orthonowcare.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The dualX device expands in both width and height providing a stable foundation for spinal fusion

LAGUNA HILLS, CALIF. (PRWEB) DECEMBER 08, 2020
Amplify Surgical, Inc., a medical device company focused on innovative dual-expanding technology for the lumbar spine, is excited to announce the launch of the dualX T/PLIF 12-Degree hyperlordotic interbody cages. Dr. Nima Salari, MD, FAAOS, from Scottsdale AZ, became the first spine surgeon to implant the new hyperlordotic dualX interbody cage, a TLIF spacer that provides additional lordosis. The minimally invasive procedure was recently performed at Honor Shea Health, one of Arizona's leading hospitals and healthcare networks.
The hyperlordotic implants developed for the TLIF procedure are the company's latest innovative advancement in an effort to improve sagittal plane correction. The implants developed for TLIF procedures offer a 12-degree hyperlordotic footprint in dualX T/PLIF implants and designed to improve sagittal balance restoration capabilities.
"Offering my patients the benefit of smaller incisions and less exposure to potential complications is why I specialize in minimally invasive surgery," said Dr. Nima Salari. "For this TLIF procedure, I needed to fuse L5/S1 posteriorly due to anterior vascular anomalies. The broad footprint and 12 degrees of lordosis provided a similar advantage to an ALIF through a posterior approach."
"The launch of dualX 12-Degree option demonstrates our commitment to improving patient outcomes by commercializing innovative solutions that accommodate the need for increased lumbar lordosis. We look forward to providing more implant options in the near future," said Andy Choi, CEO of Amplify Surgical.
About Amplify Surgical, Inc.
Amplify Surgical is a privately held spinal device company located in Laguna Hills, CA. The Company focuses on developing and commercializing innovative and minimally invasive technologies for spine surgery. Amplify Surgical is a portfolio company of IntuitiveX, a life science innovation incubator.
Contact:
Andy Choi, CEO
Amplify Surgical, Inc.
info@amplifysurgical.com
765-AMPLIFY



START your own Wordpress site, business or personal website, or online store at www.siteground.com

NW Women's Fitness Club is offering the Balanced Habits KickStart nutrition program in 2021.

PORTLAND, ORE. (PRWEB) DECEMBER 07, 2020
NW Women's Fitness, a women only fitness club located in Portland, Oregon, provides a friendly, non-intimidating environment for all women. In search for a valuable nutrition solution, NW Women's Fitness is excited to bring back the Balanced Habits KickStart 28-day program to its current and prospective members.
For nearly 30 years, Balanced Habits, headquartered in Southern California, has supported over 195,000 people throughout North America to reach their health and fitness goals by educating them how to eat real food in the right portions to reach their goals.
There is no better way to start the new year than by learning key strategies on how to make everyday food improve your nutrition goals. Starting Friday, January 15th, NW Women's Fitness will kick off the 28-day nutrition program— KickStart. This short term program has always been a virtual program with zoom meetings with your KickStart community, daily use of the Balance Habits App along with weekly emails and phone calls with your food coach.
With the high-quality KickStart customized program you will receive:

The KickStart guided booklet and mobile app complete with tips, tricks, and a Food and Exercise log to ensure you get the most out of your program

Week by week meal plans, grocery lists, and recipes

Food lists in proper portion sizes to allow you to swap items and tailor everything to your needs

Personal coaching to provide guidance and accountability

Weekly Weigh-ins and Food/Exercise Journal Reviews

"At NW Women's Fitness Club, we've been searching for a nutrition solution that our entire team could stand behind to bring more value and better results to our members and local health seekers," said Alta Acosta-Carter, NW Women's Fitness BH Food Coach. "We're excited that we've partnered with a nutrition company called Balanced Habits."
After completing the 28 days of KickStart, the Certified Food Coaches at NW Women's Fitness will continue to guide, educate, and empower all members to stay on track or continue to build on their success with Balanced Habits Life. A 3, 6 or 12 month nutrition and fitness program to help you reach all of your health and fitness goals.
People can now start pre-registering to see better results in 2021!

Early Bird Registration Only $199 until January 3rd, 2021

Join NWWF in December with a Virtual Membership and pay only $99 for KickStart

Member Price after January 3rd, 2021: $239

Non-Member Price after January 3rd, 2021: $259 (non-member includes 28 day virtual and in club membership during KickStart)

To pre-register, please visit NW Women's Fitness Club's website.
More About NW Women's Fitness Club
Northwest Women's Fitness Club provides the perfect combination of energy and serenity. Their trainers and group class teachers provide support and attention to make sure women are on the right track to health and fitness. NW Women's Fitness Club strives to empower as many women as possible to improve their fitness, health and quality of life.
For more information about their virtual memberships, personal training, massage or esthetician services please visit https://www.nwwomensfitness.com/ or email sam@nwwomensfitness.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In-store product information and purchase technology platform seamlessly bridges e-commerce and in-store shopping experiences, streamlining product information to educate consumers and retail staff

NEW YORK (PRWEB) DECEMBER 07, 2020
Triple2 Digital, a full-service digital agency specializing in building and deploying software, hardware, and managed services, today announced that its Lift + Learn in-store retail technology platform, developed in partnership with retail technology company,The Peak Beyond, has been deployed at four smart cannabis retail locations in South California. In outfitting their stores with smart displays powered by both companies, these cannabis retailers are changing the way customers discover products by offering an enhanced and more informative in-store shopping experience.
"Lift & Learn technology gives discerning cannabis customers who still want the in-store experience the detailed information they crave quickly and easily," said Anthony DiPrizio, CEO of Triple2 Digital. "In providing on-site product education and allowing the customer to make purchases without the involvement of a sales associate, if desired, Lift & Learn essentially bridges the gap between the physical store and e-commerce experiences while reducing the burden on the cannabis retailer."
With Lift & Learn, customers are free to learn and engage with products independently at a pace that is comfortable for them. When a product is lifted from the display case, detailed information is immediately displayed on a nearby touchscreen. Customers who may not want to manipulate a public screen can have the same information transferred to their mobile device either via a QR code or NFC tap, at which point they can review the entire product catalog or purchase the product without having to wait in a checkout line.
The Peak Beyond pioneered this smart store concept in the cannabis industry, with the goal of disrupting the traditional model in favor of tech-forward retail spaces that make shopping easier. In tackling the developmental challenges and meeting The Peak Beyond's vision for the application, Triple2 Digital's engineering team utilized Near Field Communication technology, due to its small footprint, flexibility, rich feature set and low power consumption. Lift & Learn is currently being utilized by 4 smart stores currently with 6 more coming soon across the West Coast of the U.S., Colorado, and Massachusetts. Due to the highly scalable nature of the technology, Triple2 Digital expects it to be used for a broader range of applications beyond retail including education, gaming, healthcare, museums, music/entertainment training, and sports.
"Retail spaces are overdue for an upgrade, and the cannabis industry is the perfect proving ground for innovation," said Jeff LaPenna, CEO, The Peak Beyond. "Our customers report that our smart stores set them apart from competitors, build customer loyalty, and increase sales. Through our partnership with Triple2 Digital and their team of engineers, we successfully developed and delivered a technology platform that has the potential to reshape the retail shopping experience in the cannabis industry and beyond."
About Triple2 Digital:
Triple2 Digital is a full-service digital development agency specializing in creating game-changing software, hardware, and managed services solutions to solve real-world business problems and needs. The company works with Fortune 500 companies to pre-revenue startups and has been chosen by companies like Air France, Intel, Netflix, and Toyota for critical engineering projects. For more information, please visit http://www.triple2digital.com.
About The Peak Beyond:
The Peak Beyond, based in Northern California, develops interactive smart displays that utilize their proprietary product recognition technology to create extraordinary in-store shopping experiences. They harness technology to bridge the gap between e-commerce and brick-and-mortar stores while creating in-store environments that are exciting, convenient, and as smart as the people that shop them. Brands use The Peak Beyond smart displays to stand out in a crowded marketplace, increasing sales, and building customer loyalty. Dispensaries utilize The Peak Beyond technology to streamline operations and promote featured products. The Peak Beyond Smart Store technology offers robust data collection functionality to optimize business strategy. For more information visit http://www.thepeakbeyond.com.
Media Contacts:
Greg Kalish
GKC for Triple 2 Digital
gkalish@gkcomms.com
917-592-1942
Jen Dye
The Peak Beyond
jen@thepeakbeyond.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this webinar, the featured speaker will discuss the applications of plant-based Meatless fibres and explain how restaurants are using these meat alternatives. Attendees will learn about the latest trends and challenges in the plant-based meat market.

TORONTO (PRWEB) DECEMBER 07, 2020
As consumer interest in plant-based meat products continues to rise, food processors are looking for new ways to incorporate texturized vegetable products into their recipes. While many meat alternatives are now on the market, they're not all created equal in terms of taste, texture and flexibility in applications.
This webinar will discuss how to make excellent vegetarian or vegan meals like pasta, stir-fried dishes and salads using Meatless vegan fibres. This webinar is the last in a series of four, handling specific techniques to make tasty food products using plant-based Meatless products. Meatless is a Dutch company that has been supplying texturized vegetable products with unique qualities to the vegetarian and vegan food processing industry for over 15 years. With the flexibility of using whole foods, proteins or even pure starches as basic raw materials for their products, Meatless produces analog fish and meat replacements.
This webinar will also include a demonstration of Meatless' ability to create innovative textures out of products like quinoa and favabean, the benefits and applications of which will be presented by experienced chefs. Participants will see that this can be done with existing equipment, within cost-price limits and with very low fat contents. Additionally, the panelists will give an in-depth view of how this market is developing and what the latest trends and challenges are.
Join Jos Hugense, CEO, Meatless, in a live webinar on Wednesday, December 9, 2020 at 9am EST (2pm GMT/UK) to learn about the applications of Meatless products and how they can help food processors meet consumer demand for food products containing plant-based protein.
For more information, or to register for this event, visit Using Meatless Products in Vegetarian and Vegan Meals and Snacks.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Austin-based Restore Hyper Wellness + Cryotherapy has been named to Inc.'s inaugural Best in Business list in the Wellness Services category.

AUSTIN, TEXAS (PRWEB) DECEMBER 07, 2020
Restore Hyper Wellness + Cryotherapy (Restore) has been named to Inc.'s inaugural Best in Business list in the Wellness Services category. The Best in Business Awards were created to honor companies that have gone above and beyond to make a positive difference.
The list, which can be found in the Winter issue of Inc. (on newsstands December 29, 2020), recognizes small- and medium-size privately held American businesses that have had a superlative impact on their communities, their industries, the environment, or society as a whole.
Restore, launched in 2015 and based in Austin, Texas, has become the market leader in proactive wellness – one of the fastest-growing segments of healthcare. Their services address chronic pain, injury recovery, athletic performance, enhanced immunity, proactive wellness and healthspan. The company now has over 70 open locations across the country with plans to grow to 500 open stores by 2023.
"We are thrilled and honored to be included on Inc.'s inaugural Best in Business list," said Jim Donnelly, CEO of Restore Hyper Wellness + Cryotherapy. "This year has certainly challenged us as a company, but it has also shown the power of our mission to make Hyper Wellness services affordable and accessible to everyone in the U.S. Our customers are increasingly seeking ways to take a more proactive approach to their health."
Scott Omelianuk, editor-in-chief of Inc., says, "It's been an incredibly challenging year for companies. Across industries, businesses have had to make brutally tough decisions and face unprecedented uncertainty. That's why we knew 2020 called for a new recognition program, something to complement our annual Inc. 5000 list of the fastest-growing private companies in the country. For Best in Business, companies have prioritized tackling today's problems to lead us to a better future, even if they've struggled to stay in the black."
Instead of relying on quantitative criteria linked to sales or funding, Inc.'s editors reviewed the companies' achievements over the past year and noted how they made a positive difference in the world. They then selected honorees in more than 30 different industries--health, software, retail, business services, and more--and in age- and revenue-based categories. The applicant pool was very competitive, with around 2,700 entries and an acceptance rate in the low single digits—a huge success for these honors in their inaugural year.
Honorees for gold, silver, bronze, and general excellence across industries and categories are featured online at inc.com/best-in-business.
About Restore Hyper Wellness + Cryotherapy
Launched in Austin, Texas in 2015, Restore Hyper Wellness + Cryotherapy (Restore) is The Hyper Wellness Company and the leading retail provider of proactive wellness services in the United States. As a comprehensive health and wellness center, Restore provides whole body and localized cryotherapy, IV drip therapy, stretch therapy, mild hyperbaric oxygen therapy, infrared sauna, red and near infrared light therapy, compression therapy, blood panels, HydraFacial and Cryoskin facials, slimming and toning. In its efforts to make wellness treatments more affordable and accessible for everyone, Restore is dedicated to helping as many people as possible feel better, so they can do more of what they love.
ABOUT INC. MEDIA
The world's most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across various channels, including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the Inc. 5000 allows these founders a chance to engage with their peers' in an exclusive community with the credibility to help drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com